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Modelling human ageing: role of telomeres in stress-induced premature 
senescence and design of anti-ageing strategies 
 
João Pedro de Magalhães, FUNDP 
 
Summary 
 
Due to the duration of human ageing, researchers must rely on models such as animals and cells. 
Replicative senescence and stress-induced premature senescence (SIPS) are two cellular models 
sharing many features. Although telomeres play a major role in replicative senescence, their 
involvement in SIPS is unclear. 
 
In this work, we first wanted to investigate how accurate models of ageing are. We published a 
new model of the evolution of human ageing, which offers a refined view of the evolution of 
ageing in humans and suggests that human models should be favoured. Though studying other 
mammals, reptiles, and birds may also be useful, we conclude that lower life forms such as yeast 
and invertebrates are not representative of the human ageing process. 
 
Secondly, we wanted to elucidate the importance of telomeres in SIPS and study gene expression 
and regulatory networks. Using a telomerase-immortalized cell line, we found no evidence that 
damage specific to the telomeres is at the origin of SIPS. In our published model, neither the 
TGF-β1 pathway nor telomeres appear to play a crucial role in SIPS. We suggest that widespread 
damage to the DNA causes SIPS and propose a rearrangement of gene expression networks as a 
result of stress. Moreover, we advise caution in using telomerase in anti-ageing therapies since 
telomerase expression may alter the normal cellular functions and promote tumorogenesis. 
 
Lastly, we published strategies to integrate the modern computational approaches to research 
ageing. Although we find it unlikely that a full understanding of ageing may be achieved within 
a near future, we argue that understanding the structure and finding key regulatory genes of the 
human ageing process is possible. 
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CHAPTER 1: HUMAN AGEING 
 
1.1. Definition and history 
 
 In the context of this work, ageing is defined as an intrinsic age-related process of loss of 
viability and increase in vulnerability (Comfort, 1964). It is possible to find cases where 
“ageing” has a positive connotation, such as “ageing wine”. Herein, however, our focus is on the 
deleterious effects of ageing, what some authors call “senescence” (Finch, 1990). More 
precisely, we are concerned with human ageing, the changes that render human beings 
progressively more likely to die (Medawar, 1952). 
 Since ageing is a universal human feature, it is not surprising that since the dawn of 
civilization many have sought to avoid it. From the Babylonian epic of Gilgamesh, to Ponce de 
Leon seeking the “fountain of youth”, countless men have dreamed of finding a way to avoid 
ageing. In modern times, our goals have changed little: to understand what causes human ageing 
and how to slow, stop, and reverse this process (de Magalhaes, 2003a). Our ultimate aim is to 
understand human ageing with the prospect of delaying age-related debilitation. 
 
1.2. The ageing phenotype 
 
 The ageing process affects multiple organs and tissues (reviewed in Hayflick, 1994) and 
involves the progressive deterioration of virtually every bodily function (Austad, 1997a; Strehler, 
1999). One outcome of ageing in many species, including humans, is the exponential increase in 
mortality associated with chronological age for all members of the species and first recognized 
by Benjamin Gompertz. The most practical way to mathematically represent the effects of 
ageing on mortality rates--though not entirely accurate because, for instance, mortality rates can 
decrease at late ages--is the Gompertz equation: Rm = R0eαt where Rm is the chance of dying at 
age t, R0 is the non-exponential factor in mortality, and α is the exponential parameter (Comfort, 
1964; Finch, 1990; Strehler, 1999; Kowald, 2002). 
 Death can be unrelated to ageing. Thus, changes in parameters such as longevity, which 
measures how long an organism is expected to live, and lifespan, which represents maximum 
longevity, may or may not be related to ageing. Since ageing results in an increase in mortality, 
many interventions affecting longevity are often confused with interventions that affect the 
ageing process (Hayflick, 1994 & 2000; Kowald, 2002; Figure 1). For example, the increase in 
average longevity expectancy of the past century in most developed countries was due to a 
  
Figure 1: Mortality curves drawn based on the Gompertz equation: Rm = R0eαt. Survival 
curves for two populations with the same ageing rate (α = 0.3), but different intrinsic 
vulnerabilities (R0 = 0.001 and R0 = 0.01). The average longevity, indicated by the 50% 
survivor threshold, and lifespan are clearly different. Taken from Kowald, 2002. 
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decrease in mortality unrelated to changes in the ageing process. Although human life 
expectancy is considerably higher, the rate of ageing and thus the ageing process appear 
unaltered since the dawn of the human species (Hayflick, 1994). In addition, many unhealthy 
habits may influence mortality without affecting ageing. Though there may be specific age-
related pathologies, ageing is universal in humans. For instance, some evidence suggests that 
age-related functional decline in athletes is similar to sedentary adults (Wiswell et al., 2001). 
 A major problem in the biology of ageing is the difficulty in measuring ageing. People 
can age at different paces (Finch, 1990). A frailty index can be estimated for elderly people to 
give a better correlation with death than age (Mitnitski et al., 2002). Nonetheless, the best way to 
determine how aged someone is remains chronological age. Even if limitations exist in 
estimating ageing for an individual, through the Gompertz equation we can estimate the rate of 
ageing for a given population by the α parameter, which gives us the rate at which mortality 
increases with age (Comfort, 1964; Finch, 1990; Kowald, 2002; Figure 1). So far, all human 
populations have been found to age at approximately the same rate. Yet different species can age 
at different paces; amongst mammals, for instance, we witness about 50-fold differences in rate 
of ageing (Finch, 1990; Austad, 1997b). 
 Since ageing has multiple effects, another problem in gerontology is distinguishing 
causes from effects of ageing. Others have claimed before how the goal of gerontology should be 
to discriminate causes from effects of ageing and find the one or few physiological processes that 
control ageing (Medawar, 1955). Yet at present, such discrimination remains elusive.  
 
1.3. Theories of ageing 
 
 Although it is difficult to distinguish causes from effects of ageing, many theories have 
emerged to explain what changes lead to ageing (for an in-depth classification, please refer to 
Medvedev, 1990). At present, no consensus exists over what causes ageing, what determines rate 
of ageing, or what changes occur in humans from age 30 to 70 to increase the chances of dying 
by 32-fold. Nevertheless, some theories have gathered more experimental support than others. 
Therefore, we based our work in those theories of ageing which have the greatest amount of 
experimental evidence in their favour. 
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1.3.1. Energy consumption hypothesis 
 
 In 1908, physiologist Max Rubner discovered a relationship between metabolic rate, body 
size, and longevity. In brief, long-lived animal species are on average bigger and spend fewer 
calories per gram of body mass than smaller, short-lived species. The energy consumption 
hypothesis states that animals are born with a limited amount of some substance, potential 
energy, or physiological capacity and the faster they use it, the faster they will die (Hayflick, 
1994). Later, this hypothesis evolved into the rate of living theory: the faster the metabolic rate, 
the faster the biochemical activity, the faster an organism will age. In other words, ageing results 
from the pace at which life is lived (Pearl, 1928). This hypothesis is in accordance with the life 
history traits of mammals in which long lifespan is associated with delayed development and 
slow reproductive rates (reviewed in Austad, 1997a & 1997b). 
 Probably the biggest discovery so far in the biology of ageing was made in 1935, 
following earlier findings (Osborne et al., 1917), by veterinary nutritionist Clive McCay and 
colleagues. They discovered they could slow ageing in laboratory rats just by making them eat 
less calories while maintaining normal levels of proteins, vitamins, and minerals (McCay et al., 
1935). This process became known as caloric restriction (CR) and appears to work in many 
animals, including rhesus monkeys (Bodkin et al., 2003); it has been particularly well-studied in 
mice. From mice, we know that CR not only increases longevity and lifespan but it also 
postpones age-related diseases, decreases the rate of ageing, and delays development (reviewed 
in Weindruch and Walford, 1988; Figure 2). Doubts have for long existed on whether CR results 
from some technical artefact. One question is whether laboratory animals fed ad libitum are 
representative of wild animals; perhaps caloric-restricted mice represent a return to the normal 
food intake of wild mice (Austad, 2001a). Recent results suggest this is not the case: after 
correcting for body mass, ad libitum fed laboratory mice eat no more than wild mice. 
Importantly, even without using body mass corrections, food consumption in CR mice is 
significantly inferior to that of wild mice, so CR studies are indeed limiting the absolute and 
relative caloric intake when compared with wild mice (Austad and Kristan, 2003). Other doubts 
persist: perhaps inbred mouse stocks are not genotipically representative of wild mice and the 
inbreeding may favour ageing (Klebanov et al., 2001 for arguments); or perhaps life-extension 
due to CR derives from alterations in body fat (Barzilai and Gupta, 1999; Bluher et al., 2003 for 
arguments). Even so, CR remains the most impressive way to delay ageing in mammals, 
particularly since it derives from a very simple intervention. 
  
Figure 2: Survival curves for Group A and Group R rats. After six weeks of age, Group A rats 
(n = 115) were fed ad libitum while Group R rats (n = 115) were fed about 60% of the mean 
amount of diet consumed by Group A. Care was taken to increase the amount of vitamins in 
the diet of Group R so that vitamin intake was similar in both groups. Mean longevity in 
Group A was 701 ± 10 days and 986 ± 25 days in Group R. Maximum longevity was 963 
days in Group A and 1435 days in Group R. The initial mortality rate (IMR) measures the 
mortality rate independently of ageing and was actually higher in Group R (IMR/year = 0.02 
in group A and IMR/year = 0.029 for Group R). In contrast, the rate of ageing was different 
since α = 2.31 for Group A and α = 1.31 for Group R. Taken from Yu et al., 1982. IMR and α 
calculations taken from Finch, 1990. 
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 Interestingly, several genes have been identified in model organisms whose effects 
appear to mimic CR. The best example is probably the urokinase-type plasminogen activator. 
Overexpression of this gene in the brain of mice causes a decrease in appetite resulting in a 20% 
decrease in food consumption and body mass, and a 20% increase in longevity (Miskin and 
Masos, 1997). CR affects the endocrine system and, for instance, decreases the plasma levels of 
insulin-like growth factor I (IGF-1) and increases the levels of growth hormone (Sonntag et al., 
1999). At least four genes appear to result in a phenotype similar to CR in generally affecting 
body size, growth hormone and IGF-1, and body temperature (reviewed in Bartke et al., 2001a). 
Yet by combining CR and mutations of one of these genes--the Prop1 gene--, we witness an 
even greater increase in longevity, suggesting that distinct mechanisms may be at work (Bartke 
et al., 2001b). Recent results suggest that although the growth hormone/IGF-1 pathway is 
involved in CR, other mechanisms also operate (Shimokawa et al., 2003). 
 Although the mechanisms behind CR remain a subject of discussion, since it involves a 
decrease in calories, one obvious hypothesis is that CR works by delaying metabolic rates and 
thus serves as strong evidence in support of the energy consumption hypothesis. Body 
temperature is crucial to determine metabolic rate since the rate of chemical reactions rises with 
temperature. One common feature of animals, such as mice, rats, and monkeys, under CR is a 
lower body temperature (Weindruch and Walford, 1988; Ramsey et al., 2000), which is 
consistent with the energy consumption hypothesis. On the other hand, some evidence indicates 
that mice under CR burn the same amount of energy as controls, suggesting they have similar 
metabolic rates. These studies, however, remain controversial in the way metabolic rate--in this 
case measured indirectly through O2 consumption--is normalized to metabolic mass (McCarter 
and Palmer, 1992). One hypothesis is that CR shifts metabolic pathways (Duffy et al., 1990). 
More recent results suggest that previous studies used unreliable estimates of metabolic mass in 
their calculations and indeed CR changes metabolic rates, supporting the rate of living 
hypothesis (Greenberg and Boozer, 2000). 
 Some experiments have cast doubts on the energy consumption hypothesis. For instance, 
mice kept at lower temperatures eat 44% more than control mice and yet do not age faster 
(Holloszy and Smith, 1986). Marsupials have lower body temperatures than eutherians but, on 
average, age faster. In contrast, birds have higher body temperatures and metabolic rates than 
mammals and yet, on average, age slower (Austad, 1997a). 
 Despite its intuitive concept, the energy consumption hypothesis does not by itself 
explain ageing but it can help explain some of the observations in the biology of ageing. It is true 
that a correlation between metabolic rates and rate of ageing can be found amongst some 
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mammalian species, but still much variation is found (Austad and Fischer, 1991; Austad, 1997a, 
1997b; Table 1). In conclusion, the energy consumption hypothesis is one of the few pieces of 
the ageing process’s puzzle that we know of, even though its true relevance remains unknown. 
 
1.3.2. Free radical theory 
 
 The idea that free radicals are toxic agents was first suggested by Rebeca Gerschman and 
colleagues (Gerschman et al., 1954). In 1956, Denham Harman developed the free radical theory 
of ageing (Harman, 1956; Harman, 1981). Free radicals and oxidants--such as singlet oxygen 
that is not a free radical--are commonly called reactive oxygen species (ROS) and are such 
highly reactive molecules that can damage all sorts of cellular components. ROS can originate 
from exogenous sources such as ultraviolet (UV) and ionising radiations or from several 
intracellular sources. Since oxidative damage of many types accumulate with age, the free 
radical theory of ageing simply argues that ageing results from the damage generated by ROS 
(reviewed at length in Beckman and Ames, 1998). 
 To protect against oxidation there are many different types of antioxidants, from vitamins 
C and E to enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase. 
Briefly, antioxidant enzymes are capable of degrading ROS into inert compounds through a 
series of chemical reactions (Ames et al., 1981). The simple existence of enzymes to prevent 
damage by ROS is a strong indicator that ROS are biologically important, dangerous molecules.  
 Most experimental evidence in favour of the free radical theory of ageing comes from 
invertebrates. Transgenic fruit flies, Drosophila melanogaster, overexpressing the cytoplasmic 
form of SOD, called Cu/ZnSOD or SOD1, and catalase have a 34% increase in average 
longevity and a delayed ageing process (Orr and Sohal, 1994). Also in Drosophila, expression of 
SOD1 in motor neurons increases longevity by 40% (Parkes et al., 1998). Finally, certain long-
lived strains of both Drosophila (Rose, 1989; Hari et al., 1998) and the nematode worm 
Caenorhabditis elegans (Larsen, 1993) also have increased levels of antioxidant enzymes. 
 In addition to antioxidants, some enzymes catalyze the repair caused by ROS. One of 
such enzymes is methionine sulfoxide reductase A (MSRA), which catalyzes the repair of 
protein-bound methionine residues oxidized by ROS. Overexpression of MSRA in the nervous 
system of Drosophila increases longevity (Ruan et al., 2002) while mice without MSRA have a 
decreased longevity of about 40% (Moskovitz et al., 2001). Whether the ageing process is 
affected remains to be seen, although the results from Drosophila suggest that age-related 
decline is also delayed by MSRA overexpression. Another enzyme that repairs oxidative damage 
Table 1: Variability of life history traits amongst terrestrial mammals. Notice how the lifetime 
energy expenditure varies almost 30-fold, which is contrary to the energy consumption 
hypothesis. The longevity quotient represents longevity standardized for body size. Adapted 
from Austad, 1997b. 
 
Trait Mammalian range 
  
Size at birth (g) 0,005-91,000 
Litter weight (as % of maternal body weight) 0.003-50 
Gestation (days) 13-660 
Litter size 1-16 
Age at first reproduction 9 days-13 years 
Maximum longevity (years) 1-120 
Maximum longevity/age at first reproduction 5-122 
Longevity quotient 0.14-5.39 
Lifetime energy expenditure (kcal/g/lifetime) 40-1,100 
Mortality rate doubling time (years) 0.3-15.4 
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is 8-oxo-dGTPase, which repairs 8-oxo-7,8-dihydroguanine, an abundant and mutagenic form of 
oxidative DNA damage. Yet contrary to the results involving MSRA, when researchers knocked 
out the gene responsible for 8-oxo-dGTPase, although the mutated mice had an increased cancer 
incidence, their ageing phenotype did not appear altered (Tsuzuki et al., 2001). 
 One important discovery in gerontology was that targeted mutation of p66shc in mice 
increases longevity by about 30%, inducing resistance to oxidative damage, and maybe delaying 
ageing (Migliaccio et al., 1999; Figure 3). Although the exact function of p66shc remains unclear, 
some evidence suggests it may be related to intracellular oxidants and apoptosis (Nemoto and 
Finkel, 2002; Trinei et al., 2002; Napoli et al., 2003). In another intriguing experiment, 
transgenic mice overexpressing the human thioredoxin gene featured an increased resistance to 
oxidative stress and an extended longevity of 35% (Mitsui et al., 2002). Like p66shc, thioredoxin 
regulates the redox content of cells and is thought to have anti-apoptotic effects (Saitoh et al., 
1998; Kwon et al., 2003). Recently, mice with extra catalase in their mitochondria lived 18% 
more than controls and were less likely to develop cataracts. It remains to be seen whether these 
catalase-enhanced mice actually age slower (Martin, 2003). Moreover, the phenotype witnessed 
in a strain called senescence-accelerated mice may be related to free radical damage (Edamatsu 
et al., 1995; Mori et al., 1998). 
 Although ROS can have several sources, the cellular metabolism which takes place in the 
cell’s energy source, the mitochondrion, has been receiving great attention. Some results suggest 
that the rate of ROS generated in the mitochondria of post-mitotic tissues helps explain the 
differences in lifespan amongst some animals, particularly amongst mammals (Sohal et al., 
1990a; Ku et al., 1993; Barja and Herrero, 2000) and between birds and mammals (reviewed in 
Barja, 2002a). One pitfall of these studies is that technical limitations exist in measuring ROS 
production in isolated mitochondria. For example, none of these studies measures the levels of 
hydroxyl radical, the most reactive and destructive of the ROS; often, hydrogen peroxide (H2O2) 
and superoxide anion are measured since they can react to give the hydroxyl radical. Even so, 
such studies may not be representative of what actually occurs. 
 Since ROS are a result of cellular metabolism, then perhaps the free radical theory can 
help explain the energy consumption hypothesis. Indeed, one possible mechanism for CR is that 
animals under CR produce less ROS and therefore age slower (Weindruch, 1996). Of course that 
delayed ageing is not the only effect of CR on animals. For instance, if CR is started early in life, 
animals have delayed development (reviewed in Hayflick, 1994). Yet some evidence also 
suggests that ROS are needed for development (reviewed in Beckam and Ames, 1998), coupling 
ROS, development, and ageing. 
 
 
Figure 3: Cumulative survival of wild-type, p66shc+/- and p66shc-/- mice showing the prolonged 
lifespan of p66shc-/- mice. Taken from Migliaccio et al., 1999. 
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 Although there is evidence to support the role of ROS in ageing, there is also 
experimental evidence against it. Several attempts have been made to overexpress or knock-out 
antioxidants in mice, but the results have been largely disappointing. In some cases animals do 
not show any differences in their ageing phenotype when compared to controls (Reaume et al., 
1996; Ho et al., 1997; Schriner et al., 2000). Experiments in feeding mice antioxidants--either a 
single compound or a combination of compounds--were able to decrease oxidative damage and 
increase average longevity but none of them delayed ageing (Harman, 1968; Comfort et al., 
1971; Heidrick et al., 1984; Saito et al., 1998; Holloszy, 1998), while other studies did not 
conclude that feeding mice antioxidants increases longevity (Lipman et al., 1998). Ubiquitous 
overexpression of SOD1 in mice also failed to increase longevity (Huang et al., 2000). 
Overexpressing bovine SOD2, the mitochondrial form of SOD, also called MnSOD, in 
Drosophila slightly extends average longevity but does not delay ageing (Fleming et al., 1992). 
In fact, recent findings suggest that the influence of SOD1 and catalase in Drosophila ageing 
may had been overestimated because they only took into account short-lived strains (Orr et al., 
2003). Inactivation of peroxiredoxin 1, an antioxidant enzyme, shortens longevity in mice but 
these do not appear to age faster but rather develop more tumours and a severe haemolytic 
anaemia probably derived from protein oxidation in erythrocytes (Neumann et al., 2003). These 
results suggest that antioxidant proteins are already optimized in mammals. Indeed, correlations 
between rate of ageing and antioxidant levels in mammals are, if they exist, very weak (reviewed 
in Finch, 1990; Sohal and Weindruch, 1996). Some studies found correlations between the levels 
of certain antioxidants and longevity in mammals, but failed to find any consensus (Tolmasoff et 
al., 1980; Ames et al., 1981; Cutler, 1985; Sohal et al., 1990b). The way antioxidants can 
increase longevity but do not affect rate of ageing suggests that antioxidants are healthy but do 
not affect the ageing process, a bit like, for instance, fish oil can extend longevity without 
affecting ageing (Jolly et al., 2001). 
 One hypothesis is that the rate of mitochondrial ROS generation rather than the 
antioxidant level may act as a longevity determinant (Sohal and Brunk, 1992; Barja, 2002b). Yet, 
for instance, one recent study in Drosophila found that lowering ROS leakage from the 
mitochondria through over-expression of the mitochondrial adenine nucleotide translocase did 
not result in extended longevity. The same study failed to find differences in ROS production in 
CR flies despite these living longer (Miwa and Bran, unpublished). 
 Several pathologies exist in mice and humans derived from mutations affecting the 
mitochondrion, which often involve an increase in ROS leakage from the mitochondrion 
(Pitkanen and Robinson, 1996; Wallace, 1999; DiMauro and Schon, 2003). Yet these 
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pathologies do not result in an accelerated ageing phenotype, but frequently diseases of the 
central nervous system. One example is Friedreich’s ataxia which appears to result from 
increased oxidative stress in the mitochondria and does not ressemble accelerated ageing (Rotig 
et al., 1997; Wong et al., 1999). Deficiency of the mitochondrial complex I has been reported in 
a variety of pathologies such as neurodegenerative disorders (reviewed in Robinson, 1998). 
Cytochrome c deficiency has also been associated with neurodegenerative disorders (reviewed in 
DiMauro and Schon, 2003) as has selective vitamin E deficiency (Burck et al., 1981). Perhaps 
ROS are involved in some pathologies involving post-mitotic cells, such as neurons; another 
alternative is that mitochondrial diseases affect mainly the central nervous system due to its high 
energy usage (Parker, 1990 for arguments). Interestingly, both Drosophila and C. elegans are 
mostly composed of post-mitotic cells, which can explain why results from these invertebrates 
are much more supportive of the free radical theory of ageing than results from mice. 
 Another recent experiment raised doubts regarding the free radical theory of ageing: 
knockout mice heterozygous for SOD2 showed increased oxidative damage at a cellular and 
molecular level but did not show significant changes in longevity or rate of ageing (Williams et 
al., 1998; Van Remmen et al., 2001; Richardson, 2002). 
 Although it is undeniable that ROS play a role in several pathologies, including age-
related pathologies, the exact influence of ROS in mammalian ageing is undetermined. 
 
1.3.3. DNA damage theory 
 
 The DNA, due to its central role in life, is bound to be implicated in ageing. One obvious 
hypothesis is that damage accumulation to the DNA causes ageing (Gensler and Bernstein, 1981 
for arguments). 
 One of the most intriguing phenotypes in the biology of ageing is the accelerated ageing 
witnessed in humans and animals as a result of certain mutations. Progeroid syndromes, as they 
are called, are rare genetic diseases of which the two most impressive forms are Werner’s (WS) 
and Hutchinson-Gilford’s syndrome (Martin and Oshima, 2000). Both these diseases originate a 
phenotype that is remarkably similar to an accelerated ageing process, particularly in the case of 
WS (Goto, 1997; Figure 4). Though differences exist in terms of pathology, what most markedly 
distinguishes these syndromes is age of onset with Hutchinson-Gilford’s syndrome almost 
exclusively affecting children while WS patients normally reach adulthood. 
 Werner’s syndrome originates in a recessive mutation in a gene, WRN, encoding a RecQ 
helicase (Yu et al., 1996; Gray et al., 1997). Since WRN is unique amongst its family in also 
  
 
Figure 4: A patient with WS at age 15 and 48. Taken from the University of Washington 
Werner syndrome Home Page: http://www.pathology.washington.edu/research/werner/ 
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possessing exonuclease activity (Huang et al. 1998), it may be involved in DNA repair. 
Although the exact functions of WRN remain a mystery, it is undeniable that WRN plays a role 
in DNA biology, particularly on unusual DNA structures (reviewed in Shen and Loeb, 2000; 
Bohr et al., 2002; Fry, 2002). In fact, cells taken from patients with WS have increased genomic 
instability (Fukuchi et al., 1989). Topoisomerases are enzymes that regulate the supercoiling in 
duplex DNA. WS cells are hypersensitive to topoisomerase inhibitors (Pichierri et al., 2000a & 
2000b). As such, WS is an indicator that alterations in the DNA over time play a role in ageing. 
 As with WRN, the protein whose mutation causes Hutchinson-Gilford’s syndrome is also 
a nuclear protein: lamin A/C (Eriksson et al., 2003). Recent results also suggest that some 
atypical cases of WS may be derived from mutations in lamin A/C (Chen et al., 2003a). The 
exact functions of lamin A/C remain unknown, but it appears to be involved in the biology of the 
inner nuclear membrane. Further evidence suggests that the DNA machinery is impaired in 
Hutchinson-Gilford’s syndrome (Wang et al., 1991; Sugita et al., 1995), again suggesting that 
changes in the DNA are important in normal ageing. 
 Other progeroid syndromes exist, though the classification is subjective. For example, 
Nijmegen breakage syndrome, which derives from a mutated DNA double-strand break repair 
protein (Carney et al., 1998; Matsuura et al., 1998; Varon et al., 1998), has been considered as 
progeroid (Martin and Oshima, 2000). Cockayne Syndrome Type I may also be accelerated 
ageing and the protein involved participates in transcription and DNA metabolism (Henning et 
al., 1995). Murine accelerated ageing syndromes have also been implicated in DNA repair such 
as the mouse homologues of xeroderma pigmentosum, group D (de Boer et al., 2002), ataxia 
telangiectasia mutated or ATM (Wong et al., 2003), p53 (Donehower, 2002; Tyner et al., 2002; 
Cao et al., 2003), and Ercc1 (Weeda et al., 1997). 
 It appears certain that DNA mutations and chromosomal abnormalities increase with age 
in mice (Martin et al., 1985; Dolle et al., 1997; Vijg, 2000; Dolle and Vijg, 2002) and humans 
(for example: Esposito et al., 1989). Yet it is impossible to tell whether these changes are effects 
or causes of ageing. In addition, there is no consensus as to what type of DNA changes is crucial 
in ageing. Correlations have been found between DNA repair mechanisms and rate of ageing in 
some mammalian species (Hart and Setlow, 1974; Grube and Burkle, 1992; Cortopassi and 
Wang, 1996), though this may be an artefact of long-lived species being on average bigger 
(Promislow, 1994). On the other hand, mice overexpressing p48, which is important in repairing 
DNA damage deriving from UV radiation, had improved DNA repair mechanisms and still did 
not live longer (Tang et al., 2000). Mice deficient in Pms2 had elevated levels of mutations in 
multiple tissues and yet did not appear to age faster than controls (Narayanan et al., 1997). 
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Embryos of mice and flies irradiated with x-rays do not age faster (reviewed in Cosgrove et al., 
1992; Strehler, 1999), though one report argued that Chernobyl victims do (Polyukhov et al., 
2000). Furthermore, the common notion that germ cells have improved DNA repair mechanisms 
and thus avoid ageing is itself debatable (reviewed in Walter et al., 2003). 
 One possibility is that ROS damage DNA and some evidence exists in favour of such 
hypothesis (Hamilton et al., 2001). Yet overexpression of catalase in the nucleus did not prevent 
oxidative damage to DNA (Schriner et al., 2000). Damage from free radicals to nuclear DNA 
remains an unproven cause of ageing but since ROS originate in the mitochondria, and since 
mitochondria possess their own genome, many advocates of the free radical theory of ageing 
consider that ROS damage to mitochondrial DNA (mtDNA) is more important (Harman, 1972; 
Linanne et al., 1989; de Grey, 1997; Barja, 2002a). For example, some evidence exists that under 
CR oxidative damage to mtDNA is more important than oxidative damage to nuclear DNA 
(reviewed in Barja, 2002a). On the other hand, the mtDNA is maternally inherited in mammals 
(Birky, 1995 & 2001; Taylor et al., 2003) and yet no evidence exists that the heritability of 
longevity is different between males and females. At present, and despite contradictory evidence 
in favour (Khaidakov et al., 2003 for arguments) and against the theory (Rasmussen et al., 2003 
for arguments), current technology does not appear capable of assessing the true relevance of 
damage to mtDNA in ageing (Lightowlers et al., 1999; DiMauro et al., 2002). Therefore, and 
although mtDNA may play a role in age-related diseases, its role in ageing remains unproven. 
 In conclusion, changes in DNA over time may play an important role in ageing, but the 
essence of those changes remains to be determined. 
 
1.4. Evolutionary theory of ageing 
 
 Since ageing increases vulnerability and ultimately leads to the death of organisms, it is 
apparently in contradiction with Darwin’s evolutionary theory. After all, how can evolution 
favour a process that, as happens in practically all mammals (reviewed in Finch, 1990), gradually 
increases mortality and decreases the reproductive capacity? 
 Although the oldest written argument on the evolution of ageing is the work of Russel 
Wallace, the problem of how ageing evolved was first debated by August Weismann 
(Weismann, 1891). Weismann’s first hypothesis was that ageing evolved to the advantage of the 
species, not the individual, a theory known as “group selection”. Yet he later dropped such ideas 
and since arguments in favour of group selection are scarce, modern evolutionary theory of 
ageing disregards group selection. Weismann then suggested that ageing evolved because 
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organisms that segregate germ and soma must invest additional resources to reproduce instead of 
maintaining the soma, and this renunciation of the soma results in ageing. Weismann’s ideas 
were later comprised by Thomas Kirkwood to become the “disposable soma theory”, which 
states that organisms must reach a balance between the resources they invest in soma 
maintenance and reproduction (Kirkwood, 1977). A consequence of the disposable soma theory 
is that ageing occurs due to the accumulation of damage during life and that multiple 
mechanisms contribute to ageing (Kirkwood and Austad, 2000). 
 Drawing on the theories from Weismann and others, Sir Peter Medawar developed the 
key idea in the evolutionary theory of ageing. His basic observation was that the force of natural 
selection declines with age (Medawar, 1952). Since all organisms eventually die of diseases, 
accidents, predation, etc., genes beneficial early in life are favoured by natural selection over 
genes beneficial late in life. For example, imagine a species with an average longevity of 2 years 
whose organisms reach puberty at age 1. There is little evolutionary advantage in having 
beneficial genes at age 10 because only a small fraction (4%) of the population will reach that 
age. On the contrary, genes that are beneficial at age 1 will be selected by evolution. Following 
the same reasoning, a gene that kills organisms at age 20 will have little impact on organisms 
bearing it since few (<0.2%) will reach such advanced ages. In other words, the greatest 
contribution to create a new generation comes from young, not old organisms and so the power 
of natural selection fades with age, making it possible for hazardous late-acting genes to exist 
(reviewed in Hamilton, 1966; Charlesworth, 2000). 
 Another important work was that of George Williams in which he strongly defended 
antagonistic pleiotropy. Since natural selection is weaker at later ages, then perhaps genes exist 
that are beneficial at earlier ages but harmful at later ages. These genes with opposite effects are 
called pleiotropic genes (Williams, 1957). 
 Therefore, evolutionary theory of ageing proposes two models for how ageing can 
evolve. One derives from Medawar’s ideas in which genetic drift and mutation accumulation 
lead to the loss of late-acting beneficial genes or to the appearance of late-acting harmful genes. 
In Williams’s model, ageing evolves due to the pleiotropic effect of genes that are beneficial 
early in life and then harmful at late ages. Some results from Drosophila, however, suggest that 
Medawar’s theory of mutation accumulation prevails over Williams’s antagonistic pleiotropy 
hypothesis (Charlesworth et al., 1996; Hughes et al., 2002), although antagonistic pleiotropy 
should not be completely disregarded (Rose et al., 2002a). 
 One way to look at animal life history and ageing is through the concepts of r and K 
selection that were formally proposed by Robert MacArthur and Edward Wilson (MacArthur and 
13 
Wilson, 1967). In brief, r selection is the density-independent component of natural selection, 
which in practice refers to reproductive rate, while K selection is density dependent, referring to 
the biggest population resources can sustain. Organisms in hazardous environments will 
maximize reproduction and thus be r-selected while organisms in non-hazardous environments 
will maximize their performance under crowded conditions and thus be K-selected. Therefore, r-
selection will favour rapid development, small body sizes, and a short lifespan while K-selection 
will favour delayed development, larger body sizes, and a longer lifespan (Pianka, 1970; Austad, 
1997b). Amongst mammals (Table 1), humans, whales, or elephants are K-selected while mice 
and voles are r-selected. 
 Evolutionary theory of ageing is supported by significant experimental evidence. In two 
classical experiments, researchers were able to delay ageing in Drosophila by only allowing 
older flies to reproduce (Luckinbill and Clare, 1985; Rose, 1991). This way, the force of natural 
selection would no longer decrease with age. Also in accordance with the theory, Steven Austad 
observed that opossums living in a predator-free island aged slower and reproduced later than the 
same species on the more hazardous mainland (Austad, 1988; Austad, 1997a). 
 Although Medawar suggested that ageing was controlled by a few, key physiological 
processes (Medawar, 1955), modern evolutionary theory of ageing argues that ageing is 
multifactorial (Rose, 1991; Kirkwood and Austad, 2000). Hence, it was a surprise the way single 
gene knock-outs could delay ageing in animals (reviewed in Tower, 2000; Johnson, 2002). In 
addition, some genetic manipulations can delay ageing while not affecting reproduction (Dillin et 
al., 2002; Marden et al., 2003), which was also unexpected. 
 One of the most intriguing phenotypes in the biology of ageing comes from animals 
which appear not to age, also called animals with “negligible senescence”. Studies conducted 
both in captivity and in the wild have shown that several species of fishes, amphibians, and 
reptiles, to name just vertebrates, fail to show signs of ageing (reviewed in Finch, 1990). Of 
course that these animals have only been studied for a limited amount of time, but even so it is 
surprising to find that in a 50-year study, Blanding’s Turtles could increase both survivorship 
and reproductive output with age (Congdon et al., 2001). Therefore, although evolutionary 
theory of ageing offers a theoretical background that explains many observations, it cannot, as it 
stands, be used to make predictions on the biology of ageing (Le Bourg, 2001 for arguments). 
14 
1.5. Models of human ageing 
 
 One major difficulty in studying human ageing is its duration, particularly because 
researchers themselves are ageing and have a limited longevity. In order to test the theories of 
ageing, it is crucial to have adequate models. Only since the human ageing process takes decades 
to develop, it is almost impossible to study it in vivo. Therefore, scientists have to resort to 
models and then extrapolate data from these different models into human ageing. 
 Animal models are a popular choice amongst gerontologists and much of what we know 
about ageing today derives from them. The short life cycles of some animals, such as Drosophila 
or C. elegans, makes them easy subjects of study and even mice have been extensively used in 
gerontology. Unicellular organisms, most notably the yeast Saccharomyces cerevisiae, have also 
been widely used to research ageing and many mutations have been found that appear to 
participate in yeast ageing (reviewed in Jazwinski, 2001). 
 The employment of inadequate models for the study of human ageing can be catastrophic 
for research since it can shift the focus of gerontology to pathways that, though relevant in a 
certain model, may be irrelevant in human ageing. Yet it can be very difficult to tell whether an 
organism is representative of human ageing or not. For example, the male of Australian mice, 
Anthecinus stuartii, has a bizarre phenotype called “Big Bang reproduction”. Once a year, during 
mating season, the males of this species have such an increased libido that they are unable to eat 
and eventually die of sexual stress (reviewed in Gosden, 1996). Breeding only once is called 
semelparity but, although it leads to death, it is much different from the gradual waning of 
humans and so Anthecinus do not appear good models of human ageing. Yet there is no a priori 
reason to expect other gradually ageing organisms to age for the same causes as humans.  
 Some mechanisms of ageing are seen across different species. For instance, CR appears 
to work in a variety of organisms. On the other hand, human physiology can be much different 
than that of model organisms. Drosophila and C. elegans are mostly composed of post-mitotic 
cells, which means that not only they do not have cancer but raises doubts on how valid results 
obtained in these animals when extrapolated to humans are. In addition, the phenotypes of 
ageing in yeast and humans are totally unalike (Gershon and Gershon, 2000a). It has been argued 
that similar mechanisms operate across many species (Longo, 1999; Longo and Fabrizio, 2002) 
while other gerontologists argue that there are mechanisms of ageing common to all species and 
mechanisms that are unique (Martin et al., 1996). At present, it is impossible to tell for sure. 
 Since CR affects the growth hormone/IGF-1 axis, one hypothesis is that CR decreases the 
stimulus for cellular replication (Sonntag et al., 1999). Therefore, another widely used model 
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involves cells, such as human cells. These have the advantage of allowing researchers to study 
human processes but the disadvantage that the difference between cells in vivo and in vitro may 
bias the results. For example, we have learned much from studying cells from patients with WS--
itself a model of normal human ageing--as well as from studying the purified WRN (reviewed in 
Bohr et al., 2002; Fry, 2002). In addition, cells from mice lacking MSRA are more susceptible to 
ROS (Moskovitz et al., 2001), demonstrating how it is possible to reconcile and integrate results 
from models of ageing to fit our theories. Nevertheless, in vitro results are often not totally 
representative of what happens in vivo (for example: Mondello et al., 1999), as will be developed 
in chapter 2. 
 The validity of each model of human ageing has always been a subject of much debate 
and will be thoroughly considered in this work. 
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CHAPTER 2: REPLICATIVE SENESCENCE AND STRESS 
 
2.1. Hayflick’s limit 
 
 In 1961, and in contradiction to what was thought at the time, Leonard Hayflick and Paul 
Moorhead discovered that human cells derived from embryonic tissues can only divide a finite 
number of times in culture (Hayflick and Moorhead, 1961). They defined the stages of cell 
culture as three phases: Phase I is the primary culture, when cells from the explant multiply to 
cover the surface of the culture flask. Phase II represents the time when cells divide in culture, 
which will be described briefly. Once cells cover a flask’s surface, they stop multiplying. For 
cell growth to continue, the cells must be subcultivated. To do so, one removes the culture’s 
medium and adds a digestive enzyme called trypsin that dissolves the substances keeping cells 
together; afterwards, growth medium is added. This growth medium contains the cells in 
suspension and can be divided by, for instance, two new flasks. Later, cells attach to the flask’s 
floor and start dividing once again until a new subcultivation is required. Cells divide vigorously 
and can often be subcultivated in a matter of a few days. Lastly, Phase III begins when cells start 
dividing slower. Eventually they stop dividing at all and die (reviewed in Hayflick, 1985; 
Hayflick, 1994). Hayflick and Moorhead noticed that cultures stopped dividing after an average 
of fifty cumulative population doublings (CPDs). This phenomenon is known as Hayflick’s 
limit, Phase III phenomenon (Figure 5), or, as it will be called herein, replicative senescence 
(RS). 
 Hayflick and Moorhead worked with fibroblasts, a cell type found in connective tissue, 
but RS has been found in other cell types: keratinocytes (Rheinwald and Green, 1975), 
endothelial cells (Mueller et al., 1980), lymphocytes (Tice et al., 1979), adrenocortical cells 
(Hornsby and Gill, 1978), vascular smooth muscle cells (Bierman, 1978; Volicer et al., 1983), 
chondrocytes (Evans and Georgescu, 1983), etc. In addition, RS occurs in cells derived from 
embryonic tissues or from adults of all ages and in cells taken from many animals: mice, 
chickens, Galapagos tortoise, etc. (reviewed in Hayflick, 1994). Early results suggested a relation 
between the number of CPDs cells undergo in culture and the longevity of the species from 
which the cells were derived. For example, cells from the Galapagos tortoise, which can live 
over a century, divide about 110 times (Goldstein, 1974), while mouse cells divide roughly 15 
times (Stanley et al., 1976; Rohme, 1981). In addition, cells taken from patients with progeroid 
syndromes such as WS endure far less CPDs than normal cells (Salk et al., 1981). Exceptions 
exist and certain cell lines never reach RS. These are said to be “immortal” and include 
  
Figure 5: Representation of the three stages of cell culture. Adapted from Hayflick and 
Moorhead, 1961. 
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embryonic germ cells and most cell lines derived from tumours, such as HeLa cells (Brunmark et 
al., 1986; Chen and Yu, 1994; Pera et al., 2000). Some types of rat cells have also been claimed 
as capable of evading RS (Mathon et al., 2001; Tang et al., 2001). 
 Cultivating cells in vitro is easy and inexpensive when compared to other models of 
human ageing and so RS has been a widely studied phenotype. 
 
2.1.1. Biomarkers of RS 
 
 The phenotype of RS in human diploid fibroblasts (HDFs), which were the subject of our 
work, is characterized by a series of features, termed “biomarkers” (reviewed in Campisi, 1999). 
The most obvious biomarker is growth arrest, i.e. cells stop dividing, which can be detected by 
[3H]-thymidine incorporation. Even vigorously dividing cultures are heterogeneous and contain a 
percentage of senescent cells that progressively increases until cells stop dividing (Cristofalo and 
Sharf, 1973; Smith and Whitney, 1980); this percentage is higher in WS cells (Kill et al., 1994). 
Senescent cells are growth arrested in the transition from phase G1 to phase S of the cell cycle 
(Sherwood et al., 1988; Figure 6). The growth arrest in RS is irreversible in the sense that growth 
factors cannot stimulate the cells to divide (reviewed in Cristofalo and Pignolo, 1993), even 
though senescent cells can remain metabolically active for long periods of time (reviewed in 
Goldstein, 1990). 
 Another important biomarker is cellular morphology. The progressive morphological 
changes cells endure while they age in vitro were particularly well-studied by Klaus Bayreuther 
and colleagues (Bayreuther et al., 1988a & 1988b). In brief, senescent cells are bigger and a 
senescent population has more diverse morphotypes than cells at earlier CPDs. In fact, a 
confluent senescent culture has a smaller cellular density than a confluent young culture, though 
this also occurs because senescent cells are more sensitive to cell-cell contact inhibition. 
 In 1995, Judith Campisi and her team discovered that the enzyme β-galactosidase has an 
abnormal behaviour associated with senescent cells, which is termed senescence-associated β-
galactosidase (SA β-gal) activity. β-galactosidase, a lysosomal hydrolase, is normally active at 
pH 4, but in senescent cells it often happens for β-galactosidase to be active at pH 6. Both in 
vitro and in vivo, the percentage of cells positive for SA β-gal increases with, respectively, CPDs 
and age (Dimri et al., 1995; Figure 7, Table 2). On the contrary, in immortal cell lines, such as 
HeLa cells, the percentage of cells positive for SA β-gal does not correlate with CPDs. In 
addition, it is possible to find a correlation between the increase in SA β-gal and the appearance 
of the senescent morphotypes (Toussaint et al., 2000). Early reports showed that lysosomes 
 
 
Figure 6: Stages of the cell cycle. Adapted from The Biology Project, developed at the 
University of Arizona: http://www.biology.arizona.edu. 
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increase in number and size in senescent cells (Robbins et al., 1970; Brunk et al., 1973). SA β-
gal appears to be a result of increased lysosomal activity at a suboptimal pH, which becomes 
detectable in senescent cells due to an increase in lysosomal content (Kurz et al., 2000). Recent 
results also suggest that during in vitro ageing increased autophagy may be associated with an 
increase of lysosomal mass and SA β-gal (Gerland et al., 2003). 
 Normal human cells are diploid. Yet with each subcultivation, the percentage of 
polyploid cells increases (Matsumura, 1980). Mutations to mtDNA also increase with age. For 
example, the first identified mutation was a deletion of 4,977 base pairs (bp) in the 16,569 bp 
mtDNA. This deletion is observed both in vivo (Corral-Debrinski et al., 1992; Yang et al., 1994; 
Liu et al., 1998) and in vitro (Dumont et al., 2000a). 
 Senescent cells also have a decreased ability to express heat shock proteins both in vivo 
(Blake et al., 1991; Fargnoli et al., 1990) and in vitro (Choi et al., 1990; Bonelli et al., 1999). In 
addition, in vitro ageing makes HDFs lose c-fos inducibility by serum (Seshadri and Campisi, 
1990). 
 The expression levels of several genes change during in vitro cellular ageing (reviewed in 
Cristofalo et al., 1998a). Some of the most commonly used biomarkers are: osteonectin, 
fibronectin, apolipoprotein J, smooth muscle cells 22 (SM22), and type II α(1)-procollagen, 
whose expression increases in senescent WI-38 and IMR-90 HDFs (Kumazaki et al., 1991; 
Gonos et al., 1998; Dumont et al., 2000a). Lastly, senescent cells also display an increased 
activity of metalloproteinases, which degrade the extracellular matrix (reviewed in Campisi, 
1999). 
 Telomeres are non-coding regions at the tips of chromosomes (Figure 8). In vertebrates, 
they are composed of repeated sequences of TTAGGG (Moyzis et al., 1988; Meyne et al., 1989). 
During in vitro ageing, the telomeres shorten gradually in each subcultivation (Harley et al., 
1990). The same process might occur in vivo too (Hastie et al., 1990; Lindsey et al., 1991; 
Allsopp et al., 1992). Since the telomeres are one of the main players in RS, we will focus on 
them in more detail in chapter 3. 
 
2.2. The theory of stress 
 
 The pioneer in the study of stress was Hans Selye, who defined biological stress as “the 
non-specific response of the body to any demands made upon it” (Selye, 1973). Biological 
systems are constantly interacting with the environment, always under some type of stress: 
variations in temperature, UV radiation, emotional stress, etc. Some kinds of stress, such as mild 
 
Figure 7: SA β-gal and replicative capacity during serial passage. Cells were radiolabeled 
with [3H]-thymidine for 72 hrs, stained, and 100-500 cells were scored for labelled nuclei and 
SA β-gal staining. Open symbols, WI-38 cells; closed symbols, HCA2 cells. Adapted, as was 
Table 2, from Dimri et al., 1995. 
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physical exercise, contribute to our wellness while others, such as intense emotional stress, 
contribute to sickness. Selye defined these two kinds of stress as, respectively, eustress, which is 
a “good” stress, and distress, a “bad” stress. According to the theory of stress, the initial reaction 
to a stressor is shock, followed by a countershock, which increases the resistance to the stressor. 
Yet although a stressor can contribute to wellness, the intensity or accumulation of stressors can 
ultimately cause sickness (Selye, 1976; Berczi, 1998). 
 One frequent feature of extended longevity is increased stress resistance (reviewed in 
Longo, 1999). Concisely, manipulations in C. elegans that extend longevity show a strong 
correlation with resistance to stress (Murakami et al., 2000). In Drosophila too some mutations 
can increase longevity and augment stress resistance (Lin et al., 1998a). The mutation of p66shc 
not only increases longevity in mice but also renders mouse embryonic fibroblasts more resistant 
to different types of stressors (Migliaccio et al., 1999). As previously mentioned, mutations in 
MSRA can influence longevity in mice and they also influence stress resistance (Moskovitz et 
al., 2001). In addition, avian cells are more resistant to oxidative stress than mice cells (Ogburn 
et al., 1998), showing a correlation between longevity and cellular stress resistance. Stress 
resistance in vitro also correlates with mammalian longevity (Kapahi et al., 1999). Finally, cells 
taken from patients with progeroid syndromes are more susceptible to stress (Gebhart et al., 
1988), as are senescent fibroblasts (Yuan et al., 1997). 
 Such findings are in accordance with the disposable soma theory, since an enhanced 
stress resistance suggests an additional investment in soma maintenance (Kirkwood and Austad, 
2000). Of course, it is not known whether stress-resistance is related to rate of ageing. 
Nevertheless, ageing and stress-resistance appear to be inversely related. Importantly, an 
association between cellular stress resistance and organismal ageing appears to exist. 
 
2.3. Stress-induced premature senescence 
 
 Stress can have beneficial effects. Low doses of potentially toxic stressors can have a 
stimulatory effect: a phenomenon known as hormesis. For example, as mentioned in chapter 
1.3.3., mice and flies exposed to low doses of x-rays at embryonic stages actually live longer 
(reviewed in Strehler, 1999). Repeated mild heat shocks appear to delay ageing in HDFs (Rattan, 
1998). Yet stress can also have harmful roles. For example, Drosophila fed H2O2 at 
concentrations ranging from 0 to 100 mM had a shorter longevity except flies fed 10 mM which 
had an augmented longevity when compared to controls (Sohal, 1988). 
 
 
Figure 8: Human metaphase chromosomes hybridised in situ with the telomere repeat 
sequence. Taken from the Shay/Wright laboratory, The University of Texas Southwestern 
Medical Center at Dallas: 
http://www.swmed.edu/home_pages/cellbio/shay-wright/intro/gallery/sw_gallery.html 
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 One easy and inexpensive way to study the harmful effects of stress is in vitro. Normally, 
cell culture conditions include 20% oxygen (O2) and these were the conditions initially used by 
Hayflick and Moorhead and most subsequent studies. When HDFs are cultured at 3% O2, which 
is closer to physiological conditions, they achieve a further 20 CPDs (Chen et al., 1995a). In 
contrast, different types of human cells cultured above 20% O2 display a reduced growth rate and 
endure fewer CPDs (Horikoshi et al., 1986; Michiels et al., 1990; Horikoshi et al., 1991; von 
Zglinicki et al., 1995). Interestingly, the same effect is not witnessed in tumour cell lines (Saito 
et al., 1995). In normal human cells, O2 has been shown to accelerate growth arrest (Alaluf et al., 
2000). If O2 is above 50%, it becomes cytotoxic (Horikoshi et al., 1991). The way subcytotoxic 
stress can accelerate the appearance of the senescent phenotype in cells is another form of 
cellular senescence. In 1999, at the EMBO workshop of Molecular and Cellular Gerontology, 
Olivone, Switzerland, the term stress-induced premature senescence (SIPS) was coined (Brack et 
al., 2000). 
 Depending on the dose of stressor used, a cell population will react in different ways. For 
instance, a high, cytotoxic dosage of a stressor causes such an amount of damage that cellular 
biochemical activities decrease leading to cellular death by necrosis. The level of damage 
sustained by cells determines whether programmed cell death, apoptosis, can unfold. If, for 
example, intracellular ATP depletion occurs past a certain threshold then necrosis occurs 
(reviewed in Lemasters et al., 1999; Nicotera et al., 1999). Since a cellular population is not 
homogeneous, the dose of the stressor will shift the percentage of cells executing each of the 
possible programs (Toussaint et al., 2002a). In order for SIPS to occur, a precise subcytotoxic 
dose must be determined for each cell population (Figure 9). 
 In addition to O2, other stressors--e.g. ethanol, ionising radiations, and mitomycin C--in 
many types of proliferative cells such as lung and skin fibroblasts, endothelial cells, 
melanocytes, and retinal pigment epithelial cells can induce SIPS (reviewed in Toussaint et al., 
2002b; Dierick et al., 2003). The list of stressors that can cause SIPS is constantly growing 
(Table 3). Studying SIPS can have medical applications (Toussaint et al., 2000 for arguments). 
For instance, skin HDFs repeatedly exposed to UVB undergo SIPS (Chainiaux et al., 2002), 
which can be used to develop solar protectors and study the ageing of the skin. 
 Of relevance to our work are ways of inducing SIPS that instead of chronic are based on a 
single or repeated short exposure(s) to stressors. Namely, our focus was on damaging agents. 
Exposure of HDFs to a single H2O2 2-hour stress induces SIPS (Chen and Ames, 1994; Chen et 
al., 1998). Another source of oxidative damage, tert-butylhydroperoxide (t-BHP), can also 
induce SIPS in WI-38 HDFs by repeated exposure (Toussaint et al., 1992; Dumont et al., 
  
Figure 9: When a cell population of a given cell type is exposed to stress at a subcytotoxic 
level (vertical dotted line), a gross majority of cells become irreversibly growth arrested and 
prematurely “senescent” while a minority of other cells might eventually resume mitosis. 
Taken from Toussaint et al., 2002a. 
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2000a). Since ROS have been implicated in ageing, oxidative stress may be a useful way to 
study ageing. Therefore, SIPS can be seen as another model of human ageing mechanisms. 
 
2.3.1. Biomarkers of SIPS induced by oxidative stress 
 
 SIPS is similar to RS and represents a state of senescence, as can be observed through 
several biomarkers. One key biomarker is growth arrest, normally at the G1/S transition. After 
exposure to H2O2, HDFs show a decrease in CPDs (Honda and Matsuo, 1983; Toussaint et al., 
1992; Chen and Ames, 1994). Loss of replicative potential has also been shown in HDFs 
exposed to H2O2 or t-BHP (Dumont et al., 2000a). 
 When HDFs are exposed to repeated stresses of UV, mitomycin C, or strong 
electromagnetic fields, a few days after the last stress they feature a senescent-like morphology 
(Rodemann, 1989; Rodemann et al., 1989a; Rodemann et al., 1989b). Exposure to H2O2 also 
induces a senescent-like morphology (Chen and Ames, 1994). Moreover, as previously 
mentioned, a correlation appears to exist between the changes in morphology and an increase in 
the proportion of HDFs positive for SA β-gal activity (Toussaint et al., 2000). In fact, an increase 
in the proportion of SA β-gal positive cells in SIPS has been reported for many types of cells 
under different stressors, namely in HDFs submitted to oxidative stress (Dumont et al., 2000a; 
Frippiat et al., 2001; Figure 10). 
 In SIPS, the common 4,977 bp deletion has been observed in HDFs following t-BHP 
stress, in the same way it gradually increases with the number of CPDs (Dumont et al., 2000a). 
 Several genes differentially expressed in RS show similar expression changes in SIPS as 
a results of oxidative stress by O2/hyperoxia (Saretzki et al., 1998), H2O2 (Chen et al., 1998; 
Frippiat et al., 2001) or t-BHP (Dumont et al., 2000a). 
 These biomarkers suggest that the phenotype seen in SIPS represents a form of 
senescence similar to RS. At the time we began our work, the role of telomeres in SIPS was 
under debate and will be discussed in chapters 3 and 4.2. 
 
2.4. Relation between ageing, RS, and SIPS 
 
 The connection between ageing and RS is not obvious. At least post partum, there is no 
relation between the number of CPDs cells can endure and the age of the donor (Cristofalo et al., 
1998b; Figure 11). Chances are previous studies showing otherwise were biased (Cristofalo, 
2001). Studies in centenarians failed to find differences in the CPDs cells from centenarians 
  
Table 3: Non-exhaustive list of the different models of SIPS in normal cell types 
together with the different biomarkers detected in these models: senescent morphology, 
SA β-gal activity, growth arrest, and G1 block. Adapted from Dierick et al., 2003.  
 
stressor cell type specie senescent SA ß-gal growth G1 reference
morphology arrest block
tert-butylhydroperoxide WI-38 fetal lung fibroblasts human OK OK OK (Dumont et al., 2000a)
" " " " " " OK OK OK (Dumont et al., 2001)
H2O2 IMR-90 fetal lung fibroblasts "     " OK OK OK (Dumont et al., 2000a)
" " " " "     " OK OK OK (Chen et al., 1998)
" " " " "     " OK OK OK (Frippiat et al., 2001)
" " WI-38 fetal lung fibroblasts "     " OK OK OK OK (Wolf et al., 2002)
" " cardiac fibroblasts rat OK (Siwik et al., 2001)
NaCl (hypertonic)                       WI-38 fetal lung fibroblasts                                      human          OK                               OK                   (Reichelt and Schachtschabel, 2001) 
H2O2, UV or γ-irradiation WI-38 and WI-38-hTERT fetal lung fibroblasts " " OK OK OK (Gorbunova et al., 2002)
" " IMR-90 and IMR-90-hTERT fetal lung fibroblasts " " OK OK OK (Gorbunova et al., 2002)
" " HCA2 and HCA2-hTERT fibroblasts " " OK OK OK (Gorbunova et al., 2002)
" " LF1, LF1-hTERT fibroblasts " " OK OK OK (Gorbunova et al., 2002)
" " LF1p21-/-, LF1p21-/-hTERT fibroblasts " " OK OK OK (Gorbunova et al., 2002)
UV HH-8 skin fibroblasts " " OK OK (Rodemann et al., 1989a)
UVB melanocytes " " OK OK (Medrano et al., 1995)
" " skin fibroblasts " " OK OK OK (Chainiaux et al., 2002)
ionizing radiation aortic endothelial cells bovine OK OK OK (Oh et al., 2001)
γ-radiation several strains of fibroblasts human OK OK (Di Leonardo et al., 1994)
strong electromagnetic fields HH-8 (skin) and WI-38 (fetal lung) fibroblasts  " " OK OK (Rodemann et al., 1989b)
ethanol WI-38 fetal lung fibroblasts " " OK OK OK (Dumont et al., 2002)
" " " " " " OK OK OK (Toussaint et al., 1995)
xanthine + xanthine oxidase cardiac fibroblasts rat OK (Siwik et al., 2001)
mitomycin C HH-8 fibroblasts human OK OK (Rodemann, 1989)
bleomycin, actinomycin D fibroblasts " " OK OK (Robles and Adami, 1998)
5-bromodeoxyuridine TIG-7 fibroblasts " " OK OK OK (Michishita et al., 1999)
" " TIG-7 fibroblasts " " OK OK (Suzuki et al., 2001a)
hydroxyurea fibroblasts " " OK OK OK (Yeo et al., 2000)
taxol WI-38 and REF-52 fibroblasts " " OK OK (Trielli et al., 1996)
psoralen photoactivation skin fibroblasts " " OK OK OK (Ma et al., 2002)
hyperoxia WI-38 fetal lung fibroblasts " " OK OK OK (von Zglinicki et al., 1995)
" " BJ and MRC-5 fibroblasts " " OK OK (Saretzki et al., 1998)
" " WI-38 and TIG-1 fibroblasts " " OK OK (Honda and Matsuo, 1983)
homocysteine umbilical vein endothelial cells " " OK OK (Xu et al., 2000)
IL-1α or TNF-α WI-38 fetal lung fibroblasts " " OK OK OK (Dumont et al., 2000b)
TGF-ß1 IMR-90 fetal lung fibroblasts " " OK OK (Frippiat et al., 2001)
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could endure (Tesco et al., 1998). In addition, they raised doubts on whether telomere shortening 
occurs in vivo and whether senescence-associated genes in vitro are also differentially expressed 
in vivo (Mondello et al., 1999). In fact, gene expression patterns show differences between in 
vitro senescent cells and cells from old donors (Takeda et al., 1992). Recently, the relation 
between SA β-gal and in vivo ageing has also been attacked (Going et al., 2002). 
 It is known that cells from older donors have a slower proliferative capacity (Waters and 
Walford, 1970; Hayflick, 1994). This effect, known as the latent period, occurs because fewer 
cells are in the replication cycle, not because they take longer to divide (Ponten et al., 1983; 
Karatza et al., 1984). Therefore, changes occur with age at a cellular level. In some tissues, such 
as the immune system, decreased proliferative ability may play a role in age-related degeneration 
(reviewed in Effros, 1996). Nevertheless, RS does not appear to be a faithful model of changes 
occurring in vivo (Gershon and Gershon, 2000b for arguments). 
 As mentioned before, a relation exists between stress resistance and ageing. Whether 
SIPS is a precise simulation of in vivo degeneration of proliferative tissues remains a point of 
discord. It appears likely, however, that the phenotype of SIPS is not exactly RS (Wright and 
Shay, 2001; Toussaint et al., 2002a). For example, one key difference between RS and SIPS is 
telomere shortening, which undeniably occurs in RS but whose involvement in SIPS is under 
discussion, as will be discussed in chapter 4.2. Yet in vivo cell senescence can be found without 
telomere shortening (Melk et al., 2003), suggesting that RS may not be the prevailing 
mechanism in vivo. Since cells taken from old donors do not endure less CPDs, one hypothesis is 
that in vivo RS does not widely occur and that cellular senescence in vivo is dependent on stress 
factors. When cell lines are derived from people, the selected cells are those that grow because 
people, even very old people, never run out of proliferating cells (Tesco et al., 1998; Cristofalo, 
2001). In fact, from a simple mathematical perspective, it appears unlikely that RS occurs in 
vivo. Assuming HDFs endure 50 CPDs, 250 is more than enough cells for several lifetimes 
(Hayflick, 1994). Therefore, only a minority of cells may reach RS in vivo (Toussaint et al., 
2002b). Of course that even a small percentage of senescent cells may interfere with tissue 
homeostasis and function (Shay and Wright, 2000), but RS such as defined by the phase III 
phenomenon appears unlikely to be widely present in vivo. 
 Although the relation between a species’ longevity and the CPDs its cells can endure in 
vitro exists, it is also debatable if this is related to ageing since optimal culture conditions vary 
from species to species. As mentioned in chapter 2.3., O2 partial pressure can affect cellular 
proliferation and recent results show that O2 limits the replicative capacity of murine fibroblasts 
(Parrinello et al., 2003). These results show that comparisons between different species, such as 
  
Figure 10:  Effects of repeated t-BHP stresses on the proportion of cells positive for SA β-gal 
activity. WI-38 HDFs from 52 to 90% of their proliferative lifespan (white columns) and 
HDFs at 56% of their proliferative lifespan submitted to five stresses of 1 h with 30 µM t-
BHP (dashed column). Taken from Dumont et al., 2000a. 
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those described in chapter 2.1., may be biased due to intra-species differences in O2 sensitivity; 
instead of showing maximum cellular proliferate capacity, these results show O2 sensitivity 
(Toussaint et al., 2002b). In addition, due to the positive correlation between body size and 
longevity (Promislow, 1993), perhaps cells taken from long-lived animals endure more CPDs 
because of the difference in size, not due to the difference in longevity. 
 Senescent cells and senescence-associated biomarkers can be found in vivo (Paradis et 
al., 2001; Going et al., 2002). Interestingly, stress-prone tissues appear to be the most affected. 
HDFs cultured from distal lower extremities of patients with venous reflux, which precedes the 
development of venous ulcers, display characteristics of senescent cells (Mendez et al., 1998a; 
Mendez et al., 1998b). Similar results also relate cellular senescence to atherosclerosis 
(Minamino et al., 2002) and benign prostatic hyperplasia, a common age-related male pathology 
(Castro et al., 2003). Senescence and inflammatory processes may also be related in age-related 
pathologies such as osteoarthritis (Martin and Buckwalter, 2002; Price et al., 2002) and skin 
ageing (Giacomoni et al., 2000). Indeed, repeated stimulation of WI-38 HDFs with pro-
inflammatory cytokines interleukin-1a or tumour necrosis factor-α induces SIPS (Toussaint et 
al., 1996). These cytokines’ circulating levels increase in vivo (reviewed in Lio et al., 2003), 
favouring inflammation and SIPS, so in vivo senescence may be a result of SIPS rather than RS. 
Some data indicate that chronic stressors may accelerate risk of a host of age-related diseases by 
prematurely ageing the immune response (Kiecolt-Glaser et al., 2003). Lastly, as hinted by the 
above mentioned results on the impact of O2 in cell proliferation, RS for many cell lines in vitro 
and in vivo may instead be better defined as SIPS resulting from oxidative stress. 
 The reasons why we employed SIPS in this study are: 1) we work with human cells, not 
that of animal models. 2) RS does not appear to be a faithful example of human ageing while 
SIPS, though not being a perfect model of human ageing, can occur in vivo and be related to both 
organismal ageing and cancer (Serrano and Blasco, 2001). 3) SIPS is involved in several 
pathologies and the elucidation of the mechanisms responsible for SIPS can have medical 
applications. 
  
Figure 11: Relationship between in vitro proliferative capacity of postnatal skin fibroblast cell 
lines and donor age (in years). A regression line (r = -0.018, P = 0.85, and n = 116) is shown. 
Males are represented by closed triangles and females by open circles. Taken from Cristofalo 
et al., 1998b. 
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CHAPTER 3: CELL CYCLE REGULATION BY THE TELOMERES 
 
3.1. Telomere shortening and RS 
 
 Early studies by Hermann Muller and Barbara McClintock showed that the ends of 
chromosomes are capped by a structure called the telomere to prevent chromosome fusions 
(Muller, 1938; McClintock, 1941). In the 1970’s, as the mechanisms behind DNA replication 
were becoming better understood, it became clear that DNA polymerase, the enzyme responsible 
for DNA replication, could not fully synthesize the 3’ end of linear DNA. In 1972, James 
Watson called this the end-replication problem (Watson, 1972; Figure 12). At about the same 
time, in a Moscow subway station, Alexey Olovnikov also recognized Watson’s problem in an 
analogy between the track that represented the DNA and the train that represented DNA 
polymerase. Yet Olovnikov went further to propose that the end-replication problem would 
result in telomere shortening with each round of replication and that this mechanism could be the 
cause of RS (Olovnikov, 1971, 1973). Soon after, studies by Leonard Hayflick and colleagues 
found that the nucleus controls RS (Wright and Hayflick, 1975; Muggleton-Harris and Hayflick, 
1976). 
 Olovkikov’s model turned out to be incredibly accurate. Telomere shortening is now 
considered the main causal mechanism of RS and telomere length is the molecular clock that 
counts the CPDs cells endure (reviewed in Wright and Shay, 2001). Although it was previously 
known that telomere shortening occurs in each subcultivation (Harley et al., 1990), the key 
finding relating the telomeres to RS was made in 1998 by scientists at Geron Corporation. 
Telomerase is a reverse-transcriptase enzyme that elongates the telomeres (Greider and 
Blackburn, 1985) thus counteracting the normal telomere erosion. Telomerase has two 
components: an RNA component (Feng et al., 1995) and a catalytic subunit (Lendvay et al., 
1996; Lingner et al., 1997; Meyerson et al., 1997; Nakamura et al., 1997; Figure 13). Previously, 
it was already apparent an association between telomere shortening, telomerase, and immortality 
in tumour cell lines (Counter et al., 1992). Yet the definitive breakthrough was that expression of 
the catalytic subunit of human telomerase (hTERT) in both retinal pigment epithelial cells and 
foreskin fibroblasts avoids RS (Bodnar et al., 1998). HDFs immortalized with hTERT divide 
vigorously, do not show increased staining for SA β-gal, and do not show signs of 
transformation (Jiang et al., 1999; Morales et al., 1999). Even expression of hTERT in old HDFs 
appears to reverse the loss of function characteristic of senescent cells (Funk et al., 2000). It 
 
 
Figure 12: DNA polymerase requires an RNA primer to initiate synthesis in the 5’→3’ 
direction. At the end of a linear chromosome, DNA polymerase can synthesize the leading 
strand until the end of the chromosome. In the lagging strand, however, DNA polymerase’s 
synthesis is based on a series of fragments, called Okazaki, each requiring an RNA primer. 
Without DNA to serve as template for a new primer, the replication machinery is unable to 
synthesize the sequence complementary to the final primal event. The result is the “end-
replication problem” in which sequence is lost at each round of DNA replication. Adapted 
from Wynford-Thomas and Kipling, 1997. 
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appears that ectopic hTERT expression is sufficient to restore telomerase activity in human cells 
(Counter et al., 1998). 
 Transient expression of hTERT for 7 CPDs in HDFs elongated the shortest telomeres by 
2.5 kilobase pairs (kbp). Afterwards, these HDFs divided for roughly 50 CPDs with a telomeres 
shortening of 50 bp per division before reaching RS. These results strongly argued that telomere 
length, not hTERT expression, is the key in avoiding RS (Steinert et al., 2000) and established 
telomere length as the clock that keeps track of CPDs and originates RS. In addition, recent 
results show that the senescent cells in dividing cultures have shorter mean telomere lengths than 
dividing cells of the same population (von Zglinicki et al., 2003; Martin-Ruiz et al., 
unpublished). 
 Telomerase is not the only mechanism capable of elongating the telomeres. There are 
several immortal telomerase-negative cell lines with, typically, a great variety of telomere 
lengths (Bryan et al., 1995; Bryan et al., 1997). Although the exact mechanisms behind what is 
called alternative lengthening of telomeres remain unknown, recombinational processes may be 
involved (McEachern and Blackburn, 1996; Dunham et al., 2000). 
 Either using telomerase or not, all known immortal cell lines must stabilize their 
telomeres (reviewed in Colgin and Reddel, 1999; Stewart and Weinberg, 2000). Tumour 
development, in particular, is dependent on telomere stabilization, normally by telomerase (Chen 
et al., 2000a). In contrast, telomerase inhibition can induce senescence in cancer cells (Shammas 
et al., 1999). The role of telomeres in tumorogenesis will be further discussed in chapter 3.3. 
Lastly, unicellular eukaryotes must also stabilize their telomeres. Indeed, defects in telomere 
replication have been shown to trigger senescence in yeast (Lundblad and Szostak, 1989) and in 
the protozoan Tetrahymena (Yu et al., 1990). 
 
3.2. How telomere dysfunction induces senescence 
 
 Although telomere length regulates RS and can be seen as a mitotic clock, it is neither the 
only nor the ultimate timekeeper of cells (reviewed in Blackburn, 2000). During telomerase-
immortalization of human cell lines, including HDFs, several researchers noticed that 
immortalized cells had shorter telomeres than growth arrested controls (Ducray et al., 1999; 
Yang et al., 1999; Zhu et al., 1999). Surprisingly, immortalized cells featured less chromosome 
fusions, which are the most noticeable outcome of short telomeres (Hande et al., 1999). 
Similarly, it was noticed in yeasts that certain telomerase-negative strains would senesce with 
longer telomeres than immortal telomerase-positive strains (Prescott and Blackburn, 1997; Roy 
 
 
Figure 13A: Model of telomerase as an RNA-reverse transcriptase complex. The p123/Est2p 
subunit (green) is based on the right hand model of HIV-1 reverse transcriptase; thumb and 
fingers extend toward the reader. The reverse transcriptase motifs are in the palm, and the 
active site aspartates are near the 3’ end of the telomeric DNA substrate (red). The RNA 
subunit (blue) has its template region in the palm; the location of the remainder of the RNA is 
unknown and is shown schematically in its secondary structure representation. The telomeric 
DNA substrate is shown base-paired but not intertwined with the RNA subunit. The extent of 
base pairing and the sites of interaction of the nucleic acids with the protein are not known. 
Taken from Lingner et al., 1997. 
 
 
 
Figure 13B: Telomerase, a reverse transcriptase with an RNA subunit, extends the lagging 
DNA strand. Taken from TelDB at Washington University School of Medicine based on the 
work of Carol Greider: http://www.genlink.wustl.edu/teldb/ 
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et al., 1998). More recently, studies with HDFs strains derived from different individuals showed 
great variability in telomere length at the time of senescence (Serra and von Zglinicki, 2002). 
Since telomere length alone could not explain these observations, other players had to be 
involved. 
 Using electron microscopy, it was revealed that telomeres are not linear, but instead 
appear to form duplex loops, called t-loops. Crucial in these loops are the telomeric repeat-
binding factors TRF1 (van Steensel and de Lange, 1997) and TRF2 (Smogorzewska et al., 
2000). In particular, TRF2 can remodel linear telomeric DNA into t-loops (Griffith et al., 1999). 
Although much remains unknown, the prevailing hypothesis is that these loops stabilize or cap 
the telomeres (Figure 14). Capping may protect the telomeres from being recognized as DNA 
damage. TRF2 protects telomeres (van Steensel et al., 1998): inhibition of TRF2 induces 
apoptotic cell death (Karlseder et al., 1999) while overexpression of TRF2 reduces the senescent 
checkpoint of cells in terms of telomere length (Karlseder et al., 2002). These results suggested 
that telomere capping, not just telomere length, is crucial in avoiding telomere dysfunction and 
preventing apoptosis and senescence. Recent results showing that telomerase disruption can slow 
cell proliferation and alter the 3’ single-stranded telomeric overhang without telomere shortening 
support this view (Masutomi et al., 2003). One plausible hypothesis is that telomere shortening 
may destabilize or even prevent the capping of telomeres, leading to senescence (Shay, 1999). 
Importantly, we still lack a detailed view of the mechanisms involved. For instance, murine 
TRF1 knock-out mice die at embryonic stages suggesting that TRF1 has an essential function 
that is independent of telomere length regulation (Karlseder et al., 2003). 
 Whether the end-replication problem alone is responsible for telomere shortening has 
become a centre for debate. Senescence can occur in HDFs in the absence of cell division and 
short telomeres. HDFs kept confluent for long periods of time--up to 12 weeks--exited the cell 
cycle. The small proportion of HDFs that continued dividing endured fewer cumulative 
population doublings than normal presumably due to compensatory cycling (Munro et al., 2001). 
Although quiescent cells do not appear to lose telomeres (von Zglinicki, 1998 & 2000), HDFs 
endure an accelerated telomere shortening following extensive periods of confluency (Sitte et al., 
1998). One hypothesis is that telomere dysfunction occurs in confluent cells despite lack of 
telomere shortening. Therefore, the end-replication problem as a model to explain telomere 
shortening may be biased. Telomeres end in a single-stranded G-rich 3’-overhang, presumably as 
a result of C-rich strand degradation during telomere processing (Wellinger et al., 1996; 
Makarov et al., 1997; Wright et al., 1997). Recent results suggest that erosion of the overhang 
occurs at senescence, prevented by telomerase expression. Progressive erosion appears to be a 
 
Figure 14: A new view of the mammalian telomere. At the end of the chromosome, the 
mammalian double-stranded telomere bends back on itself forming a large telomere loop (t-
loop). The 3’ G-rich single-stranded overhang at the end of the t-loop invades the double-
stranded telomere and produces a displacement loop (d-loop). The sequestration of the G-rich 
single-stranded overhang may prevent inappropriate DNA damage checkpoint responses. The 
telomere-specific DNA-binding proteins TRF1 and TRF2 are required for normal telomere 
function along with the TRF1-associated proteins tankyrase and TIN2. Homodimerization of 
TRF1 is required to form a stable complex with DNA in mammalian cells. Whereas tankyrase 
may only associate with TRF1 transiently, TIN2 appears to be recruited to TRF1, and this 
complex, together with TRF2, may make the 3' G-rich overhang inaccessible to telomerase. 
Thus, TRF1 and its associated proteins (TIN2 and tankyrase), TRF2, the telomerase 
holoenzyme, and perhaps as yet unidentified proteins, are important regulators of human 
telomere length. Taken from Shay, 1999. 
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result of cell division and not an effect of senescence (Stewart et al., 2003). As such, the exact 
molecular mechanisms behind telomere shortening and dysfunction remain undetermined. 
 Another source of controversy is whether it is mean telomere length or the shortest 
telomere to trigger RS. Evidence from mice indicates that the shortest telomeres, not mean 
telomere length, are responsible for inducing RS (Hemann et al., 2001). Yet in HDFs the onset 
of RS shows a better correlation with mean telomere length than with chromosomes with the 
shortest telomere (Martens et al., 2000). Therefore, the debate rages on. 
 
3.2.1. Uncapped telomeres recognized as DNA damage 
 
 Even before hTERT-derived immortalization, it was possible to immortalize HDFs using 
viral genes such as the simian virus 40 (SV40) T-antigen, E1A and E1B from adenovirus, or the 
human papillomavirus E6 and E7 genes. The E1B and E6 proteins bind and inactivate the 
tumour suppressor protein p53 while E1A and E7 bind and inactivate the retinoblastoma protein, 
also called pRb (Dyson et al., 1989; Werness et al., 1990). Immortalization requires E6 and E7 
or E1A plus E1B, so both p53 and pRb must be inactive (Figure 15). SV40 immortalization is 
also dependent on inactivation of both p53 and pRb (Shay et al., 1991). These findings led to the 
present concept that two pathways are responsible for inducing senescence. Confirming these 
suspicions, inhibition of p53 and pRb by antisense technology caused cells to endure 50 CPDs 
more than normal (Hara et al., 1991). 
 Re-expression of pRb in pRb/p53-defective immortal tumour cells induces senescence 
(Xu et al., 1997). In agreement with its anti-oncogenic profile, pRb is a central regulator of cell 
cycle progression and its state of phosphorylation determines cell cycle regulation (Buchkovich 
et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; reviewed in Herwig and Strauss, 1997). 
Hyperphosphorylated pRb allows the cell cycle to proceed while hypophosphorylated pRb 
prevents cell cycle progression. Presumably, pRb operates through inactivation of the E2F 
family of transcription factors, responsible for transcription of several genes involved in G1/S 
transition and DNA synthesis (Weintraub et al., 1992; Farnham et al., 1993; Sladek, 1997; 
Campisi, 1999). Briefly, the phosphorylation of pRb is dependent on cyclin-dependent kinases 
(CDKs) that govern the progression through the various phases of the cell cycle (reviewed in 
Lees, 1995). Inactivation of the G1 CDKs, responsible for the phosphorylation of pRb, prevents 
transition from phase G1 to phase S and blocks the cell cycle, originating, for example, RS. 
 Cyclin-dependent kinase inhibitors (CDKIs), as the name implies, inhibit the activity of 
CDKs. One of such proteins is p16INK4a, whose lack of activity was found in cancers, correlating 
G1
S
RB
Adenovirus E1A
HPV E7
SV40 Lg T
APOPTOSIS
p53
Adenovirus E1B(55K)
HPV E6
SV40 Lg TAdenovirus E1B (19K)
(Bcl2-like)
Viral Oncogenes Induce 
Proliferation 
and Suppress Apoptosis
Figure 15: Immortalization through viral proteins. Adapted from Amy Yee, Tufts University 
School of Medicine: http://www.tufts.edu/med/biochemistry/faculty/yee/yee.html
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with pRb but not p53 (Okamoto et al., 1994; Whitaker et al., 1995). p16INK4a disrupts and 
inhibits the activities of CDK4 and CDK6, thus preventing cell cycle progression (Serrano et al., 
1993; Hara et al., 1996). Exogenous expression of p16INK4a induces senescence in young HDFs 
and in immortal cells without p53 activity (McConnell et al., 1998; Vogt et al., 1998). In 
addition, immortalization may also be achieved by disruption of both p16INK4a and p53 (Rogan et 
al., 1995). pRb is needed for growth suppression mediated by p16INK4a (Medema et al., 1995). 
These results suggest that p16INK4a acts upstream of pRb in regulating RS. If telomere 
dysfunction activates p16INK4a, the mechanism is not known despite p16INK4a’s involvement, in 
parallel with p53, in the DNA damage response (Shapiro et al., 1998), as will be detailed in 
chapter 4. Furthermore, the levels of p16INK4a increase in senescent, but not pre-senescent, HDFs 
(Wong and Riabowol, 1996), suggesting other signalling pathways originating in the telomeres 
trigger RS (Alcorta et al., 1996). 
 Another important CDKI is p21WAF1, which also has the ability to block the cell cycle by 
inhibiting CDK2, CDK4, and CDK6 and thus preventing pRb phosphorylation (Harper et al., 
1993; Noda et al., 1994; Harper et al., 1995; Stein et al., 1999). Other mechanisms have been 
proposed, such as disruption of DNA synthesis by binding and inhibiting a protein called 
proliferating cell nuclear antigen (Waga et al., 1994; Chen et al., 1995b; Luo et al., 1995). Either 
way, p21WAF1 can induce senescence independently of p16INK4a (McConnell et al., 1998; Vogt et 
al., 1998). Since p21WAF1 expression levels increase in pre-senescent cells--i.e. before p16INK4a 
overexpression--, p21WAF1 is likely to trigger senescence before p16INK4a (Tahara et al., 1995; 
Alcorta et al., 1996; Wong and Riabowol, 1996; Dulic et al., 2000). In contrast, p16INK4a remains 
overexpressed in senescent cells while p21WAF1 levels wane (Stein and Dulic, 1998). 
 p53 induces p21WAF1 (el-Deiry et al., 1993). Microinjection of antibodies directed against 
p53 into senescent HDFs prevented p21WAF1 expression and resulted in cells entering the S phase 
and proliferating (Bond et al., 1996). Although it is possible that other downstream targets of 
p53 exist, p21WAF1 is involved in RS induced by p53 (reviewed in Wang et al., 2003). 
 In brief, p53 is a multifunctional protein, a transcription factor capable of acting both as a 
transcriptional activator and suppressor. Overexpression of p53 leads to cell cycle arrest or 
apoptosis (Sugrue et al., 1997). The induction of p53 by DNA-damaging agents led to the 
suggestion that p53 is a checkpoint factor that prevents cells from accumulating mutations by 
inducing apoptosis or growth arrest (reviewed in Ko and Prives, 1996). p53 may help maintain 
genetic stability (Linke et al., 2003 for arguments). 
 Increased levels of p53 have been associated with critically short telomeres (Vaziri and 
Benchimol, 1996; Gonzalez-Suarez et al., 2000), p53-deficiency attenuated the phenotype of 
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telomere dysfunction (Bond et al., 1994; Bond et al., 1996; Chin et al., 1999), and 
microinjection of anti-p53 antibodies restores cell division in senescent HDFs (Gire and 
Wynford-Thomas, 1998). Thus p53 is probably responsible for recognizing dysfunctional 
telomeres--e.g. critically short telomeres--as DNA damage and triggering RS. Indeed, activation 
of p53 occurs as HDFs approach senescence (Atadja et al., 1995; Kulju and Lehmn, 1995; Bond 
et al., 1996). Therefore, p53 appears to be the major initiator of senescence, while p16INK4a 
presumably maintains senescence (Alcorta et al., 1996; Dulic et al., 2000; Serrano and Blasco, 
2001; Wang et al., 2003). 
 p16INK4a appears to be important in the response to DNA damage (Robles and Adami, 
1998; Shapiro et al., 1998; Schmitt et al., 2002; te Poele et al., 2002) and other stimuli like 
oncogenic signals (Serrano et al., 1997). The immortalization of human epithelial cells requires 
inactivation of p16INK4a--or E7 expression to inhibit pRb--in addition to hTERT activity (Kiyono 
et al., 1998). Yet under 2% O2, epithelial cells can be immortalized with hTERT activity alone, 
suggesting that stressful culture conditions may activate p16INK4a and induce senescence 
independently of the telomeres (Ramirez et al., 2001; Rheinwald et al., 2002). The role of 
p16INK4a in the DNA damage response will be further discussed in chapter 4. Lastly, p16INK4a 
does not appear to be involved in RS of murine cells (Smogorzewska and de Lange, 2002), 
indicating that the regulation of RS and telomere dysfunction in murine and human cell lines is 
different, as suggested by others (Hamad et al., 2002; Kim et al., 2002). 
 p53 itself may be upregulated. Although the issue is still controversial, some evidence 
indicates that the ATM gene, or other players involved in DNA damage response, may be the 
“sensor” that detects telomere dysfunction and then regulates p53 (Vaziri et al., 1997; Rouse and 
Jackson, 2002). Moreover, recent results confirm that the chromosome ends of senescent cells 
directly contribute to the DNA damage response and that uncapped telomeres directly associate 
with many DNA damage response proteins (d'Adda di Fagagna et al., 2003). 
 Other players are likely to be involved. For example, the INKa locus also encodes p14ARF 
(Mao et al., 1995; Stone et al., 1995), a tumour suppressor protein mutated in several human 
tumours (Eischen et al., 1999; Lindstrom et al., 2001). In mice, p19ARF can induce growth arrest 
by interacting with MDM2 (Stott et al., 1998), a protein that degrades p53 (Momand et al., 
1992), or through p53-independent pathways (Korgaonkar et al., 2002). In general, p16INK4a 
appears to have a more important role in SIPS and RS of HDFs than ARF while mouse 
fibroblasts appear to rely more on ARF, and so we focus on p16INK4a (reviewed in Serrano and 
Blasco, 2001; Collins and Sedivy, 2003). Intriguingly, some evidence suggests that the Bmi-1 
protein, which controls gene expression through methylation, represses the INK4a locus and 
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extends replicative life span (Itahana et al., 2003). Another possible player is the cyclin D1 
oncogene, which associates with CDKs 4 and 6 (Matsushime et al., 1992; Meyerson and Harlow, 
1994). Ectopic overexpression of cyclin D1 inhibits DNA synthesis and cell growth (Pagano et 
al., 1994; Atadja et al., 1995; Han et al., 1995). Recent results suggest that a novel 
transcriptional element regulates cyclin D1, and possibly other senescence-associated genes, in 
senescence cells (Berardi et al., 2003). 
 Immortalization with viral proteins is not as simple as it may seem at first. Infection of 
HDFs with viral oncogenes results in an extended life span after which cells enter a stage called 
crisis (reviewed in Goldstein, 1990; McCormick and Campisi, 1991; Wei and Sedivy, 1999). For 
example, introduction of SV40 sequences confers an extra 20-30 CPDs to pre-senescent HDFs. 
During crisis, cells proliferate but the rate of apoptotic cells gradually increases and thus cell 
numbers eventually diminish (Macera-Bloch et al., 2002). Since both p53 and pRb/p16INK4a 
pathways are inactive and chromosomal instability and fusions are abundant, crisis is thought to 
emerge due to extremely short telomeres. Occasionally, immortal cells emerge from crisis with 
stabilized telomeres, normally involving telomerase activation (reviewed in Stewart and 
Weinberg, 2000; Mathon and Lloyd, 2001). In a sense, crisis can be seen as the ultimate 
consequence of telomere dysfunction (Figure 16). 
 Even assuming that the p53 and pRb/p16INK4a pathways explain RS, they do not entirely 
explain the gradual ageing of cells in culture. One hypothesis is that telomeres exert a position 
effect on nearby genes. Telomere position effect was first identified in yeast (Gottschling et al., 
1990) but its role in the cellular ageing of human cells has been defended (Baur et al., 2001). 
Perhaps telomere shortening causes the underexpression of important sub-telomeric genes that 
contribute to the changes seen in the in vitro ageing of human cells. Another alternative is that 
cell populations become more heterogeneous as they age. For example, since the percentage of 
cells actively dividing decreases with CPD, it is normal that the cell population as a whole ages, 
without changes other than more cells entering RS. 
 In conclusion, whatever changes occur during telomere dysfunction, the mechanisms 
triggering growth arrest appear to involve DNA damage pathways. As such, the most likely 
explanation is that dysfunctional telomeres are recognized as DNA damage and repairing the 
short telomeres leads to chromosome fusions. Although unidentified genes may also be involved 
(Sugawara et al., 1990; Ogata et al., 1993; Blasco and Hahn, 2003; Yawata et al., 2003), the 
most widely accepted hypothesis is that the p53 and pRb/p16INK4a pathways collaborate to stop 
cellular proliferation derived from telomere shortening in normal HDFs. Probably, the p53 
pathway involving p21WAF1 is activated beforehand, while p16INK4a prevails under strong 
 
 
Figure 16: Telomere shortening determines the proliferative lifespan of human diploid 
fibroblasts. After 60–80 population doublings in culture, short telomeres in human diploid 
fibroblasts trigger a damage response that leads to senescence. Overcoming senescence, by 
abrogation of the pRb and p53 tumour-suppressor pathways, allows continued division until 
critically short telomeres trigger crisis. Rare cells emerge from crisis by activating 
mechanisms for telomere stabilization. Exogenous expression of telomerase reverse 
transcriptase (TERT) at any stage in the replicative history allows immortalization of these 
cells. Taken from Mathon and Lloyd, 2001. 
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physiological stimuli or stress and to maintain cells growth arrested, a state also called 
quiescence. 
  
3.3. Ageing, cancer, and the telomeres 
 
 Telomere shortening is most likely a tumour suppressor mechanism. Mice lacking 
telomerase were viable up to six generations. Telomeres gradually shortened and cells from 
animals of generation four displayed aneuploidy and other chromosomal aberrations. Knocking-
out telomerase in mice through deletion of the RNA component from the germline, while not 
preventing cancer (Blasco et al., 1997; Rudolph et al., 1999), appears to increase cancer 
resistance (Gonzalez-Suarez et al., 2000; Rudolph et al., 2001). On the other hand, telomerase 
overexpression in mice promoted cancer development (Gonzalez-Suarez et al., 2001; Artandi et 
al., 2002). In addition, as presented in chapter 3.2.1, the connection between the telomere 
signalling pathways and cancer is obvious (reviewed in Fearon, 1997). The human Li-Fraumeni 
syndrome has been associated with mutations in p53 and is characterized by increased cancer 
incidence (reviewed in Varley et al., 1997). Human germline mutations in p53 are also 
associated with a major cancer risk (Hwang et al., 2003) and p53 may suppress telomerase 
(Stampfer et al., 2003). Retinoblastoma is also recognized as hereditary cancer (Murphree and 
Benedict, 1984; Weichselbaum et al., 1988; Goodrich and Lee, 1993). Germline mutations in 
p16INK4a have too been implicated in familial melanoma (Hussussian et al., 1994). Lastly, 
telomerase activation has been associated with skin malignancy as a result of exposure to UV 
(Ueda et al., 1997). 
 More dubious is the role of telomeres in animal ageing. Telomerase expression has been 
found in lobsters and trout, two species in which ageing remains undetected (Klapper et al., 
1998a & 1998b). On the other hand, in the frog Xenopus laevis, another animal with a slow rate 
of ageing (Brocas and Verzar, 1961), not only a great variation in telomere length exists 
(Bassham et al., 1998) but telomere length can diminish from parents to offspring, despite 
telomerase activity in germ cells, with no detectable consequences (Mantell and Greider, 1994). 
Recently, telomerase expression has also been found in zebrafish, though little is know about its 
ageing process (Kishi et al., 2003). Lastly, telomeric DNA in chicken appears to be ten times 
bigger than in humans (Delany et al., 2003) and chicken somatic tissues express telomerase 
(Venkatesan and Price, 1998), showing how our knowledge of telomere biology is limited 
regarding other species. 
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 No connection exists between mean telomere length and mammalian ageing. Of all 
studied primates, humans appear to have the shortest telomeres and the longest lifespan (Kakuo 
et al., 1999; Steinert et al., 2002). As mentioned before, telomerase overexpression does not 
affect ageing in mice (Gonzalez-Suarez et al., 2001). Mice also have long telomeres and feature 
high telomerase activity in many organs, in contrast to humans (Prowse and Greider, 1995). 
Interestingly, inbred mice have long (Kipling and Cook, 1990) while wild mice have short 
telomeres, suggesting telomere length does not affect organismal longevity (Hemann and 
Greider, 2000). In fact, telomerase activity appears to be crucial for the normal functioning of 
highly proliferative organs in mice (Lee et al., 1998). Therefore, telomere length and/or 
telomerase activity do not explain why humans age slower than other primates and mice. Yet it 
helps explain why mice have a much higher cancer incidence than men (Blasco, 2003). 
 As mentioned in chapter 2.4., the relation between RS and organismal ageing is 
unproven. Thus, whether telomere shortening plays a role in human ageing is debatable. As with 
replicative potential, telomere length in vivo is very heterogeneous (Serra and von Zglinicki, 
2002; Takubo et al., 2002). Telomere shortening in vivo has been reported in liver cells (Aikata 
et al., 2000), lymphocytes (Mariani et al., 2003), skin cells (Lindsey et al., 1991), blood (Iwama 
et al., 1998), and colon mucosa (Hastie et al., 1990). Other studies found weak correlations 
between donor age and telomere length (Allsopp et al., 1992; Kammori et al., 2002), while some 
studies found no correlation (Mondello et al., 1999; Renault et al., 2002; Serra and von 
Zglinicki, 2002; Takubo et al., 2002). Finally, long telomeres have been found in cells from 
centenarians (Franceschi et al., 1999). Taken as a whole, these results indicate that telomere 
length varies widely amongst individuals and between different tissues and that telomere 
shortening might occur in some tissues in vivo.  
 Most, not all, human somatic tissues have no detectable telomerase activity (reviewed in 
Collins and Mitchell, 2002). In the bone marrow, hematopoietic cells express telomerase. 
Telomerase activity is higher in primitive progenitor cells and then downregulated during 
proliferation and differentiation (Chiu et al., 1996). Other reports associate, normally low, levels 
of telomerase activity with human stem cells (Sugihara et al., 1999), though not mesenchymal 
stem cells (Zimmermann et al., 2003). Telomerase activity has been detected in several normal 
human somatic proliferating cells: for instance, skin (Harle-Bachor and Boukamp, 1996; Taylor 
et al., 1996; Yasumoto et al., 1996), immune system (Counter et al., 1995; Morrison et al., 1996; 
Weng et al., 1997), and colorectal tissues (Tahara et al., 1999). Human germ cells have been 
found to express hTERT (Kilian et al., 1997). 
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 hTERT expression appears to be regulated by the oncogene transcription factor c-Myc 
(Wu et al., 1999). This is intriguing and may relate telomerase to ageing, particularly since c-
Myc is also involved in WRN regulation (Grandori et al., 2003). Yet other players have been 
suggested as regulators of hTERT: Sp1, Mad, and Max (Wick et al., 1999; Xu et al., 2001). 
Therefore, further data is necessary to elucidate the regulation of hTERT expression.  
 Dyskeratosis congenita is an inherited disease involving skin and bone marrow failure 
(reviewed in Marrone and Mason, 2003). It is caused by a mutation in the DKC1 gene. 
Intriguingly, the protein encoded by DKC1, dyskerin, is a component of telomerase. Mutations 
in the RNA component of telomerase are associated with the autosomal dominant form of 
dyskeratosis congenita (Vulliamy et al., 2001). Families with this form of the disease are more 
severely affected in later generations, suggesting telomere shortening mechanisms are involved. 
Features of dyskeratosis congenita include bone marrow failure, which is the most usual cause of 
death, abnormal skin pigmentation, leukoplakia and nail dystrophy (Knight et al., 1998). The 
role of stem cells has also been suggested (Mason, 2003). 
 As judged from the phenotype of dyskeratosis congenita, telomeres are crucial in rapidly 
proliferating tissues but it is unclear whether telomere shortening is involved in human ageing. It 
is possible, however, that telomere shortening is involved in age-related deterioration. Despite 
having active telomerase, the telomeres of lymphocytes shorten with age (Pan et al., 1997). A 
decline in telomerase activity was also found in blood mononuclear cells with age (Iwama et al., 
1998). Though mean telomere length at birth does not correlate with longevity in birds, telomere 
shortening in erythrocytes inversely correlates with bird longevity. Telomere shortening in a 
variety of tissues also correlates, though to a lesser extent, with mammalian longevity 
(Haussmann et al., 2003; Vleck et al., 2003; Figure 17). In fact, a correlation between 
erythrocyte longevity and organismal longevity was previously shown, suggesting that cells, in 
this case erythrocyte stem cells, from long-lived animals divide fewer times (Rohme, 1981). The 
role of telomeres in RS has led to suggestions that telomerase can be used as an anti-ageing 
therapy (reviewed in Fossel, 1996; Blasco, 2003). 
 Lastly, it is unquestionable that RS and SIPS are important tools to study cancer and 
develop anti-cancer treatments (reviewed in Campisi et al., 2001; Blasco and Hahn, 2003; Hahn, 
2003; Lee and Schmitt, 2003; Wang et al., 2003). 
 Figure 17: The relationship between rate of change in mean telomere length (base pairs lost 
[negative numbers] or gained [positive numbers] per year) in various tissues and life span for 
five birds (circles) and eight mammals (boxes). For each class, lines connect the points (or 
mean of the points for species with the same lifespan). Taken from Vleck et al., 2003. Also 
refer to Haussmann et al., 2003 for data sources. 
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CHAPTER 4: MECHANISMS OF SIPS 
 
4.1. From DNA damage to SIPS 
 
 So far, our focus has been on premature cellular senescence induced by damaging agents. 
Yet SIPS can be induced by several oncogenes such as ras (Serrano et al., 1997). p16INK4a or 
p21WAF1 overexpression also induces senescence (McConnell et al., 1998). This further 
demonstrates the connection between cellular senescence and cancer and suggests that SIPS can 
also be a tumour-protective mechanism, like RS was proposed to be. As such, the pathways 
involved in SIPS are of particular interest to research the mechanisms behind cancer and ageing, 
the two of which may be related (Miller, 1991; Anisimov, 2001). 
 In parallel to what happens in RS, pRb plays a crucial role in SIPS. In fact, cells 
expressing E7, that blocks pRb activity, do not undergo SIPS as a consequence of H2O2 
treatment (Chen et al., 2000b). These results suggest that the phosphorylation status of pRb is 
critical for G1/S growth arrest and the appearance of SIPS. Also important in SIPS is p53. DNA 
damage activates p53 which in turn triggers p21WAF1 (Di Leonardo et al., 1994; Chen et al., 
1998). p21WAF1 itself appears an important player since HDFs lacking p21WAF1 failed to arrest the 
cell cycle in response to DNA damage (Brown et al., 1997). Yet blocking p53 through E6 
expression does not prevent SIPS (Dulic et al., 2000). p53’s protein level increases shortly after 
H2O2 stress but returns to basal level at 48 hrs. On the contrary, p21WAF1’s level remains elevated 
for at least 21 days (Chen et al., 1998). These results suggested that p53 may not be a crucial 
player in SIPS. Although p53-independent induction of p21WAF1 has been reported (Tahara et al., 
1995), p21WAF1 action through DNA damage is probably regulated by p53 (Michieli et al., 1994). 
Nevertheless, the possibility exists that p21WAF1 induces SIPS without p53. In addition to the 
p53/p21WAF1 pathway, p16INK4a is also involved in SIPS and p16INK4a is induced by DNA damage 
(Robles and Adami, 1998; Shapiro et al., 1998). Taken together, these results suggest that DNA 
damage triggers a set of molecular pathways similar to those involved in RS (Figure 18). 
Interestingly, ras-induced senescence also appears to involve the p53 and p16INK4a pathways 
(Serrano et al., 1997; Ferbeyre et al., 2002), again arguing in favour of seeing cellular 
senescence as an anti-cancer mechanism. Yet other mechanisms may play a role: the anticancer 
drug cisplatin can cause SIPS in cancer cells independently of p53, p21WAF1, and p16INK4a (Wang 
et al., 1999). 
 Although it is undeniable that the p53/p21WAF1 and pRb/p16INK4a pathways are involved 
in SIPS, it is unclear how they are activated in response to DNA damage. The mitogen-activated 
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Figure 18: DNA-damage pathways into cell-cycle exit. DNA-damage (black lines) can induce 
p16INK4a or may be sensed by ATM or related kinases which then activate p53. p16INK4a and 
p53 cooperate to induce SIPS. Apoptotic pathways may also be activated through p53. 
Adapted from Lee and Schmitt, 2003. 
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protein kinase (MAPK) family was shown to be involved in ras-induced senescence by 
activating p53, 21WAF1, and p16INK4a and triggering SA β-gal activity (Lin et al., 1998b). JunB 
may also be a transcriptional activator of p16INK4a (Passegue and Wagner, 2000). As for p53, 
many signalling pathways activated by stress, such as ROS, can contribute to p53’s activation 
(reviewed in Martindale and Holbrook, 2002). The tumour suppressor PLM may regulate p53 in 
response to oncogenic stimuli (Pearson et al., 2000). Proteins involved in DNA damage 
recognition, such as ATM, may be involved in p53 activation (Banin et al., 1998; Canman et al., 
1998; Rouse and Jackson, 2002). In fact, ATM has been hypothesized as a sensor of stress 
(Rotman and Shiloh, 1997). As happens in RS, the mRNA levels of the oncogene c-fos also 
decrease in SIPS (Dumont et al., 2000a), suggesting a loss in the activity of AP-1, which has 
been hypothesized to activate p53 in RS (Irving et al., 1992). Other results, however, deem such 
conclusions as unlikely and indicate that AP-1 and c-fos are not critical for cellular senescence 
(Lucibello et al., 1993). The transcription factor NF-κB has also been suggested to upregulate 
p53 (Wu and Lozano, 1994; Dumont et al., 1999). NF-κB itself may be activated, in some, but 
not all, cell lines, in response to UVB (Helenius et al., 1999) or H2O2 (reviewed in Li and Karin, 
1999; Bowie and O’Neill, 2000). On the other hand, ROS may activate p53 directly by 
modulating the redox status of a set of cysteins in the DNA-binding domain (Meplan et al., 
2000). Despite the knowledge of multiple pathways that respond to stress (reviewed in 
Martindale and Holbrook, 2002), the exact cascade of events leading to SIPS is unknown. 
 One important player may be transforming growth factor-β1 (TGF-β1). Briefly, the TGF-
β family is involved in multiple functions including development, differentiation, morphology, 
and cellular proliferation (reviewed in Alevizopoulos and Mermod, 1997; Padgett et al., 1998). 
Immortalization has been associated with loss of response to TGF-β and incubation of HDFs 
with TGF-β induces a senescent phenotype (Sorrentino and Bandyopadhyay, 1989; Herrera et 
al., 1996; Katakura et al., 1999). SIPS triggers the release of TGF-β1 while incubation with 
antibodies against TGF-β1 or its receptor II represses SIPS (Frippiat et al., 2001). Intriguingly, 
TGF-β1 induces H2O2 production in HDFs, suggesting that a positive feedback loop may be 
formed (Thannickal and Fanburg, 1995). TGF-β1 can downregulate the CDK2 (Hu et al., 2001). 
Not surprisingly, pRb interacts with the TGF-β family. Not only TGF-β can alter the 
phosphorylation status of pRb (Laiho et al., 1990), but pRb can regulate the expression of TGF-
β1 (Kim et al., 1991). 
 One possible link between DNA damage and TGF-β involves a member of the MAPK 
family: p38MAPK, which was shown to be involved in growth arrest in response to oxidative 
stress (Kurata, 2000). Activation of p53 by p38MAPK has also been reported (Bulavin et al., 
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1999). Clearly, p38MAPK is activated shortly after stress (Chen et al., 2001a; Kabuyama et al., 
2001; Volonte et al., 2001) and can remain active for 72 hrs after stress (Frippiat et al., 2002). 
One hypothesis is that p38MAPK activates the activating transcription factor-2 or ATF-2 (Cheong 
et al., 1998; Waas et al., 2001), which in turn can interact with pRb (Kim et al., 1992). The 
interaction of ATF-2 and pRb has been demonstrated by immunoprecipitation (Frippiat et al., 
2002) but exactly how pRb interacts with ATF-2 is unclear. Nonetheless, evidence suggests that 
ATF-2 mediates pRb’s regulation of other genes while at the same time ATF-2 is important in 
the transcription of pRb (Park et al., 1994). TGF-β1 would then be overtranscribed by the 
concerted action of ATF-2 and pRb, as has been shown to occur to TGF-β2 (Kim et al., 1992). In 
turn, TGF-β1 can activate p38MAPK and consequently ATF-2 (Hanafusa et al., 1999). These 
results led to the suggestion of a regulatory loop between TGF-β1 and p38MAPK (Figure 19). 
Indeed, antibodies against TGF-β1 prevented the sustained, but not short term, phosphorylation 
of p38MAPK and ATF-2 under SIPS, while inhibition of p38MAPK or ATF-2 prevents 
overexpression of TGF-β1 and represses SIPS. It was also shown that the appearance of SA β-
gal activity in H2O2-induced SIPS depends on the activation of p38MAPK and ATF-2 (Frippiat et 
al., 2002). Moreover, a recent study found that p38MAPK inhibition repressed SIPS and delayed 
RS. A differential role of pRb was also suggested. The same study suggested that unidentified 
factors act upstream of p38MAPK in response to H2O2 because activation of p38MAPK continued 
even after exposure to H2O2 (Iwasa et al., 2003), yet it may be that the regulatory loop between 
TGF-β1 and p38MAPK activated p38MAPK. Importantly, though, pRb’s regulation of TGF-β1 and 
even TGF-β1’s functions vary between different cell lines (Kim et al., 1991; Massague, 1998). 
 Although the p53/p21WAF1 and pRb/p16INK4a pathways are involved in activating SIPS, it 
is likely that other pathways also have the ability to cause SIPS. At least in some cell lines, one 
of those pathways may involve p38MAPK and TGF-β. 
 
4.2. The telomeres 
 
 Although telomeres are a key factor in RS, when we began our work, their role in SIPS 
was a subject of debate. Of importance is the work of Thomas von Zglinicki, who initially 
showed that HDFs cultured at 40% O2 undergo SIPS after a maximum of three CPDs. Telomere 
shortening of cells under hyperoxia was around 500 bp per population doubling (PD) when 
compared to the 90 bp/PD shortening of controls. A telomere cut-off length of 4 kbp at which 
cells were growth arrested was also found. These results led to the suggestion that telomere 
shortening is the signal that initiates senescence (von Zglinicki et al., 1995). 
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Figure 19: Representation of the closed regulatory loop that induces and maintains the biomarkers of SIPS at a long term after H2O2 stress. The 
early events are indicated with light grey arrows and the late events in dark grey. Adapted  from the thesis of Christophe Frippiat.
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 It was already known at the time that DNA damage could result in growth arrest (Di 
Leonardo et al., 1994). Yet further results from von Zglinicki and his colleagues suggested that 
telomeres are important “sensors” of DNA damage. Single and double strand breaks are the 
hallmark of oxidative damage resulting from ionizing radiation or H2O2 (reviewed in Beckam 
and Ames, 1998). As a result of different types of oxidative damage, single-strand regions--
breaks, overhangs, and gaps--appear to accumulate more often in the telomeres than in other 
regions of the genome (Petersen et al., 1998). These results suggested that telomeres are 
“guardians of the genome”, triggering senescence in both RS and SIPS (von Zglinicki and 
Saretzki, 1997). It was also hypothesized that different rates of telomere shortening within 
cultures would determine the heterogeneity of cell populations (Rubelj and Vondracek, 1999). In 
addition, oxidative stress mediated the production of single-strand damage that would lead to 
growth arrest through the p53/p21WAF1 pathway. Furthermore, the introduction of telomeric 
oligonucleotides into HDFs induced a growth inhibition also based on the p53/p21WAF1 pathway 
(Saretzki et al., 1999). 
 In its essence, the hypothesis relating telomeres to SIPS was that oxidative damage would 
cause single-strand damage to telomeric DNA. Unlike damage to the genome, damage to the 
telomeres cannot be repaired in normal HDFs since these lack telomerase activity, resulting in 
telomere shortening and single-strand DNA that would trigger SIPS through the p53 pathway 
(reviewed in von Zglinicki, 1998).  
 Shortly after we began our work, one experiment in our laboratory raised doubts on the 
influence of telomere shortening in SIPS. HDFs exposed to four subcytotoxic t-BHP stresses 
every two PDs underwent a telomere shortening of 245 bp/PD, in contrast to 107 bp/PD in 
controls. Accelerated telomere shortening was also witnessed in the PD following five repeated 
stresses with t-BHP or a single H2O2 stress: respectively, 381 and 322 bp. Telomere shortening 
in subsequent PDs was similar to controls: 108 bp/PD in the t-BHP-treated HDFs, 93 bp/PD in 
the H2O2-treated HDFs, and 109 bp/PD in controls. Since telomeres did not reach their critical 
length, it was hypothesized that telomere shortening was a consequence rather than a cause of 
SIPS. Compared to controls, about 20% of cells could proliferate after stress, meaning that these 
cells had to compensate for the growth-inhibited ones, termed compensatory cycling. Having 
cells divide more often would result in an increase in telomere shortening, and thus telomere 
shortening would be a result rather than a cause of SIPS. These results indicated that the role of 
telomeres in SIPS might be overestimated and suggested that other mechanisms may be at work 
(Dumont et al., 2001). Earlier results had already shown that senescence could be induced 
without telomeres reaching their critical lengths (Michishita et al., 1998; Suzuki et al., 2001b). 
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 More recent calculations on the rate of telomere shortening in HDFs under oxidative 
stress showed that compensatory cycling is not sufficient to explain the observed telomere 
shortening under mild oxidative stress, and so oxidative stress accelerates telomere shortening 
(Toussaint et al., 2002a; von Zglinicki, 2002). Yet since senescence could be observed in the 
absence of critically short telomeres, the importance of telomeres in SIPS was unclear. 
Addressing the role of telomeres in SIPS was one of the aims of our work and will be thoroughly 
discussed herein. 
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CHAPTER 5: COMPUTATIONAL METHODS 
 
5.1. From genes to ageing 
 
 An old debate in the field of gerontology is whether genetic or environmental factors are 
predominant in ageing. Irrespectively of what factors are predominant, in humans, age-related 
degenerative changes and diseases can result from genetic or environmental factors, or a 
combination of both. For example, the chances of developing lung cancer can be increased by 
genetic and environmental factors (Reif, 1981). Therefore, age-related changes derived from 
both intrinsic and extrinsic factors deserve medical attention and both must be studied for us to 
have a complete picture of the ageing phenotype. Indeed, there is a great variability in the human 
ageing phenotype as a consequence of both genetic and environmental factors (reviewed in 
Finch, 1990). In addition to developing methods to study age-related changes mostly derived 
from extrinsic factors--i.e. using SIPS--, our aim was also to develop tools and strategies to study 
the genetic basis of human ageing. 
  Many others have tried to study the genetics of ageing by way of approaches which will 
be discussed succinctly. One common strategy is to search life-extending genetic manipulations 
in model organisms (reviewed in Johnson and Shook, 1997) such as Drosophila (reviewed in 
Tower, 2000), C. elegans (reviewed in Johnson, 2002), or mice (for example: Flurkey et al., 
2001). These studies have already found a few genes that may play a role in human ageing. The 
problem, as mentioned in chapter 1.5., is that genetics of ageing in model organisms may or may 
not be similar to the genetics of ageing in humans. For example, mutations in the human WRN 
appear to accelerate ageing (Goto, 1997 for arguments) while mutating the WRN homologue in 
mice has no visible effect on their ageing process (Lombard et al., 2000; Wang et al., 2000a), 
despite WRN being involved in murine tumour suppression (Lebel et al., 2001 & 2003). Another 
approach is to attempt to locate genes in humans that influence ageing by studying, for example, 
families with exceptional longevity (Puca et al., 2001). Though potentially useful, these studies 
may be secondary to ageing for the genes located may influence longevity without affecting 
ageing (Perls et al., 2002). In fact, many genes may influence age-related changes (Martin, 
1982). Although studying genes that affect one or a few age-related pathologies without 
affecting rate of ageing is medically sound, our priority is to understand the genetics of the 
ageing process rather than individual diseases. Even SIPS, though based on extrinsic factors, can 
be helpful in understanding the genetics of ageing for genes involved in stress resistance might 
be involved in the ageing process. Yet, of course, extrapolating from in vitro senescence to 
40 
organismal ageing is not straightforward, as mentioned in chapter 2.4. Overall, studying human 
ageing is limited by the available models, as pointed out in chapter 1.5. 
 Scientific discovery has always been limited by the available technologies. The recent 
sequencing of the human genome has unleashed a flood of data (Lander et al., 2001; Venter et 
al., 2001). Due to our lack of knowledge regarding the human ageing process, such large 
amounts of data can be particularly useful to study the genetics of ageing. So far we only know 
of a few genes that modulate rate of ageing in animals, and probably only one or two in humans-
-i.e. the progeroid genes. Yet findings such as WRN show the extraordinary influence of genes 
on the ageing phenotype. Discovering more genetic players in the human ageing process would 
be a major breakthrough and a step forward in uncovering the genetic basis of human ageing. 
Therefore, we wanted to develop new approaches to study the genetics of human ageing based 
on the incoming tidal wave of data. In addition to genomic sequence--i.e. DNA sequence--, the 
life sciences are also being flooded by protein sequences, macromolecular structures, and gene 
expression data. To organize, analyse, and interpret biological data, bioinformatics was born 
(reviewed in Luscombe et al., 2001; Yaspo, 2001). 
 
5.1.1. Comparative genomics 
 
 One powerful way to analyze and interpret genomes is by comparing different genomes, 
known as comparative genomics (reviewed in Clark, 1999; O’Brien et al., 1999; Wei et al., 
2002; Ureta-Vidal et al., 2003). The basic assumption when comparing two genomes is that they 
had a common ancestor and so each base pair in each genome results from a combination of the 
ancestral genome plus evolution. Comparative genomics can be employed at a holistic level. 
Briefly, structural genomic features such as genome size, nucleotide statistics (G+C content and 
G+C distribution across the genome), gene density, and distribution of DNA repeats can be 
determined. Also relevant is the analysis of synteny, which describes regions of two genomes 
that share similar genes and DNA sequences and thus are likely to have evolved from a common 
evolutionary ancestor. Syntenic regions give clues on genome organization and evolution. 
 Comparisons can also focus on coding regions (reviewed in Wei et al., 2002; Ureta-Vidal 
et al., 2003). Unlike bacteria, eukaryotes have introns and large non-coding intergenic regions, 
making gene prediction much more difficult. Since mutations accumulate less often in gene-
coding regions, the identification of conserved sequences between different genomes often 
reveals coding regions. Indeed, new genes have already been discovered based on comparative 
genomics between the mouse and human genomes (Dehal et al., 2001; Pennacchio et al., 2001). 
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 When several bacterial genomes became available--not only from different species but 
also from different sub-species and even from different strains--, comparisons between different 
genomes allowed a better understanding of gene function (reviewed in Yaspo, 2001; Wei et al., 
2002). One approach is to build a phylogenetic profile by determining the presence or absence of 
a protein across many genomes. Functionally related proteins are expected to have similar 
profiles and thus can be grouped together. Although the method does not solve the problem of 
false negatives, functionally similar proteins do tend to have similar phylogenetic profiles 
(Pellegrini et al., 1999). Hints about protein function and protein-protein interactions in an 
organism can also be studied by finding protein fusions in other organisms (Marcotte et al., 
1999a). Another approach involves a detailed comparison of specific pathways. In one example, 
researchers compared DNA repair pathways from the bacterium Escherichia coli and S. 
cerevisiae across different genomes in order to understand the evolution of repair systems 
(Aravind et al., 1999). 
 To make comparative genomics possible, a variety of algorithms and computer programs 
exist, from tools to perform whole-genome alignments to programs to produce alignments 
between subregions of sequences, called local alignments (reviewed in Wei et al., 2002; 
Couronne et al., 2003; Frazer et al., 2003; Pennaccio and Rubin, 2003; Ureta-Vidal et al., 2003). 
Of course that comparative genomics is not without its limitations, particularly when applied to 
the large vertebrate genomes. One major problem arises from inaccurate biological information 
added or missing from genome sequence, called genome annotation. For example, common 
errors arise in gene prediction. Another type of limitation results from the unpredictable nature of 
biological systems. Two structurally-related genes can have different functions and vice-versa 
(reviewed in Yaspo, 2001). Despite these pitfalls, comparative genomics is becoming an 
increasingly important tool for deciphering gene function and understanding biological systems. 
 
5.1.2. Transcriptional regulation 
 
 One of the surprising discoveries from the sequencing of mammalian genomes is their 
extraordinary similarity. For example, DNA sequences between humans and chimpanzees share 
about 95% of base pairs (Britten, 2002) and probably chimpanzees have our same set of genes 
(Wade, 2001). Even mice and humans share 97% of their genes, according to the lowest of the 
latest estimates (Mural et al., 2002; Waterstone et al., 2002). What appears to determine the 
differences between humans and chimpanzees is not gene content per se but rather when and 
how the genes are expressed (Enard et al., 2002). In other words, the genes may well be similar 
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between humans and other animals, but they are used or transcribed differently and the way they 
are transcribed determines the differences between humans and other animals (reviewed in 
Levine and Tjian, 2003). 
 In eukaryotes, transcription begins with the assembly of a large complex of proteins, 
including RNA polymerase II, called transcription initiation complex (TIC). The TIC is 
assembled in a region called the “promoter” or “core promoter” that is located upstream--i.e. is 
in the 3’→5’ direction--of the first nucleotide to be transcribed; this site where transcription of 
RNA begins is called transcription start site (TSS) (Hampsey, 1998; Lemon and Tjian, 2000; 
Figure 20). 
 Transcriptional regulation is a complex process that only recently began to be understood 
(reviewed in Arnone and Davidson, 1997; Fickett and Wasserman, 2000). Importantly, the 
regulatory program in eukaryotes is defined in the non-coding genome sequence, largely in the 
form of cis-regulatory sequences that are critical in development and cellular differentiation. 
These elements are sequence-specific targets of DNA-binding proteins called transcription 
factors (TFs) that, together with proteins that bind them, control gene activity. Both positive and 
negative cis-regulatory interactions exist, called, respectively, enhancers and silencers. Negative 
regulators can shut down the TIC but normally they work by disrupting positive regulators. 
These regulatory elements are normally located within 1,000 bp upstream of the TSS, though 
some elements can be thousands of bp away. Regulatory elements can also be present within 
introns downstream of the TSS (Figure 21). Although components of the TIC can modulate gene 
expression (Holstege et al., 1998), TFs are the major players in transcriptional regulation 
(Coulson and Ouzounis, 2003 for arguments). 
 In brief, TFs work together to control gene expression (reviewed in Arnone and 
Davidson, 1997; Fickett and Wasserman, 2000). The binding specificity of TFs, not their 
arrangement, is critical to control gene expression. A cluster of TF binding sites (TFBS) where 
any TF affects gene expression is called a module. From a structural point of view, TFs probably 
cooperate through DNA looping. In fact, certain proteins, such as Sp1, appear to help modules 
interact by promoting or stabilizing loops (Pascal and Tjan, 1991). Combining regulatory 
elements from the gut-specific Endo 16 gene and from the skeletogenic SM50 gene, scientists 
obtained a combined gut and skeletogenic mesenchyme pattern of expression, showing how two 
modules can cooperate (Kirchhamer et al., 1996). Yet a gene’s regulation can occur through 
single or multiple modules. Lastly, chromatin modifications can prevent transcription by 
blocking access to the genome and, though the mechanisms involved are unclear, have profound 
effects on gene expression (Felsenfeld and Groudine, 2003). Although TFs can be seen as 
 
 
Figure 20: The eukaryotic promoter consists of core elements, which include the TATA box 
and other DNA sequences that define transcription start sites, and regulatory elements, which 
either enhance or repress transcription in a gene-specific manner. Regulatory elements bind 
gene-specific factors, which affect the rate of transcription by interacting, either directly or 
indirectly, with components of the transcriptional machinery. Adapted from Tjian, 1995 and 
Hampsey, 1998. 
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upstream of other genes from a genomic perspective, it is also important to have in account 
protein-protein interactions as well as the regulatory interactions between TFs that give rise to 
complex regulatory networks. One example of a well-characterized regulatory region is that of 
the Endo 16 gene from the sea urchin (Yuh et al., 1998; Figure 22). 
 As a whole, TF target sites in the regulatory regions of a gene determine the inputs to 
which the gene will respond and the target sites of a TF determine the response that TF will 
generate. Since transcriptional regulation is located in the genetic information, bioinformatics is 
also attempting to tackle regulatory networks. Although regulatory analysis requires molecular 
manipulations such as analysis of DNA-protein interactions in vitro, mutations, and synthetic 
expression constructs, computational tools are becoming increasingly important in understanding 
regulatory networks. Algorithms can locate putative TFBS in genome sequence, though these 
continue to suffer from an excessive number of false positives (reviewed in Stormo, 2000; Ohler 
and Niemann, 2001; Pennacchio and Rubin, 2001). This problem probably results from 
competitions amongst TFBS as well as changes in chromatin structure that influence the 
functionality of TFBS (Audic and Claverie, 1998; Fickett and Wasserman, 2000). 
 Comparative genomics of transcriptional regulation, or phylogenetic footprinting (Tagle 
et al., 1988), is a branch of comparative genomics also based on the principle that functionally 
important regions have lower mutation rates (reviewed in Hardison et al., 1997; Ansari-Lari et 
al., 1998; Hardison et al., 2000; Pennacchio and Rubin, 2001). Consequently, locating conserved 
non-coding regions may help determine regulatory regions since these appear to have a higher 
density of regulatory signals (Hardison et al., 1997; Levy et al., 2001). Phylogenetic footprinting 
has already been successfully used in the discovery of mammalian regulatory elements of genes 
such as Bruton’s tyrosine kinase and β-globin (Hardison et al., 1997), interleukins 4, 5, and 13 
(Loots et al., 2000), stem cell leukaemia gene (Gottgens et al., 2000 & 2001), as well as many 
others (for example: Ellsworth et al., 2000; Leung et al., 2000; Wu et al., 2001). In addition, 
with the availability of more genomes, phylogenetic footprinting should become gradually more 
powerful (Hardison et al., 1997; Dubchak et al., 2000; Mouchel et al., 2001). One major 
problem with phylogenetic footprinting, as well as overall TFBS identification by computational 
methods, is the presence of false positives. Nevertheless, phylogenetic footprinting followed by 
experimental identification is an effective method for the identification of transcriptional 
regulatory regions. 
  
 
Figure 21: Representative example of a eukaryotic promoter. In biology the term “promoter” 
has two meanings: it can refer to the region immediately upstream of the TSS (marked 
“promoter” in the figure) or it can refer to cis-acting genetic elements controlling the rate of 
the TSS (marked “enhancer” in the figure). In this work we use the later definition, unless 
otherwise noticed, as in the case of this figure. Adapted from Tjian, 1995. 
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5.1.3. Gene expression studies 
 
 One powerful new tool to understand how transcription works is the DNA microarray 
(reviewed in Lander, 1999 and the subsequent Nature Genetics supplement). The most common 
goal of employing DNA microarrays is to monitor RNA expression levels. One important 
limitation is the frequent lack of correlation between messenger RNA (mRNA) and protein 
levels (Gygi et al., 1999), meaning that mRNA levels give information about regulation but not 
necessarily functionality. 
 Briefly, DNA microarrays derive from the principle that labelled nucleic acid molecules 
can be used to interrogate genetic material to determine DNA sequence attached to a solid 
support (Southern, 1975). The first protocols resembling modern DNA microarrays used DNA 
robotically spotted to a microscopic glass slide. DNA complementary to the mRNA of each gene 
to be studied was used. mRNA double-labelled samples were hybridized with the slides and gene 
expression would then be quantified by measuring the fluorescence on each spot (Schena et al., 
1995). Other ways of building DNA microarrays have also been developed, such as DNA 
microarrays that use samples with complementary DNA or RNA. With recent progresses, DNA 
microarrays can now feature thousands of genes (reviewed in Bowtell, 1999; Lockhart and 
Winzeler, 2000). 
 DNA microarrays can be divided into low and high density microarrays, being the 
threshold normally set at 400 spots/cm2 due to a patent of the Affymetrix company. The great 
advantage of high density microarrays with thousands of genes--often including genes with no 
known function--is that it is not necessary to know what genes are important in the process under 
study (Figure 23). Their major limitation is that it can be difficult to analyse the data, results are 
often less reproducible, and high density microarrays are much more expensive. In contrast, low 
density microarrays are cheaper, in general yield more reproducible results, and these are easier 
to analyze since we know the genes under study. Their major limitation is that they require a 
priori knowledge about the process under study and the genes involved (reviewed in Lockhart 
and Winzeler, 2000; Zammatteo et al., 2002). 
 If the aim of a study using DNA microarrays is to find, for instance, tumour markers, then 
examining the genes whose expression change more markedly is an efficient technique. Yet if 
the goal is to understand a process based on large amounts of gene expression data, then a more 
careful analysis is needed. Clustering genes whose expression patterns are similar is a typical 
step in the analysis of a complex process; a large numbers of clustering algorithms exist 
(reviewed in D’Haeseleer et al., 2000). Genes with similar functions tend to cluster together, 
 
 
Figure 22: Endo16 cis-regulatory system and interactive roles of module A. (A) Diversity of 
protein binding sites and organization into modular subregions. Specific DNA binding sites 
are indicated as red blocks; modular subregions are denoted by letters G to A (Bp, basal 
promoter). Proteins binding at the target sites considered in this work are indicated: Otx, 
SpOtx-1; SpGCF1; the proteins CG, Z, and P, which are not yet cloned; and protein C (a 
CREB family protein) in subregion F. Proteins for which sites occur in multiple regions of the 
DNA sequence (indicated by the black line) are shown beneath. (B) Sequence of module A 
and location of protein binding sites. Sites are indicated in the same colours as in (A). A 
fragment containing CG3 and CG4 sites as well as Bp has no endodermspecific activity and 
services other upstream cis-regulatory systems promiscuously; similarly, the Endo16 cis-
regulatory system functions specifically with heterologous promoters substituted for Bp. 
Boxed sequences indicate conserved core elements of the target sites, not the complete target 
site sequences. (C) Integrative and interactive functions of module A. Module A 
communicates the output of all upstream modules to the basal transcription apparatus. It also 
initiates endoderm expression, increases the output of modules B and G, and is required for 
functions of the upstream modules F, E, and DC. These functions are repression of expression 
in nonendodermal domains and enhancement of expression in response to LiCl. Adapted from 
Yuh et al., 1998. 
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making gene expression patterns good indicators of the status of cellular processes. In addition, 
insights can be gained on genes with unknown functions if they cluster together with known 
genes (DeRisi et al., 1997; Chu et al., 1998; Eisen et al., 1998; Spellman et al., 1998). 
 Large amounts of gene expression data obtained under different conditions can be used to 
identify cis-regulatory regions (reviewed in Ohler and Niemann, 2001; Pennacchio and Rubin, 
2001). Genes expressed similarly are presumably regulated similarly and therefore may share 
cis-regulatory elements (Chu et al., 1998; Tavazoie and Church, 1998). As such, it is possible to 
find putative cis-regulatory elements in yeast by analysing, with motif discovery programs, the 
regions upstream of genes clustered together (Tavazoie et al., 1999). Identifying novel motif 
combinations that affect expression patterns at various stages of yeast development is also 
possible, leading to a better understanding of the regulatory machinery (Pilpel et al., 2001). 
 Other technical variants and applications of DNA microarrays exist (reviewed in 
Lockhart and Winzeler, 2000). One powerful technique for the understanding of transcriptional 
regulation in yeast is genome-wide location analysis (reviewed in Wyrick and Young, 2002). In 
brief, the technique involves a DNA microarray with the complete set of yeast intergenic regions 
(Figure 24). DNA enriched with an antibody against the TF of interest is labelled and hybridized 
against the DNA microarray revealing which promoters, and often which genes, are regulated by 
the TF. This approach has been used to gather information about yeast regulatory networks 
(Simon et al., 2001) as well as to identify new functions of yeast transcriptional activators (Ren 
et al., 2000; Iyer et al., 2001). Employing genome-wide location analysis to human cells has also 
been developed using a selection of human promoter sequences. Several genes were identified as 
potentially activated by E2F including several genes with no known connection to E2F (Ren et 
al., 2002). 
 
5.2. Systems biology 
 
 Understanding a complex process such as human ageing will likely depend on the 
employment of both computational tools and experimental approaches. The integration of these 
two forms of biological information requires a systems biology approach (reviewed in Ideker et 
al., 2001a; Kitano, 2002a & 2002b). Systems biology is based on information obtained from a 
given biological system under different genetic or environmental conditions. Information is then 
mathematically treated to construct a model that explains the system. For example, insights into 
the regulation of galactose use in yeast have been obtained through systems biology by gathering 
information from gene expression and protein levels, as well as protein-protein and protein-DNA 
 Figure 23: Yeast genome microarray. The actual size of the microarray is 18 mm by 18 mm. 
A fluorescently labelled cDNA probe was prepared from mRNA isolated from cells harvested 
shortly after inoculation (culture density of <5 X 106 cells/ml and media glucose level of 19 
g/liter) by reverse transcription in the presence of Cy3-dUTP. Similarly, a second probe was 
prepared from mRNA isolated from cells taken from the same culture 9.5 hours later (culture 
density of ~2 X 108 cells/ml, with a glucose level of <0.2 g/liter) by reverse transcription in 
the presence of Cy5-dUTP. In this image, hybridization of the Cy3-dUTP–labelled cDNA 
(that is, mRNA expression at the initial timepoint) is represented as a green signal, and 
hybridization of Cy5-dUTP–labeled cDNA (that is, mRNA expression at 9.5 hours) is 
represented as a red signal. Thus, genes induced or repressed after the diauxic shift appear in 
this image as red and green spots, respectively. Genes expressed at roughly equal levels 
before and after the diauxic shift appear in this image as yellow spots. This image was 
obtained using a fluorescent scanning confocal microscope. Taken from DeRisi et al., 1997. 
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interactions under different genetic perturbations (Ideker et al., 2001b). Our understanding of sea 
urchin development has also been improved by a systems biology approach (Davidson et al., 
2002). 
 One drawback of gene expression data is that although they can be used to identify genes 
involved in a process, they does not identify the causal relationship between the genes (Kitano, 
2002a). Several algorithms exist that attempt to infer a genetic network from gene expression 
data (reviewed in D’Haeseleer et al., 2000). These methods also follow a systems biology 
approach since they are based on obtaining a large amount of data under different conditions 
(Akutsu et al., 1999; Wagner, 2001). Integration of data will be crucial for understanding 
complex biological systems. For example, understanding transcriptional regulation will likely 
require the integration of information from phylogenetic footprinting, computer algorithms, and 
regulatory regions identified from gene expression data (Pennacchio and Rubin, 2001). 
 Rising from the ongoing genomic revolution, the goals of systems biology are to build a 
detailed simulation of human cells followed by an identification of all genetic variations, drug 
responses, and environmental stimuli responses (Kitano, 2002a).  
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Figure 24: Strategy for analysing genome-wide protein ± DNA interactions. The reference 
probe can either consist of DNA generated in parallel from a strain bearing a deletion of the 
gene encoding the protein of interest (as depicted), or of unfractionated genomic DNA 
amplified and labelled in the same manner. Alternatively, an epitope-tagged version of the 
protein of interest can be immunoprecipitated with an antibody directed against the epitope. 
The DNA microarray includes all of the intergenic regions or promoters from the genome. 
The Cy5/Cy3 fluorescence ratio for each locus reflects its enrichment by immunoprecipitation 
and therefore, in general, its relative occupancy by the cognate protein. Taken from Iyer et al., 
2001. 
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Aim of the Work 
 
 
 
 Human ageing derives from a combination of genetic and environmental factors. In this 
work, we wanted to tackle both. As mentioned earlier, studying human ageing is dependent on 
the available models, such as animal and cellular models. Integrating studies from several 
sources has always been problematic, particularly since it is difficult to determine how 
representative of human ageing each model is. Therefore, one of the goals of this work was to 
assess models of ageing and determine which are the most appropriate to study the human ageing 
process. 
 
 The different ageing phenotypes found in nature, such as animals that appear not to age, 
suggest that the evolution of ageing is heterogeneous (reviewed in Finch, 1990). So the first part 
of our work was to determine how specific the evolution of human ageing is. By analysing the 
evolution of ageing in humans and evolutionary close taxa, we wanted to have a better view on 
what organisms are more appropriate to study ageing. 
 
 The main reason for choosing cellular biology as a model to study ageing was that it 
allowed us to focus on human biology rather than that of model organisms. We chose to study 
senescence in human diploid fibroblasts since the molecular and regulatory pathways involved in 
RS may be different, for instance, in human, mouse, and chicken cells (Kim et al., 2002). For 
reasons already mentioned, our main focus was SIPS. Stress resistance in vitro correlates with 
mammalian longevity (Kapahi et al., 1999), so the study of SIPS should not only help clarify 
extrinsic factors in age-related degeneration, but may also help elucidate the mechanisms of 
ageing. 
 Since reactive oxygen species have been proposed to be an important player in ageing 
(reviewed in Beckman and Ames, 1998), we employed a single 2-hour stress with H2O2 to 
induce SIPS, a model previously established (Chen and Ames, 1994; Chen et al., 1998; Chen et 
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al., 2000b). When we began our work, our laboratory was developing a new SIPS model based 
on UVB (Chainiaux et al., 2002). Although our priority was oxidative stress with H2O2, in 
collaboration with Florence Chainiaux, we also employed five repeated daily exposures to UVB 
to induce SIPS. 
 Telomeres play a critical role in RS (Bodnar et al., 1998 for arguments). Since SIPS also 
accelerates telomere shortening, telomeres have been proposed as the key signalling process in 
SIPS (von Zglinicki et al., 1995; von Zglinicki and Saretzki, 1997; von Zglinicki, 1998). At 
about the time we began our work, other results cast doubts on the importance of telomere 
shortening in SIPS. Rather than telomeres being a cause of SIPS, it was proposed that telomere 
shortening was partly a result of compensatory cycling and a consequence of SIPS (Dumont et 
al., 2001; Toussaint et al., 2002a). Our aim in this work was to elucidate the importance of the 
telomeres in SIPS. 
 Since telomerase prevents RS in human cells and appears to stabilizes the telomeres 
(Blackburn, 2000), by employing a telomerase-positive cell line, we wanted to investigate the 
effects of telomerase in SIPS. Using hTERT-BJ1 human diploid fibroblasts and BJ controls, we 
wanted to know whether different mechanisms may be active in provoking SIPS in these two cell 
lines. Our aim was to study the telomeres to understand the interactions between cellular 
senescence and stress. 
 Werner’s syndrome appears to cause accelerated ageing (Goto, 1997). If hTERT-BJ1 
cells can be seen as having enhanced DNA repair, Werner’s syndrome fibroblasts have defective 
DNA repair systems (Fukuchi et al., 1989). Consequently, we also wanted to establish a model 
of SIPS to study Werner’s syndrome fibroblasts. 
 
 One technology deriving from the recent genomic revolution is the DNA microarray 
(reviewed in Lockhart and Winzeler, 2000). In collaboration with Eppendorf Array Technologies 
(Namur, Belgium), we employed DNA microarray technology in our research on SIPS. 
 Computational methods are becoming an integrative part of biological research. We 
wanted to develop computer methodologies to understand the genetic basis of human ageing. 
How can researchers take advantage of the recent tools in bioinformatics to study ageing? We 
wanted to build a strategy for the use of high-throughput computational approaches to the study 
of ageing that may serve as basis in modelling the human ageing process and developing anti-
ageing interventions. This strategy will be developed in a special chapter (11) of this work’s 
discussion. 
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Results 
 
 
 
Chapter 6: Human ageing: evolution and research models 
6.1. Article 1: The evolution of mammalian aging (Experimental Gerontology, volume 37, 
pages 769-775, 2002) 
Chapter 7: Role of the telomeres in SIPS 
7.1. Article 2: Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin 
fibroblasts (FEBS Letters, volume 523, pages 157-162, 2002) 
Chapter 8: Gene expression in SIPS 
8.1. Article 3: All roads lead to Rome: How gene expression networks reorganize in 
premature senescence of human skin fibroblasts expressing or not telomerase (submitted 
for publication) 
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CHAPTER 6: HUMAN AGEING: EVOLUTION AND RESEARCH MODELS 
 
 Since the study of human ageing is based on extrapolations from models, it is critical that 
we have an assessment of how adequate each model is. The employment of model organisms to 
study ageing has been, for a long time, a common practice in gerontology. Nonetheless, it is 
unknown whether mechanisms found in model organisms are representative of the human ageing 
process. The first part of our work was to address this problem through a comparative biology 
approach. By comparing the human ageing process with other ageing phenotypes we attempted 
to have a clearer view on the evolution of ageing and the conservation of the human ageing 
process. 
 
6.1. Article 1: The evolution of mammalian aging (Experimental Gerontology, volume 37, pages 
769-775, 2002) 
 
 At the time we began our work, the evolution of ageing was thought to be derived from 
two basic mechanisms: antagonistic pleiotropy, and mutation accumulation (reviewed in Rose, 
1991). It was known that changes in extrinsic factors altered a species’ mortality and could shape 
the pace of ageing (Austad, 1988; Austad, 1997a). Yet although the evolutionary theory of 
ageing offered an explanation for how ageing may have evolved, it did not present specific 
models to explain all the different ageing phenotypes. In addition, many of the theory’s 
postulates were under attack, such as the inevitability of ageing (reviewed in Finch, 1990). 
Therefore, we wanted to build a model for the evolution of ageing in humans that explained the 
phenotype of human ageing when compared to other phenotypes. 
 In this first article, we compared the ageing phenotypes of different species in order to 
find trends in the evolution of ageing. Since our goal is to understand the evolution of ageing in 
humans, we focused on the human taxonomic class, mammals, and closely related taxa. 
 It was already known that different mammals show a similar ageing phenotype (Finch, 
1990). Yet our review of the literature revealed a striking shift in the ageing phenotype of 
mammals when compared to other classes such as reptiles and amphibians. Although only a 
fraction of animals had had their ageing phenotype studied, it appeared that the ageing phenotype 
was somehow more potent in mammals when compared to our reptilian ancestral class. This key 
insight led us to analyse the evolution of mammals and propose a unique model for the evolution 
of mammalian ageing. Our model is based on an acceleration of ageing in the primordial 
mammals whose effects prevail until today. 
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 The implications of our model are multiple and thought-provoking. If indeed mammalian 
ageing is a more severe phenotype of the process witnessed in reptiles, then studies in reptiles 
may be useful to understand how genetic and molecular mechanisms can shape ageing and 
perhaps even reveal potential anti-ageing therapeutic targets. For example, it has been known for 
a long time that cells taken from the long-lived Galapagos tortoise divide about 110 times 
(Goldstein, 1974), which is about two-fold the cumulative population doublings human cells can 
endure. The mechanisms involved are unknown. 
 If our model is correct, then the evolution of ageing in mammals is a unique 
phenomenon, meaning mammalian ageing is probably a unique process. Consequently, the 
organisms best suited to model human ageing are mammals or, more precisely, eutherians. Of 
course that lower life forms can still be used to gather hints about ageing, but our model clearly 
establishes that extrapolations into human ageing are inadequate if mammalian models are not 
employed. 
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CHAPTER 7: ROLE OF THE TELOMERES IN SIPS 
 
 Based on our evolutionary model, we decided to study ageing using human cells. By 
focusing on human physiology, we avoid having to extrapolate our results from model 
organisms. Of course that in vitro cell culture is not a phenocopy of human ageing, but since 
most animal models that we advocate are practically impossible to study in vivo, we started by 
working with cellular biology and could not find a better organism to study than Man. 
 Since telomeres are so important in RS (Wright and Shay, 2001 for arguments), we 
wanted to investigate their role in SIPS. Our strategy was to employ a cell line (hTERT-BJ1) 
immortalized with the catalytic subunit of human telomerase. 
 During our work, we tried to establish the molecular mechanisms responsible for SIPS in 
both cell lines in hope of determining whether telomeres are relevant or not to SIPS. 
 
7.1. Article 2: Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin 
fibroblasts (FEBS Letters, volume 523, pages 157-162, 2002) 
 
 Our first step was to establish a model of SIPS using hTERT-BJ1 and control BJ cells. 
We chose to use two stress models: a single 2-hour H2O2 stress and five repeated UVB stresses 
to induce SIPS; we collaborated with Florence Chainiaux in establishing a model for inducing 
SIPS with UVB (Chainiaux et al., 2002). To determine the subcytotoxic dose of each stressor 
necessary to induce SIPS, mortality curves were obtained for each cell line and senescent 
biomarkers were studied: SA β-gal activity, cellular morphology, and [3H]-thymidine 
incorporation. 
 In this first article on SIPS, our goal was to establish a working model and have a general 
view of the mechanisms involved. After we established our model of SIPS, we determined 
whether telomere length was affected by stress. Since we also sought to elucidate the 
mechanisms involved, we investigated the effect of SIPS on the protein levels of p53, p21WAF1, 
and p16INK4a, as well as on the phosphorylation status of pRb, by Western blot analysis. Lastly, 
we also determined how stress affects the expression levels of TGF-β1 by reverse transcription-
polymerase chain reaction (RT-PCR). Intriguingly, the expression levels of TGF-β1 were not 
affected by either of the stresses. Since we knew that different cell lines respond to TGF-β1 
differently (Kim et al., 1991; Massague, 1998), we assumed that TGF-β1 did not participate in 
SIPS in BJ cells and so decided not to continue investigating its involvement. 
60 
 This was the first ever published paper to show that SIPS can occur in normal HDFs 
immortalized with telomerase. hTERT-BJ1 and parental BJ cells responded to UVB and H2O2 
stress similarly. Since telomere shortening was only slightly increased in SIPS, our results 
suggested that mechanisms other than the telomeres must be at work. 
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Abstract To test the involvement of the telomeres in the sen-
escent phenotype, we used telomerase-immortalized human fore-
skin ¢broblasts (hTERT-BJ1). We exposed hTERT-BJ1 and
parental BJ cells to either UVB or H2O2 subcytotoxic stress(-
es). Both cell lines developed biomarkers of replicative senes-
cence: loss of replicative potential, increase in senescence-asso-
ciated L-galactosidase activity, typical senescence-like
morphology, overexpression of p21WAF1 and p16INK4a, and
decreased level of the hyperphosphorylated form of pRb. Telo-
mere shortening was slightly higher under stress for both BJ and
hTERT-BJ1 but still much lower than that reported for other
cell lines. We conclude that pathways alternative to telomere
shortening must cause the appearance of the senescence
phenotype. 3 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: Cellular senescence; Fibroblast; Telomere;
Telomerase; H2O2 ; UVB
1. Introduction
Telomeres are repeated sequences at the end of chromo-
somes that shorten, normally by 20^200 bp, with each cell
division. Previous research suggested that telomere shortening
represents a mechanism for counting cell division triggering
cellular senescence [1]. Short telomeres might activate a p53
DNA damage response pathway that in turn leads to growth
arrest [2] ; cellular senescence can also be induced by the pRb
pathway [3]. Telomerase is a reverse-transcriptase enzyme that
elongates the telomeres [4]. The catalytic subunit of human
telomerase was transfected into normal human ¢broblasts.
Cell lines were thereby established that failed to reach cellular
senescence without transformation [5].
Stress-induced premature senescence (SIPS) is characterized
by a cell cycle arrest similar to cellular senescence. SIPS can
be triggered by way of single or repeated subcytotoxic stress
such as UVB [6] or H2O2. After at least 48 h of recovery, the
cells begin to display biomarkers of cellular senescence: senes-
cence-associated L-galactosidase (SA L-gal) activity, changes
in the expression of several genes, similarities in the regulation
of the G1 growth arrest, cellular morphology, etc. (for a re-
view see [7]).
WI-38 fetal lung human diploid ¢broblasts (HDFs) kept
under 40% O2 for three population doublings (PDs) undergo
SIPS. An accelerated telomere restriction fragment (TRF)
shortening of 500 bp per PD is observed [8]. When subcyto-
toxic H2O2 stress or ¢ve repeated subcytotoxic tert-butylhy-
droperoxide (t-BHP) stresses are performed on cells during a
given PD, respectively, a 322E 55 bp and a 381E 139 bp TRF
shortening are observed during the ¢rst PD after stress [9].
HDFs at early PD exposed to 150 WM H2O2 once or 75 WM
H2O2 twice in 2 weeks display biomarkers of senescence. Two
treatments with 75 WM H2O2 fail to induce signi¢cant TRF
shortening, suggesting that SIPS can emerge without telomere
shortening [10].
In this work, we compared SIPS induced by H2O2 or UVB
in human diploid BJ ¢broblasts expressing telomerase
(hTERT-BJ1) and in parental BJ cells to know if major di¡er-
ences would be found in the proportion of cells entering SIPS
when telomerase activity is present.
2. Materials and methods
2.1. Cell culture and exposure to UVB and H2O2
hTERT-BJ1 HDFs were purchased from Clontech (USA) at 111
PD and stressed around 130^140 PD. BJ HDFs were a kind gift of
Dr. E.E. Medrano, Baylor College (USA). HDFs were routinely sub-
cultivated as previously described [11].
Con£uent cultures of BJ HDFs at early PD and hTERT-BJ1 HDFs
were submitted to ¢ve repeated subcytotoxic exposures to UVB stress
with one stress per day for 5 days as described previously [6]. Con-
£uent cultures were submitted to a single 2 h exposure to H2O2
diluted in medium+10% fetal calf serum (FCS), as was described
previously [12]. Control cultures at the same PD followed the same
schedule of medium changes without UVB or H2O2 treatment.
2.2. Cytotoxicity assays
At 48 h after the (last) stress, cells were washed twice with phos-
phate bu¡er saline (PBS) and lysed with NaOH 0.5 N.
To measure cytotoxicity, ¢ve exposures to UVB or a single expo-
sure to H2O2 stress were performed at increasing doses. Cytotoxicity
was measured at 48 h after the (last) stress. The cellular protein con-
tent was assayed by the Folin method [13], which has proven to give
results similar to those found with the MTT assay and cell counts
[6,14,15]. Triplicates were always performed. Results are expressed as
mean valuesE S.D.
2.3. SA L-gal activity and [3H]thymidine incorporation
At 48 h after the (last) stress, the cells were seeded at a density of
700 cells/cm2. After 24 h, SA L-gal activity was assessed as described
in [16]. The proportion of cells positive for SA L-gal was determined
in three samples of 400 cells per dish, each sample in a di¡erent dish.
Results are expressed as mean valuesE S.D.
0014-5793 / 02 / $22.00 M 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 2 9 7 3 - 3
*Corresponding author. Fax: (32)-81-724135.
E-mail address: olivier.toussaint@fundp.ac.be (O. Toussaint).
Abbreviations: SIPS, stress-induced premature senescence; SA L-gal,
senescence-associated L-galactosidase; HDF, human diploid ¢bro-
blast; PD, population doubling; TRF, terminal restriction fragment;
t-BHP, tert-butylhydroperoxide
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At 24 h after the (last) stress, cells were seeded at 10 000 cells/2 cm2
well. 1 WCi [3H]thymidine (speci¢c activity: 2 Ci/mmol, Du Pont
NEN, USA) was added to the culture medium for 48 h. The incorpo-
rated radioactivity was quanti¢ed by a scintillation counter (Beckman
Coulter Inc., USA). The procedure was repeated each day for 4 days
after stress. Triplicates were always performed. Results are expressed
as mean valuesE S.D.
2.4. Telomere length and telomerase activity
Two days after the (last) stress, cells were trypsinized and seeded at
a 1:2 ratio. When cells became con£uent, genomic DNA was ex-
tracted, digested with 25 U RsaI and HinfI (Pharmingen, USA), elec-
trophoresed, transferred to a nylon membrane, pre-hybridized and
hybridized with a 51-mer biotinylated telomere probe using the re-
agents and bu¡ers of the Telomere Length Assay kit (#559838, Phar-
mingen, San Diego, CA, USA), as used previously [9]. The mean
terminal restriction fragment (TRF) length was calculated for each
sample by integrating the signal density above background over the
entire TRF distribution as a function of TRF length, using the for-
mula L=g(ODiULi)/g(ODi), where ODi and Li are respectively the
signal intensity and TRF length at position i on the gel image, as
described in the manufacturer’s recommendations. We also deter-
mined telomere length before the (¢rst) stress. Results are expressed
as mean valuesE S.D. on three experiments. Telomerase activity was
studied by TRAP assay (Intergen Inc., USA) following the manufac-
turer’s recommendations.
2.5. Western blot detection of p53, p21WAF1, p16INK4a and pRb
The cells were washed twice with ice-cold PBS and protein extrac-
tion was conducted as previously described [12]. Samples of 20 Wg
protein were electrophoresed and transferred overnight on Immobi-
lon-P membrane (Millipore, Bedford, MA, USA). Each protein was
detected with its speci¢c antibody: anti-p16, anti-p21, anti-Rb (Santa
Cruz, Germany) and anti-p53 (Pharmingen). After incubation with
horseradish peroxidase-linked secondary antibody, the bands were
visualized after incubation with chemoluminescent substrates using
the ECL detection kit (Pharmacia, Belgium). Results are expressed
as mean valuesE S.D. on three experiments.
3. Results
3.1. Cytotoxicity after UVB irradiation or H2O2 stress
The results were expressed as percentages of the controls,
which were subjected to the same conditions for the same
period of time without being subjected to H2O2 or UVB. As
expected, the cytotoxicity increased with the UVB or H2O2
doses (Fig. 1A,B). BJ and hTERT-BJ1 cells behaved similarly.
From day 0 to day 3 ( = 48 h after H2O2 stress) and day 7
( = 48 h after the last UVB stress), we found that the cellular
protein content of the controls increased roughly by, respec-
tively, 20 and 40%. Thus an apparent decrease of 20 or 40% of
cellular protein shown at 48 h after stress with respectively
H2O2 or UVB corresponds to absence of growth rather than
cell death. These results suggested to use the doses of 1.2 mM
H2O2 and 600 mJ/cm2 in our experimental conditions and to
consider them as subcytotoxic doses.
3.2. SA L-gal activity, cell morphology and cellular
proliferation
SA L-gal activity was described to appear in replicative se-
nescence and SIPS [16]. After a single H2O2 stress at 1.2 mM
H2O2, the percentage of SA L-gal positive cells increased by
15^20% in both BJ and hTERT-BJ1 cells (Fig. 2). When
hTERT-BJ1 cells were exposed to H2O2 at a cytotoxic con-
centration (1.5 mM) the percentage of positive cells increased
only by 7% (not shown). After ¢ve UVB stresses, the percent-
age of cells positive for SA L-gal activity increased by 30^35%
at 600 and 800 mJ/cm2 UVB for BJ cells and reached similar
values at 500 and 800 mJ/cm2 UVB for hTERT-BJ1 cells (Fig.
2). An appreciation of cellular morphology shows that after a
H2O2 stress, both BJ and hTERT-BJ1 cells develop a higher
incidence of abnormal morphology, resembling a senescent
morphology. The di¡erences between controls and stressed
cells are not so intense following ¢ve UVB stresses.
Subcytotoxic stress with agents such as H2O2, t-BHP or
UVB triggers irreversible growth arrest of a large proportion
of a population [6,9,17]. In this work we tested whether cells
transfected with hTERT would show a di¡erent behavior
after being stressed with UVB or H2O2 as far as
[3H]thymidine incorporation is concerned. After a single
H2O2 stress, the level of incorporation fell by 50% in BJ
and hTERT-BJ1 HDFs, indicating that only about 50% of
the cells were still able to divide when compared to non-
stressed controls, from day 3 to day 7 after stress (on the
graph, day 1 indicates the ¢rst day of measurement of incor-
poration corresponding to 72 h after stress) (Fig. 3). After ¢ve
consecutive UVB stresses, the di¡erence was smaller, being
respectively 20^25% from day 3 to day 7 after the last stress
for BJ and for hTERT-BJ1 cells (Fig. 3). The time-dependent
decrease observed in hTERT-BJ1 cells, stressed or unstressed,
was highly reproducible and will be considered in Section 4.
3.3. Telomere shortening
A very low and similar TRF shortening occurred in both BJ
and hTERT-BJ1 cells without stress: 37E 18 bp/PD and
43E 13 bp/PD, respectively. These results are within those
described earlier [18,19]. After H2O2 stress, TRF shortening
was multiplied by two in BJ cells and by four in hTERT-BJ1
Fig. 1. Cytotoxicity of a single exposure to H2O2 (A) or ¢ve repeated exposures to UVB (B) with one stress per day in BJ (white columns)
and hTERT-BJ1 (gray columns) HDFs. The results are expressed as percentages of the values found in control cells at 48 h after the (last)
stress. Results are given as mean valuesE S.D. from three independent experiments.
J.P. de Magalha‹es et al./FEBS Letters 523 (2002) 157^162158
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cells, indicating that H2O2 stress a¡ected telomere length (Fig.
4A). We did not explain that di¡erence between the two types
of cells. After repeated UVB stresses, BJ cells underwent a
TRF shortening of 70E 27 bp, while TRF shortening in
hTERT-BJ1 cells was 38E 30 bp. It might be considered
that about 25^30% of the cells do not resume mitosis after
the stress, from the data obtained with [3H]thymidine incor-
poration and SA L-gal histochemistry. Calculations of ex-
pected TRF shortening due to compensatory cycling of the
fraction of cells recovering mitotic capability suggest that the
limited shortening observed cannot be accounted for by the
compensatory cycling and is also supposed to be caused by
DNA damage.
3.4. Telomerase activity
Although we cannot discard minor telomerase activity £uc-
tuations, our results suggest that telomerase activity is not as
a¡ected by the stress as when SIPS is established (Fig. 4B).
Indeed, we detected similar telomerase activity before and
after each type of stress in hTERT-BJ1 cells. No telomerase
activity was detected in BJ cells. These ¢ndings con¢rm pre-
vious results obtained in di¡erent experimental conditions
[19].
3.5. Expression level of p53, p21WAF1, p16INK4a and
phosphorylation level of Rb
It was shown that p53 is overexpressed by IMR-90 HDFs
after subcytotoxic H2O2 stress and comes down to basal level
within 44 h after the stress [17]. Only minimal overexpressions
of p53 were found in BJ cells at 72 h after H2O2 stress (about
20%) and after UVB stress (about 40% overexpression). No
overexpression of p53 was found in hTERT-BJ1 cells at 72 h
Fig. 2. E¡ects of a single H2O2 stress or ¢ve repeated UVB exposures on the proportion of BJ and hTERT-BJ1 HDFs positive for SA L-gal
activity. Results represent the proportion of cells positive for SA L-gal. The results are presented as mean valuesE S.D. from three independent
experiments.
Fig. 3. Estimation of the proliferative potential of BJ and hTERT-BJ1 HDFs exposed to a single H2O2 stress or ¢ve consecutive exposures to
UVB by measurement of the incorporation of [3H]thymidine into DNA between day 1 and day 4 after stress. The results obtained are ex-
pressed as percentages of the cpm incorporated by the control cells. The results represent the mean valuesE S.D. from three independent experi-
ments.
J.P. de Magalha‹es et al./FEBS Letters 523 (2002) 157^162 159
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after both types of stress (Fig. 5A.1). This suggests that p53
remains overexpressed a little longer in BJ cells compared to
IMR-90 cells and the presence of telomerase activity blocks
this overexpression.
p21WAF1 is overexpressed at 72 h after ¢ve repeated t-BHP
stresses in WI-38 HDFs [14] and after a single H2O2 stress in
IMR-90 HDFs [15,17]. A 2.1- and 1.8-fold overexpression of
p21WAF1 was found at 72 h after subcytotoxic H2O2 stress
and ¢ve repeated UVB stresses on BJ cells, respectively (Fig.
5A.2). In hTERT-BJ1 cells, a 1.8- and 1.5-fold overexpression
of p21WAF1 protein was found at 72 h after, respectively,
H2O2 or UVB stress. Measurements of the DNA binding
capability of p53 would give information on the dependence
of this overexpression of p21WAF1 toward p53. No di¡erence
of p16INK4a protein level was observed in BJ cells exposed to
H2O2 and in hTERT-BJ1 cells exposed to H2O2 or UVB (Fig.
5A.3). A limited 35% overexpression was observed in BJ cells
exposed to UVB. A similar change in the phosphorylation
status of pRb was observed after stress in all four situations
(UVB and H2O2 in BJ and hTERT-BJ1 cells) (Fig. 5B).
4. Discussion
SIPS has previously been demonstrated to occur after sub-
cytotoxic stress with, for example, H2O2 in IMR-90 HDFs,
t-BHP and hyperoxia in WI-38 HDFs (for a review see [7])
and in FS skin HDFs exposed to UVB [6]. BJ HDFs are
extremely resistant to hyperoxia and H2O2 [19]. This work
also shows the remarkable resistance of these cells to H2O2
and UVB, with respective subcytotoxic doses of 1.2 mM and
Fig. 4. A: E¡ect of a single H2O2 or ¢ve UVB exposures on telomere shortening in BJ and hTERT-BJ1 HDFs. Lane 1: cells at con£uence be-
fore the stress. Lane 2: control cells for H2O2 experiment. Lane 3: cells exposed to H2O2. Lane 4: control cells for UVB experiment. Lane 5:
cells exposed to UVB. Telomere shortening of stressed cells was measured by comparing telomere length of stressed cells to controls. Controls
correspond to HDFs submitted to the same culture conditions as the stressed cells but without any H2O2 or UVB. The results represent the
mean valuesE S.D. from at least three independent experiments. B: No e¡ect of a single H2O2 or ¢ve UVB exposures on telomerase activity.
Lane 1: BJ cells before the experiment. Lane 2: hTERT-BJ1 cells before the stress. Lane 3: control BJ cells for H2O2. Lane 4: control
hTERT-BJ1 cells for H2O2. Lane 5: BJ cells exposed to H2O2. Lane 6: hTERT-BJ1 cells exposed to H2O2. Lane 7: control BJ cells for UVB.
Lane 8: control hTERT-BJ1 cells for UVB. Lane 9: BJ cells exposed to UVB. Lane 10: hTERT-BJ1 exposed to UVB.
J.P. de Magalha‹es et al./FEBS Letters 523 (2002) 157^162160
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0.15 mM H2O2 in BJ and IMR-90 HDFs [12], and respective
subcytotoxic doses of 600 and 500 mJ/cm2 UVB in BJ and FS
HDFs [6], these two strains being derived from the skin.
The growth of BJ HDFs and their telomerase positive der-
ivates was only slightly reduced under hyperoxia. A high re-
sistance of BJ cells to oxidative damage is known [19]. We
found a lower proportion of BJ cells to enter SIPS after sub-
cytotoxic H2O2 stress. Indeed, the percentage of SA L-gal
positive cells after exposure of two strains of fetal lung
HDFs, IMR-90 and WI-38, to, respectively, 150 and 160 WM
H2O2 was around 55% [9,12]. However, similar results were
obtained after UVB stress at the respective subcytotoxic doses
of 600 and 500 mJ/cm2 in BJ and FS HDFs [6].
Both BJ and hTERT-BJ1 cells showed a decrease in pro-
liferative capability on the long term after H2O2. The level of
[3H]thymidine incorporation was not much di¡erent in the BJ
and hTERT-BJ1 cells after UVB. There might be a lag time
before unstressed BJ and hTERT-BJ1 cells resume mitosis
after the many days of con£uency occurring between and after
the UVB stresses (7^11 days before [3H]thymidine incorpora-
tion ¢nishes). This could explain the small di¡erence of thy-
midine incorporation between the UVB-stressed and non-
stressed BJ and hTERT-BJ1 HDFs.
After a period of extension of telomere length following
ectopic expression of telomerase, telomere length starts to
fall slowly over time, reaching a length similar to the parental
cells [19], as con¢rmed in this work. The remaining low telo-
merase activity appears to stabilize predominantly the shortest
telomeres, allowing the growth of these cells despite the aver-
age telomere length becoming eventually shorter than in the
parental cells at senescence [20]. Therefore, these cells were
ideal to test whether SIPS could still appear despite the pres-
ence of an hTERT activity that would maintain the telomeres
at a subcritical length, thereby allowing the maintenance of
the cell cycle.
The limited telomere shortening after stress was found to be
about two and four times higher after H2O2 stress than in
control cells, in BJ and hTERT-BJ1 cells, respectively. This
is intriguing since telomerase remained active in the stressed
cells and control hTERT-BJ1 cells. It could be that this TRF
shortening a¡ected those telomeres which were at a subcritical
length, thereby triggering growth arrest. After the UVB stress,
the presence of telomerase activity seems to have o¡ered some
protection against any further telomere shortening. Anyway,
these di¡erent shortenings did not lead to a di¡erent percent-
age of cells in UVB-induced SIPS in BJ or hTERT-BJ1 cells.
It might, however, have a¡ected the kinetics of recovery of the
proportion of the cell population not in SIPS. This result can
be correlated with the slight increase in p16INK4a level after
UVB only in BJ cells.
It is possible to induce the senescence of HeLa cells, which
have short telomeres, by repressing the human papillomavirus
Fig. 5. A: Western blots and quanti¢cations of the protein level of p53 (A.1), p21WAF1 (A.2), and p16INK4a (A.3) when BJ and hTERT-BJ1
cells are exposed once to H2O2 or ¢ve times to UVB. B: Phosphorylation status of the Rb protein at 72 h after stress. P-Rb stands for phos-
phorylated Rb; Rb for hypophosphorylated Rb. The results represent the mean valuesE S.D. from three independent experiments.
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type 18 E6 and E7 genes, resulting in reactivation of the
dormant p53 and pRb tumor repressor pathway. Stable clones
of HeLa cells that express hTERT have elevated telomerase
activity and extended telomeres. These clones gave an identi-
cal response when the E6 and E7 proteins were repressed:
growth arrest, SA L-gal activity, altered morphology and in-
creased auto£uorescence. Therefore, HeLa senescence induced
by these means was not triggered by short telomeres [21]. pRb
has been shown not only to be involved in the control of the
cell cycle but also in the appearance of di¡erent biomarkers of
senescence after H2O2 stress in IMR-90 HDFs (SA L-gal ac-
tivity, altered morphology, overexpression of ¢bronectin, os-
teonectin, apolipoprotein J) [12,22]. In this cell strain, over-
expression of transforming growth factor-L1 (TGF-L1)
starting at 24 h after subcytotoxic H2O2 stress triggered the
appearance of these biomarkers. TGF-L1 overexpression dis-
appeared when E7 was stably expressed in these cells [12].
However, we failed to ¢nd any increase in TGF-L1 after
UVB or H2O2 stress in BJ or hTERT-BJ1 cells (results not
shown).
H2O2 might have modi¢ed the level of the telomeric DNA
binding proteins TRF-1 or TRF-2. It was recently shown that
overexpression of TRF-2 protects critically short telomeres
from fusion and represses chromosome-end fusions in pre-
senescent HDFs, even if accelerated telomere shortening is
observed [23]. UVB might not a¡ect the TRF-2 expression
level. In addition, it was already known that the introduction
of TTAGGG oligonucleotides into HDFs induces a p53- and
p21WAF1-dependent long-term growth inhibition [24]. Bind-
ing of TRF-2 protein by these oligonucleotides might also
explain these results.
In conclusion, this study shows that, besides telomere short-
ening and TGF-L1 overexpression, other mechanisms might
exist which can trigger SIPS.
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CHAPTER 8: GENE EXPRESSION IN SIPS 
 
 From a theoretical perspective, having the human genome sequence means having the 
digital code from which all processes arise, including ageing and cellular senescence. 
Unfortunately, deciphering that code is a monumental task. The development of computer 
applications to make sense of the flood of data invading the life science is crucial (reviewed in 
Luscombe et al., 2001). Moreover, a combination of experimental and computational tools will 
be necessary to understand the genome and how it governs the complex human physiology. One 
of the modern high-throughput techniques is the DNA microarray to study gene expression. We 
wanted to employ DNA microarrays to study SIPS and develop methodologies to study ageing at 
a genomic level. 
 
8.1. Article 3: All roads lead to Rome: How gene expression networks reorganize in premature 
senescence of human skin fibroblasts expressing or not telomerase (submitted for publication) 
 
 Once with the model established, we wanted to have a more detailed view of SIPS in BJ 
cells. Since the TGF-β1 and telomere pathways did not appear to be involved in our model, we 
wanted to find which pathways were causing SIPS. In association with Eppendorf Array 
Technologies (Namur, Belgium), we employed the low-density DNA microarray DualChip 
Human General to study gene expression patterns before and after a single H2O2 stress. The 
DualChip Human General represents 202 pre-selected genes of general interest in cell biology. 
We decided to focus our study on SIPS induced by H2O2 since as judged by the biomarkers of 
senescence, such as [3H]-thymidine incorporation, the senescent phenotype is more pronounced 
due to a single H2O2 stress than to five repeated UVB stresses. 
 In addition to studying gene expression patterns, we also determined the temporal 
resolution of the DNA-binding activity of several transcription factors. By determining 
transcription factor activity in conjunction with gene expression we hoped to understand the 
underlying mechanisms of SIPS in our model. 
 Our gene expression results suggested a rearrangement of gene expression patterns with 
SIPS in both hTERT-BJ1 and BJ HDFs. Also taking into account our results from article 2, we 
defined a model where p53 and p21WAF1 appear as crucial components of SIPS. 
Telomeres/telomerase did not appear to play a critical role in SIPS and telomerase did not protect 
against SIPS. Importantly, our results also suggested that telomerase is unlikely to become a 
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useful anti-ageing therapy since it changes the normal cellular functions and may promote 
tumorogenesis. 
 Although we focused on SIPS of hTERT-BJ1 and BJ cells induced by H2O2, we also 
studied a cell line--AG00780--derived from a patient with WS that we obtained from the 
American Type Culture Collection (Rockville, Maryland, USA). We attempted to establish a 
model of SIPS using WS fibroblasts, which was not satisfactory. Even so, we suggested that 
gene expression patterns in WS fibroblasts are more closely related to old rather than young BJ 
HDFs. 
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in premature senescence of human skin fibroblasts expressing or not 
telomerase 
 
Keywords: aging, cellular senescence, telomeres, H2O2 
 
João Pedro de Magalhãesa, Françoise de Longuevilleb, Véronique Mainfroida, Valérie Migeota, 
Laurence Marcqb, José Remacleb, Michel Salmona, Olivier Toussainta* 
 
aResearch Unit on Cellular Biology, Dept. of Biology, University of Namur (FUNDP), B-5000 
Namur, Belgium 
bEppendorf Array Technologies, Rue du Séminaire, 12. B-5000 Namur, Belgium 
 
Abbreviations: bp, base pairs; HDFs, human diploid fibroblasts; PDs, population doublings; RS, 
replicative senescence; hTERT, catalytic subunit of human telomerase; RS, replicative 
senescence; SIPS, stress-induced premature senescence; WS, Werner’s syndrome; SA βgal, 
senescence-associated; FCS, fetal calf serum. 
 
*Address for Correspondence: University of Namur (FUNDP), Research Unit on Cellular 
Biology (URBC), Rue de Bruxelles, 61, B-5000 Namur, Belgium. Telephone: +32 81 724132; 
Fax: +32 81 724135, E-mail: olivier.toussaint@fundp.ac.be 
70 
Abstract 
 We compared the DNA-binding activity of transcription factors and gene expression 
patterns in BJ human diploid fibroblasts (HDFs) expressing or not telomerase (hTERT) in stress-
induced premature senescence (SIPS). Senescent BJ cells and fibroblasts obtained from a patient 
with Werner’s syndrome (WS), which feature defects in DNA repair, were also studied. 
 H2O2-induced SIPS modulated gene expression in both BJ and hTERT-BJ1 cells. 
Increased p21WAF-1 mRNA level was amongst the common gene expression changes in BJ and 
hTERT-BJ1 cells induced by SIPS. Both cell lines also displayed sustained DNA-binding 
activity of p53. Telomerase expression markedly changed gene expression in non-stressful 
conditions. Expression patterns of senescent BJ cells partially overlapped those of BJ and 
hTERT-BJ1 cells in SIPS. Gene expression patterns of WS fibroblasts were closer to senescent 
BJ cells than to BJ cells at early population doublings whereas we failed to induce SIPS in WS 
fibroblasts. 
 Our results indicate that similar mechanisms involving p21WAF-1 and probably p53 are at 
work in BJ and hTERT-BJ1 HDFs under H2O2-induced SIPS, suggesting that generalized DNA 
damage rather than telomere length/telomerase plays a crucial role in H2O2-induced SIPS. We 
propose that H2O2-induced SIPS involves a rearrangement of proliferative and apoptotic 
pathways. The marked changes in gene expression induced by telomerase suggest that apart from 
immortalization of HDFs, telomerase also alters the normal cellular functions but does not 
protect against SIPS. 
71 
1. Introduction 
Normal human diploid fibroblasts (HDFs) stop dividing after a certain number of 
population doublings (PDs) in vitro (Hayflick and Moorhead 1961). This phenomenon is termed 
replicative senescence (RS). Telomere shortening observed at each cell division eventually leads 
telomeres to critical lengths. Critically short telomeres are probably recognized as DNA damage 
and activate p53, which triggers growth arrest through the overexpression of cyclin-dependent 
kinase inhibitors such as p21WAF-1. p21WAF-1 in turn inhibits the phosphorylation of the 
retinoblastoma protein (Vaziri and Benchimol, 1996). Telomerase is a reverse-transcriptase 
enzyme that elongates the telomeres. HDFs transfected with the catalytic subunit of human 
telomerase (hTERT), although they are not transformed, do not display RS when considered as 
cell populations (Bodnar et al., 1998). Recent data, however, indicates that high levels of 
telomerase expression could favor RS of a small fraction of the cell population of HDFs 
(Gorbunova et al., 2003). 
 Stress-induced premature senescence (SIPS) establishes several days after exposure of 
HDFs to subcytotoxic concentrations of numerous types of oxidants and DNA-damaging agents 
such as hydrogen peroxide (H2O2) or UV radiation. HDFs in SIPS display features common with 
RS: a senescent morphology, senescence-associated β-galatosidase (SA βgal) activity, growth 
arrest in the G1 phase of the cell cycle, etc. (Chen et al., 1998, 2000). Oxidative stress can 
increase the shortening of telomeres in HDFs. WI-38 HDFs exposed to 40% hyperoxia undergo a 
mean telomere shortening of 500 bp per PD, compared to the 90 bp/PD normal shortening 
observed under 20% atmospheric O2. Such accelerated shortening rapidly leads the telomeres to 
their critical length, triggering irreversible growth arrest of the HDFs (von Zglinicki et al., 1995). 
Yet H2O2 can induce SIPS without critical shortening of the telomere length. After exposure to 
subcytotoxic H2O2 stress, BJ foreskin HDFs expressing hTERT display features of senescent 
cells at levels comparable to the wild type BJ HDFs exposed to the same concentration of H2O2. 
Only a slight telomere shortening is observed in both BJ and hTERT-BJ1 HDFs (de Magalhaes 
et al., 2002; Gorbunova et al., 2002) and so the role of the telomeres in SIPS remains unclear. 
 Werner’s syndrome (WS) is a human autosomal recessive disease caused by a mutation 
in the Werner protein (WRN), a RecQ helicase. The pathology of WS affects multiple organs 
and resembles accelerated aging, including skin changes, gray hair, and increased cancer 
incidence. The WRN protein appears to be related to DNA repair since it has exonuclease 
activity. Fibroblasts taken from patients with WS have a shorter proliferative lifespan, an 
extended S phase, and display genomic instability. WS fibroblasts have an increased mean 
telomere loss, are hypersensitive to 4-nitroquinoline 1-oxide, and sensitive to ionizing radiation, 
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but not to other DNA-damaging agents such as UV (reviewed by Bohr et al., 2002). Recently, 
telomerase positive tumor cells expressing a dominant-negative mutation of the WRN protein 
showed an increased rate of telomere loss and chromosome fusions, but no detectable changes in 
average telomere length. The WRN protein also appeared to downregulate telomerase (Bai and 
Murnane, 2003). 
 We used a low-density DNA array representing genes of general interest in cell biology 
to characterize gene expression of BJ and hTERT-BJ1 HDFs in H2O2-induced SIPS. Our interest 
was to identify changes in gene expression in BJ cells in SIPS and to know whether similar 
changes exist in BJ cells expressing hTERT. In contrast to studying the effects of hTERT, a 
protein that repairs the DNA, we investigated if we could induce SIPS by H2O2 in WS 
fibroblasts, which have increased DNA damage, and study gene expression patterns in WS 
fibroblasts. Furthermore, we studied gene expression in senescent BJ HDFs. The excellent 
reproducibility and validity of the data obtained with low-density DNA arrays technically 
identical to those employed in the present report was previously demonstrated in terms of 
chemistry of covalent binding of DNA on activated glass support, optimized length and 
sequence, hybridization, and statistical analysis (de Longueville et al., 2002). Lastly, and in order 
to help understand the changes in gene expression, we studied the DNA-binding activity of 
several transcription factors. 
 
2. Materials and Methods 
2.1. Cell culture, induction of SIPS by H2O2, isolation of mRNA 
hTERT-BJ1 HDFs (Clontech, Palo Alto, CA, USA) at 111 PD were exposed to H2O2 
between PD 130 and 150. BJ HDFs were a kind gift from Dr. E.E. Medrano, Baylor College, 
Houston, TX, USA and were stressed between PD 20 and 35. Previous reports indicated that the 
only consequence of hTERT transfection was immortalization (Bodnar et al., 1998; Jiang et al., 
1999; Morales et al., 1999). Both BJ and hTERT-BJ1 cells were cultivated in DMEM medium + 
10% fetal calf serum (FCS) under the classical conditions previously described (Hayflick and 
Moorhead, 1961). H2O2 at 1,200 µM diluted in medium with 10% serum for 2 hrs was 
previously shown to be subcytotoxic and trigger SIPS in both BJ cell lines (de Magalhaes et al., 
2002). Control cultures at the same PD followed the same schedule of medium changes without 
exposure to exogenous H2O2. At 72 hrs after stress, mRNA was isolated (FastTrack 2.0 mRNA 
isolation kit, Invitrogen, Carlsbad, CA, USA). Seventy-two hrs after subcytotoxic H2O2 stress is 
an optimal time to study H2O2-induced SIPS at least in WI-38, IMR-90, BJ, and hTERT-BJ1 
HDFs (Frippiat et al., 2001; de Magalhaes et al., 2002; Gorbunova et al., 2002). AG00780 WS 
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dermal fibroblasts were obtained from the American Type Culture Collection (Rockville, MD, 
USA) and were subcultivated in BME + 10% FCS. We exposed confluent cultures at PD 16 to 
different concentrations of H2O2 diluted in medium plus FCS for 2 hrs and determined the 
cytotoxicity 48 hrs after by measuring lactate dehydrogenase release (Cytotoxicity Detection Kit 
(#1644793), Roche, Basel, Switzerland). SA βgal activity was detected as described previously 
(Dimri et al. 1995). 
2.2. Low-density DNA array design, synthesis of labeled DNA, and hybridization conditions 
The DualChip Human General design (Eppendorf, Hamburg, Germany) is based on a 
system with two arrays per glass slide and three sub-arrays per array. The array represents a 
range of 202 genes involved in basic cellular processes such as metabolism, apoptosis, cell cycle, 
stress response, pro-inflammatory state and transcription (Supplemental Data). The sequences of 
the DNA covalently linked to the glass slide were carefully chosen by sequence comparison and 
it was checked experimentally that no cross-hybridization takes place. Several positive and 
negative hybridization controls plus detection controls were spotted on the array in order to 
control the reliability of the experimental data. 0.5 µg of each sample of mRNA was 
retrotranscribed into DNA according to the manufacturer’s instructions. Three synthetic 
poly(A)+tailed RNA standards were spiked at three different amounts (10 ng, 1 ng and 0.1 ng 
per reaction) into the purified mRNA as required by the array kit (Eppendorf, Hamburg, 
Germany). Normalization of data was possible thanks to three internal standard controls 
described above and eight housekeeping genes. Triplicates from three independent experiments 
were performed, meaning hybridizations on nine sub-arrays. The DualChip Human General 
hybridization was carried out according to the manufacturer’s instructions as reported (de 
Longueville et al., 2002). Detection was performed using a Cy3-conjugated IgG anti-biotin 
(Jackson Immuno Research laboratories, West Grove, PA, USA). 
 
2.3. Imaging, statistical analysis, and clustering 
Fluorescence of the hybridized arrays was scanned using the Packard ScanArray 
(PerkinElmer, Boston, MA, USA) at a resolution of 10 µm. To maximize the dynamic range of 
detection, the same arrays were scanned at different photomultiplier gains for quantifying both 
the high- and low-copy expressed genes. The scanned 16-bit images were imported into the 
ImaGene 4.1 software (BioDiscovery, Los Angeles, CA, USA) to quantify the signal intensities. 
The fluorescent intensity of each DNA spot (average of intensity of each pixel present within the 
spot) was calculated using local mean background subtraction. A signal was accepted if the 
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average intensity after background subtraction was at least 2.5-fold higher than their local 
background. The three intensity values of the triplicate DNA spots were averaged and used to 
calculate the intensity ratio between the reference and the test samples. 
The data were normalized in two steps. First, the values were corrected using a factor 
calculated from the intensity ratios of the internal standards in the references and test samples. 
The presence of the three internal standards probes at two different locations of the array allowed 
a measurement of local background and evaluation of the array homogeneity, which is 
considered in the normalization. However, since the internal standard control does not take into 
account the purity and quality of the mRNA, a second step of normalization was performed 
based on expression levels of the housekeeping genes. This process involves calculating the 
average intensity for a set of housekeeping genes. The variance of the normalized set of 
housekeeping genes is used to generate an estimate of expected variance, leading to a predicted 
confidence interval for testing the significance of the ratios obtained. Ratios outside the 95% 
confidence interval were determined to be significantly different (reviewed by de Longueville et 
al., 2002). 
 
2.4. ELISA kits for detection of transcription factor DNA-binding activity 
 Nuclear extracts were obtained from BJ and hTERT-BJ1 cells exposed or not to a single 
H2O2 stress of 1,200 µM at 2, 6, 24, 48, and 72 hrs after the stress. We then determined the 
DNA-binding activity of p53, HIF-1, CREB, AP-1, NF-κB, ATF-2, PPARg, and NFAT using 
the TransAM kits (ActiveMotif, San Diego, CA, USA), according to manufacturer’s instructions. 
Triplicates were always performed from three independent experiments. 
 
3. Results 
3.1. Gene expression varies in H2O2-induced SIPS in BJ ± ectopic hTERT HDFs 
 BJ and hTERT-BJ1 human diploid skin fibroblasts were exposed to a 2h-stress with H2O2 
at 1,200 µM, which represented subcytotoxic conditions. At 72 hrs after stress, both cell lines 
displayed a large increase in the proportion of the SA βgal positive cells, a sustained decrease in 
incorporation of [3H]-thymidine into their DNA, and p21WAF-1 overexpression (de Magalhaes et 
al., 2002). The low-density DNA array DualChip Human General was used to study the mRNA 
levels of 202 pre-selected genes (Supplemental Data, Fig. 1) in BJ and hTERT-BJ1 HDFs in 
H2O2-induced SIPS. At 72 hrs after H2O2 stress, 21 genes were found to be differentially 
expressed in BJ cells, with 14 genes displaying an increased and 7 genes a decreased mRNA 
steady-state level. In hTERT-BJ1 cells in H2O2-induced SIPS, 9 genes displayed an increased 
Gain 50 Gain 70 Gain 100
| sub-array 1 | sub-array 2 | sub-array 3 | | sub-array 1 | sub-array 2 | sub-array 3 | | sub-array 1 | sub-array 2 | sub-array 3 |
Figure 1: Representative example of images obtained with DualChip scanned at different photomultiplier gains. Each 
DualChip features triplicate spots (sub-arrays) on each array. Three DualChip were used in each experiment.
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while 7 genes displayed a decreased mRNA steady-state level. Thirty-four genes were 
differentially expressed in BJ cells at late PDs when compared to young BJ cells. Lastly, 54 
genes were also differentially expressed in hTERT-BJ1 compared to BJ cells (Table 1). The 
correspondence between real-time RT-PCR and this array’s data has been checked for several 
differentially expressed genes including: APOJ, FN1, MMP-1, MMP-2, p21, and SM22. Other 
genes such as FOS, ON, and p53 were also verified though these were not differentially 
expressed in our experimental conditions. Although mRNA and protein levels may not always 
correlate, changes in mRNA generally correspond to changes at the protein level. Our gene 
expression results yield an insight at the regulatory level but further analysis of protein or 
enzymatic activities is necessary to understand functional changes in these pathways. 
 
3.2. Changes in gene expression triggered by hTERT 
The overexpression of CTGF, VEGF, and FGF2 (growth factors) suggests that 
telomerase could favor cellular proliferation, reinforcing a recent study on human mammary 
epithelial cells (Smith et al., 2003). Also in accordance with the results from mammary epithelial 
cells that suggest telomerase causes resistance to the anti-proliferative effect of transforming 
growth factor beta, TGFBR2 was underexpressed in hTERT-BJ1 cells. Yet many other genes are 
differentially expressed. For example, the anti-oxidant SOD2 is downregulated by telomerase. 
Downregulation of SOD2 could be related to the increased resistance to apoptosis conferred by 
hTERT (Gorbunova et al., 2002), since SOD2 may be involved in p53-mediated apoptosis 
(Drane et al., 2001). IL6, an important gene in differentiation and inflammatory response is also 
downregulated. The expression level of several MMPs is decreased but there is also a large 3-
fold decrease in tissue inhibitor of metalloproteinase 1. Lastly, IGFBP3 is overexpressed in 
hTERT-BJ1 HDFs, which is intriguing since IGFBP3 is overexpressed in senescent HDFs 
(Moerman et al., 1993). Taken as a whole, these results suggest that telomerase prevents RS and 
promotes proliferation but disrupts many normal cellular functions. 
 
3.3. Characterization of gene expression in H2O2-induced SIPS in BJ and hTERT-BJ1 cells 
In BJ cells in H2O2-induced SIPS, 14 genes displayed an increased- and 7 genes 
displayed a decreased-mRNA steady-state level (Table 2, Fig. 2A). Several are involved in 
cellular proliferation: e.g. increases in CTGF, EGR1, FGF2, ODC mRNA levels. The increase in 
EGR1 level is puzzling since EGR1 has been recently suggested, in mice, to control p53 
(Krones-Herzig et al., 2003). Interleukin-1 beta (IL1B), which was previously shown to be 
Table 1: Genes differentially expressed in hTERT-BJ1 HDFs when compared to normal BJ HDFsa
Genes overexpressed as a result of the presence of telomerase
Symbol Gene name T/C Function GenBank
CTGF Connective tissue growth factor ↑10.7 Cell proliferation U14750
CAV1 Caveolin-1 ↑4.0 Signal transduction; endocytosis; potocytosis NM_001753
IGFBP3 Insulin growth factor binding protein3 ↑3.6 Signal transduction; disrupts binding of IGF-1 X64875
GADD153 DNA damage inducible transcript3 ↑3.4 Stress response S40706
CANX Calnexin ↑3.0 Protein secretion; probably apoptosis NM_001746
FN1 Fibronectin ↑3.0 Cell adhesion/migration X02761
ODC Ornithine decarboxylase1 ↑2.4 Cell cycle & proliferation NM_002539
PKM2 pyruvate-kinase-muscle 2 ↑2.4 Energetic metabolism M26252
SM22 Transgelin ↑2.2 Muscle development M95787
MEK1 Mitogen activated protein kinase kinase1 ↑2.2 Cell proliferation control L11284
TFAP2C Transcription factor AP2-gamma ↑2.1 Morphology NM_003222 
TPA Plasminogen activator tissue ↑2.0 Cell migration and tissue  remodeling NM_000930
FGF2 fibroblast growth factor 2 ↑2.0 Cell proliferation NM_002006
VEGF Vascular endothelial growth factor ↑1.8 Angiogenesis; Cell proliferation AF022375
AOP2 Anti-oxidant-protein2 ↑1.8 Defense system NM_004905
SMAD3 SMAD3 ↑1.8 Signal transduction U68019
VEGFB Vascular endothelial growth factor B ↑1.7 Angiogenesis; Cell proliferation U43368
SHC p66-SHC transforming protein1 ↑1.6 Cell proliferation; apoptosis U73377
Genes not found expressed in BJ cells
CATB Catenin, beta 1 ↑ Cell adhesion; transduction signal NM_001904
Genes underexpressed as a result of the presence of telomerase
SOD2 Superoxide dismutase2 ↓18.0 Stress response NM_000636
IL6 Interleukin 6 ↓5.6 Immune response NM000600
APOJ ApolipoproteinJ ↓4.1 Lipid metabolism J02908
MMP7 Matrix metalloproteinase 7 ↓4.1 Degradation of extracellular matrix NM_002423
MYBL2 b-myb ↓4.0 Cell cycle control X13293
CCNF CyclinF ↓3.7 Cell cycle control NM_001761
MMP2 Matrix metalloproteinase 2 ↓3.4 Degradation of extracellular matrix NM_004530
TIMP1 Tissue inhibitor of metalloproteinase1 ↓3.2 Inhibitor of degradation of extracellular matrix NM_003254  
FES Feline sarcoma oncogene ↓3.0 Cell proliferation X52192
CCND3 CyclinD3 ↓3.0 Cell cycle control NM_001760
CSF1R Colony stimulating factor 1 receptor ↓2.7 Cell proliferation NM_005211
TFAP2B Transcription factor AP2-beta ↓2.7 Neurogenesis; morphology X95694
CDK6 Cyclin dependent kinase6 ↓2.7 Cell proliferation NM001259
FGF8 Fibroblast growth factor 8 ↓2.3 Cell proliferation U36223
SPRR1B Cornifin ↓2.3 Cell structure NM_003125
BAD BCL2-antagonist of cell death ↓2.2 Pro-apoptotic NM_004322
BIN1 Bridging integrator 1 ↓2.2 Cell cycle control; apoptosis NM_004305
VWF Factor von willebrand ↓2.1 Role in blood coagulation NM_000552
E2F2 E2F transcription factor2 ↓2.1 Cell cycle control; apoptosis NM_004091
CDH11 Cadherine11 ↓1.9 calcium-dependent glycoprotein;  Cell adhesion NM_001797
CTSD CathepsinD ↓1.9 Intracellular degradation and turnover of proteins NM_001904
H4FM Histone4 member M consensus ↓1.8 Cell cycle NM_003495 
IGF1R Insulin like growth factor1 receptor ↓1.8 Cell proliferation; anti-apoptotic NM_000875
MMP14  Matrix metalloproteinase 14  ↓1.8 Degradation of extracellular matrix NM_004995 
IL11RA Interleukin 11-receptor-alpha ↓1.8 Signal transduction U32324
CKB Creatin-kinase-brain ↓1.8 Energy homeostasis M16364
MMP11 Matrix metalloproteinase 11 ↓1.8 Degradation of extracellular matrix NM_005940
TGFBR2 TGF-beta-R2 ↓1.7 Cell proliferation D50683
MMP15 Matrix metalloproteinase 15 ↓1.7 Degradation of extracellular matrix NM_002428 
Ki-67 Ki-67 ↓1.6 Cell proliferation NM_002417 
JUND Jun D proto-oncogene ↓1.6 Transcription factor NM_005354
Genes not found expressed in hTERT-BJ1 cells
MMP3 Matrix metalloproteinase 3 ↓ Degradation of extracellular matrix NM_002422
PAI2 Plasminogen activator inhibitor type2 ↓ Fibrinolysis; Cell cycle J02685
ESR2 Estrogen receptor beta ↓ Cell-cell signaling X99101 
BCLX BCLX ↓ Apoptosis NM_001191
 
aWe calculated the ratio of the normalized hybridization intensity of hTERT-BJ1 cells and the 
BJ controls (T/C).  Genes not expressed in one condition but whose value in the other 
condition is higher than the mean value for all genes in the corresponding array are 
represented as genes not found expressed. 
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overexpressed in senescent BJ HDFs (Shelton et al., 1999), becomes expressed in BJ cells in 
H2O2-induced SIPS. 
In hTERT-BJ1 cells, 16 genes were differentially expressed in H2O2-induced SIPS (Table 
3, Fig. 2B). Noteworthy is the increased mRNA level of p21WAF-1 in SIPS of BJ and hTERT-BJ1 
cells, which correlates with the results obtained previously at the protein level (de Magalhaes et 
al., 2002). Also in both cell lines, MMP3 is upregulated as a result of stress. The levels of MMP 
increase in aged skin, a process exacerbated by sun-exposure (Chung et al., 2001). IGFBP5 is 
also overexpressed in both cell lines. Since IGFBP5 disturbs the binding of IGF-1, evidence 
suggests it favors growth arrest and/or apoptotic pathways (Schneider et al., 2002). One previous 
study in BJ HDFs showed that senescent cells overexpress IGFGP5 (Shelton et al., 1999). The 
BCL2-associated X protein gene (BAX) is also upregulated by oxidative stress. BAX forms a 
heterodimer with BCL2 and functions as an apoptotic activator, mediated by p53. Its increased 
mRNA level suggests that some apoptotic pathways could be active as a result of a single H2O2 
stress. MDM2 becomes expressed in BJ cells after stress, which is in contrast with BAX since 
MDM2 inhibits p53-mediated apoptosis. Also interesting is the downregulation of GADD153 in 
both cell lines since GADD153 has been previously shown to be involved in stress response 
(Guyton et al., 1996). In murine cells, GADD153 levels increase with age and make cells more 
susceptible to oxidative stress (Ikeyama et al., 2003). 
 There are many genes differentially expressed between the non-stressed BJ and hTERT-
BJ1 cells. Therefore, comparisons between both cell lines must be taken with care. Several genes 
differentially expressed in SIPS of BJ cells but not in hTERT-BJ1 cells were also differentially 
expressed in non-stressed control hTERT-BJ1 cells when compared to non-stressed BJ cells and 
inversely (Tables 1, 2 and 3). For example, CTGF and CANX are overexpressed in BJ cells as a 
result of a single H2O2 stress but not in hTERT-BJ1 cells; yet these genes are already 
overexpressed in BJ cells compared to hTERT-BJ1 controls. Therefore, in those cases, when 
looking at the effects of the H2O2 stress on the gene profiles of BJ or hTERT-BJ1 cells, we 
witness a converging shift in gene expression. 
 
3.4. Failure to induce premature senescence in WS skin fibroblasts 
 Based on the mortality curve obtained at day 2 after exposure of WS skin fibroblasts to 
H2O2 (Fig. 3A), we decided to use a subcytotoxic concentration of 75 µM H2O2.  The percentage 
of cell survival obtained at 25, 50, and 75 µM was not different, indicating that these doses are 
cytotastic, given the limited 20% increase in the cell population between day 0 (stress day) and 
Table 2: Genes differentially expressed in BJ HDFs in H2O2-induced SIPS
a
Genes overexpressed in H2O2-induced SIPS hTERT-BJ1
Gene Name S/C Function GenBank in SIPS
MMP3 Matrix metalloproteinase 3 ↑4.5 Degradation of extracellular matrix NM_002422 + expression
CTGF Connective tissue growth factor ↑2.7 Cell proliferation U14750 =
BAX BCL2-associated X protein ↑2.4 Apoptosis NM_004324 ↑1.6
EGR1 Early growth response1 ↑2.4 Transcriptional regulator NM_001964 =
FGF2 fibroblast growth factor 2 ↑2.3 Cell proliferation NM_002006 =
p21 Cyclin dependent kinase inhibitor 1A ↑2.1 Cell cycle control U03106 ↑2.1
ODC Ornithine decarboxylase1 ↑1.6 Cell cycle & proliferation NM_002539 ↓1.8
CANX Calnexin ↑1.6 Protein secretion; probably apoptosis NM_001746 =
IGFBP5 Insulin growth factor binding protein5 ↑1.6 Signal transduction; disrupts binding of IGF-1 M65062 ↑2.1
Genes not found expressed in non-stressed BJ fibroblasts
CATB Catenin, beta 1 ↑ Cell adhesion; transduction signal NM_001904 =
CASP9 Caspase9 ↑ Apoptosis NM_001229 =
IL1B Interleukin1 beta ↑ Inflammatory and immune responses M15330 =
CASP2 Caspase2 ↑ Apoptosis NM_001224 =
MDM2 MDM2 ↑ Cell cycle control NM_002392 =
Genes underexpressed in H2O2-induced SIPS
AOP2 Anti-oxidant-protein2 ↓2.6 Defense system NM_004905 =
TFAP2A Transcription factor AP2-alpha ↓1.8 Morphology M36711 ↑1.9
VEGFR2 Vascular endothelial growth factor receptor2 ↓1.7 Angiogenesis; Cell proliferation NM_002253 =
VEGFR3 Vascular endothelial growth factor receptor3 ↓1.6 Angiogenesis; Cell proliferation NM_002020 =
GADD153 DNA damage inducible transcript3 ↓1.6 Stress response S40706 ↓4.7
PAI1 Plasminogen activator inhibitor type1 ↓1.6 Fibrinolysis; Cell cycle M14083 =
IGF1R Insulin like growth factor1 receptor ↓1.5 Cell proliferation; anti-apoptotic NM_000875 =
 
aWe calculated the ratio of the normalized hybridization intensity of BJ cells in H2O2-induced 
SIPS and the BJ controls (S/C). Genes not expressed in one condition but whose value in the 
other condition is higher than the mean value for all genes in the corresponding array are 
represented as genes not found expressed. 
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day 2 after the stress. 75 µM H2O2 is much inferior to the concentrations used to induce SIPS in 
AG04431, BJ, IMR-90, and WI-38 HDFs (Fig. 3B). In other words, the WS fibroblasts are much 
more sensitive to H2O2. 
 Contrary to other strains of fibroblasts, the percentage of SA βgal positive cells did not 
increase with the dose of H2O2 used (Fig. 3C). Also intriguing, although in accordance with 
previous reports (Choi et al., 2001), the percentage of WS fibroblasts positive for SA βgal in the 
control was relatively low (10.4%) when compared to pre-senescent WI-38, IMR-90, or BJ 
fibroblasts. 
 We used the low-density DNA arrays described above to compare gene expression 
patterns between WS fibroblasts and both young and old BJ cells. Although AG00780 and BJ 
cell lines are derived from the skin, it is difficult to determine if alterations in gene expression 
are due to the WRN protein or to differences between the cell lines. Even so, we found a higher 
percentage of genes altered when comparing WS fibroblast and young BJ cells than when 
comparing old BJ cells and WS fibroblasts (20 versus 12%), though this pattern concerns a high 
diversity of genes. 
 The list of genes that are differentially expressed in WS fibroblasts when compared to 
young BJ cells and not differentially expressed when compared to old BJ cells is given in Table 
4. The number of these changes was quite limited and concerned 26 genes. The most striking 
changes are observed for IL11RA, which is involved in resistance against apoptosis (Leng et al., 
1997) and is down-regulated by 64%. MSRA, involved in protection of proteins against 
oxidative stress and GSTPi, a glutathione transferase also involved in protection against 
oxidative stress, roughly decreased by half. FGF receptor is decreased by 40%. Regarding genes 
overexpressed, we found an overexpression of p66shc, a downstream target of p53 involved in 
apoptosis (Trinei et al., 2002). These results explain in part the increased sensitivity of WS cells 
to oxidative stress. SM22 has been found to be overexpressed in senescent IMR-90 and WI-38 
HDFs and is overexpressed in WS cells. Pyruvate kinase protein level was found to increase in 
senescent WI-38 HDFs (Dierick et al., 2002) and the mRNA level of this gene shows a 3.3-fold 
increase in WS cells. Caveolin-1 is phosphorylated in NIH-3T3 cells in H2O2-induced SIPS and 
its overexpression causes premature senescence (Volonte et al., 2002), and a 3.7-fold increase 
was found in WS cells. PAI2 overexpression is a marker of senescence in normal HDFs and a 
4.6-fold increase was found in WS cells. Lastly, PCNA was overexpressed, as it was in SIPS in 
hTERT-BJ1 cells. PCNA is involved in multiple functions, such as DNA repair, and some 
evidence suggests it is regulated by p53 through p21WAF-1 (Xu and Morris, 1999). The 
MMP3
MMP1
TFAP2A
MAX
ODC
VEGFB
p21
CCNF
PCNA
IGFBP5
GADD153
BAX
BIN1
-8.0 -3.0 2.0 7.0
Fold change in expression after stress
TFAP2B
B
AOP2
PAI1
MMP3
TFAP2A
IGF1R
ODC
VEGFR2
EGR1
CTGF
VEGFR3
FGF2
p21
GADD153
IGFBP5
BAX
CANX
-4.0 -2.0 0.0 2.0 4.0 6.0
A
BJ
hTERT-BJ1
Figure 2: Genes differentially expressed in BJ (A) and hTERT-BJ1 (B) fibroblasts in 
H2O2-induced SIPS. Values represent the ratio of the normalized hybridization intensity. 
Each gene has been classified by function according to what best suits its role based 
on the present literature: Pro-apoptotic = Red; Anti-proliferative = Yellow; Pro-
proliferative = Green; Anti-apoptotic = Blue; Morphology = Pink; Pro- or anti-apoptotic 
depending on context = Gray; Degradation of extracellular matrix = White; 
Miscellaneous = Black.
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overexpression of PCNA appears to be part of the cellular response to DNA damage both in 
hTERT-BJ1 cells in SIPS and in WS fibroblasts. 
 
3.5. Gene expression in senescent BJ cells versus BJ cells at early PD 
 We also compared young versus old BJ cells (Table 5). As previously mentioned, gene 
expression changed more between young and old BJ cells than when we submitted young BJ 
cells to H2O2 stress. Although some key genes were common between SIPS and RS (e.g. 
p21WAF-1), the degree of gene expression shift between SIPS and RS suggests that SIPS and RS 
are not exactly the same process. It remains to be seen which of the processes, RS or SIPS, is 
predominant in the in vivo degeneration of tissues, namely stress-prone tissues like the skin. 
MMP3 and MMP1 are upregulated in old BJ cells, as happens in aged or photoaged skin (Chung 
et al., 2001), perhaps as a result of p21WAF-1 activity (Perlman et al., 2003). IGFBP5, PAI2, IL-6, 
caveolin-1, pyruvate kinase, etc. are also upregulated by senescence, as reported by others 
(Shelton et al., 1999; Dierick et al., 2002; Volonte et al., 2002; Zhang et al., 2003). CCNF and 
MYBL2 are downregulated, as has been previously reported (Shelton et al., 1999; Ly et al., 
2000). A decrease of 2.1-fold of IGF1-receptor is also worth to be reported, given its potential 
role in resistance against apoptosis. 
 
3.6. DNA-binding activity of p53, HIF, CREB, AP-1, NF-κB, PPARg, and NFAT 
 Although DNA arrays offer a picture of the changes that cells undergo during SIPS, they 
cannot by themselves offer an explanation as to what mechanisms regulate the process. 
Therefore, we studied the activity of several transcription factors at different times after a single 
H2O2 stress in an attempt to uncover the underlying mechanisms responsible for SIPS. 
 The DNA-binding activity of p53 increases after a single H2O2 stress in both BJ (Fig. 4A) 
and hTERT-BJ1 cells (Fig. 4B). There appears to be a peak of p53’s DNA-binding activity at 2 
hrs after the stress, which stabilizes at 6 hrs. Interestingly, 72 hrs after the stress, p53 activity is 
still considerably higher (+/- 2-fold) than in control cells. In contrast, p53 protein level 
upregulation has been previously shown in BJ and hTERT-BJ cells at 24 hrs after stress (Morales 
et al., 1999), but not at 72 hrs (de Magalhaes et al., 2002). In addition, results from IMR-90 
fibroblasts showed that p53 upregulation after stress fades in a few days, which led to the 
conclusion that the role of p53 in SIPS was minor (Chen et al., 1998, 2000). Finally, the basal 
level of p53 DNA-binding activity is slightly lower in hTERT-BJ1 cells when compared to BJ 
controls, suggesting that this difference may be responsible for the SOD2 downregulation in 
hTERT-BJ1 cells (Drane et al., 2001). 
Table 3: Genes differentially expressed in hTERT-BJ1 HDFs in H2O2-induced SIPS
a
Genes overexpressed in H2O2-induced SIPS
Symbol Gene name S/C Function GenBank BJ in SIPS
TFAP2B Transcription factor AP2-beta ↑13.6 Neurogenesis; morphology X95694 =
CCNF CyclinF ↑3.1 Cell cycle control NM_001761 =
p21 Cyclin dependent kinase inhibitor 1A ↑2.1 Cell cycle control U03106 ↑2.1
IGFBP5 Insulin growth factor binding protein5 ↑2.1 Signal transduction; disrupts binding of IGF-1 M65062 ↑1.6
TFAP2A Transcription factor AP2-alpha ↑1.9 Morphology M36711 ↓1.8
BIN1 Bridging integrator 1 ↑1.8 Cell cycle control; apoptosis NM_004305 =
PCNA Proliferating cell nuclear antigen ↑1.6 Control of DNA replication NM002592 =
BAX BCL2-associated X protein ↑1.6 Apoptosis NM_004324 ↑2.4
Genes not found expressed in non-stressed hTERT-BJ1 fibroblasts
MMP3 Matrix metalloproteinase 3 ↑ Degradation of extracellular matrix NM_002422 ↑4.5
Genes underexpressed in H2O2-induced SIPS
GADD153 DNA damage inducible transcript3 ↓4.7 Stress response S40706 ↓1.6
MMP1 Matrix metalloproteinase 1 ↓2.8 Degradation of extracellular matrix NM_002421 =
MAX MAX protein ↓2.2 Cell proliferation control NM_002382 =
ODC Ornithine decarboxylase1 ↓1.8 Cell cycle & proliferation NM_002539 ↑1.6
VEGFB Vascular endothelial growth factor B ↓1.6 Angiogenesis; Cell proliferation U43368 =
Genes not found expressed in hTERT-BJ1 cells in H2O2-induced SIPS
HMOX Heme-oxygenase ↓ Defense system NM_002133 =
KNSL6 Mitotic-centromere-associated-kinesin ↓ Cell proliferation NM_006845 =
 
aWe calculated the ratio of the normalized hybridization intensity of hTERT-BJ1 cells in 
H2O2-induced SIPS and the respective controls (S/C). Genes not expressed in one condition 
but whose value in the other condition is higher than the mean value for all genes in the 
corresponding array are represented as genes not found expressed. 
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 It is clear that HIF-1’s DNA-binding activity increases as a result of a single H2O2 stress, 
both in BJ (Fig. 4C) and hTERT-BJ1 (Fig. 4D) cells. This data is in agreement with the 
mitochondrial model of HIF-1 in which oxidative stress activates HIF-1, meaning that H2O2 
might directly activate HIF-1 (Michielis et al., 2002). The increase in DNA-binding activity of 
HIF-1 can help explain the overexpression of FGF2 in H2O2-induced SIPS since FGF2 levels 
have been suggested to be mediated by HIF-1 (Li et al., 2002). 
 Although the DNA-binding activity of NF-κB does not appear to be altered during the 72 
hrs after a single H2O2 stress, we noticed that the basal NF-κB DNA-binding activity is at least 
2-fold higher in BJ cells compared to hTERT-BJ1 (243 ± 82%). On the contrary, phosphorylated 
ATF-2’s basal DNA-binding activity is much higher in hTERT-BJ1 cells compared to BJ 
controls (at least 3-fold since the DNA-binding activity increases 371 ± 60%). Regarding the 
other studied transcription factors (AP-1, CREB, NFAT, PPARg), we did not find any significant 
differences in DNA-binding activity either as a result of a single H2O2 stress or between BJ and 
hTERT-BJ1 cells (data not shown). 
 
4. Discussion 
 It was reported that p21WAF-1 is overexpressed at mRNA and protein levels in H2O2-
induced SIPS in IMR-90 (Chen et al., 1998, 2000) and BJ HDFs (de Magalhaes et al., 2002). 
p21WAF-1 inhibits the phosphorylation of the retinoblastoma protein by cyclin-dependent kinases, 
explaining the growth arrest observed in SIPS and the appearance of biomarkers of senescence 
such as SA β-gal, senescent morphology, etc. This overexpression of p21WAF-1 can be due to an 
increased DNA-binding activity of p53, as observed here from 2 to 72 hrs after stress. 
Upregulation of p53’s protein level had been reported previously at 24 (Morales et al. 1999) but 
not at 72 hrs after stress in BJ cells (de Magalhaes et al., 2002). Our DNA array results also did 
not show any significant change in the steady-state mRNA level of p53 following H2O2 stress in 
either cell line. Yet evidence suggests that post-translational modifications activate p53 in high-
passage HDFs (Atadja et al., 1995), explaining why p53’s DNA-binding activity, but not protein 
or mRNA levels, increases at 72 hrs after H2O2 stress. Although p53-independent induction of 
p21WAF-1 has been reported, p21WAF-1 activation due to DNA damage probably involves p53 
(Michieli et al., 1994). Nevertheless, a p53-independent induction of p21WAF-1 is possible since 
IMR-90 HDFs lacking p53 due to ectopic expression of the viral protein E6 are still able to 
develop a senescent phenotype after subcytotoxic H2O2 stress, while cells lacking E7 cannot, 
since pRb is necessary for SIPS to occur (Chen et al., 2000). Moreover, the kinase activity of 
Table 4: Genes differentially expressed in WS fibroblasts when compared to young BJ HDFs and not differentially expressed when compared to old BJ HDFsa
Genes overexpressed in WS fibroblasts
Symbol Gene name WS/Y Function GenBank Old vs. Young
PAI2 Plasminogen activator inhibitor type2 ↑4.6 Fibrinolysis; Cell cycle J02685 ↑3.2
ANX1 Annexin1 ↑3.7 Anti-inflammatory NM_000700 ↑3.1
CAV1 Caveolin-1 ↑3.7 Signal transduction; endocytosis; potocytosis NM_001753 ↑2.9
PKM2 pyruvate-kinase-muscle 2 ↑3.3 Energetic metabolism M26252 ↑3.1
PCNA Proliferating cell nuclear antigen ↑2.6 Control of DNA replication NM002592 ↑2.5
CANX Calnexin ↑2.6 Protein secretion; probably apoptosis NM_001746 =
SM22 Transgelin ↑2.4 Muscle development M95787 =
CTSB CathepsinB ↑2.3 Intracellular degradation and turnover of proteins NM_001904 =
TB10 Thymosin beta 10 ↑2.3 Cell motility NM_021103 =
CCND1 CyclinD1 ↑2.2 Cell cycle control NM_053056 =
RRM1 Ribonucleotide-reductase M1 ↑2.1 DNA synthesis NM_001033 =
ITGB1 Integrin beta1 ↑2 Cell adhesion NM_002211 =
VEGFC Vascular endothelial growth factor C ↑1.9 Angiogenesis; Cell proliferation NM_005429 =
HSP70 Heat shock 70kD protein1 ↑1.8 Defense system AB023420 =
SHC p66-SHC transforming protein1 ↑1.7 Cell proliferation; apoptosis U73377 =
Genes underexpressed in WS fibroblasts
FHIT Fragile histidine triad gene ↓2.9 Purine metabolism NM_002012 =
IL11RA Interleukin 11-receptor-alpha ↓2.8 Signal transduction U32324 =
Ki-67 Ki-67 ↓2.8 Cell proliferation NM_002417 =
MMP11 Matrix metalloproteinase 11 ↓2.3 Degradation of extracellular matrix NM_005940 =
MSRA Methionine-sulfoxide-reductase A/peptide ↓2.3 Stress response AF183420 =
CSF1R Colony stimulating factor 1 receptor ↓2.2 Cell proliferation NM_005211 =
GSTPi Glutathione S-transferase pi ↓1.8 Detoxification NM_000852 =
MMP15 Matrix metalloproteinase 15 ↓1.7 Degradation of extracellular matrix NM_002428 =
FGFR Fibroblast growth factor receptor 1 ↓1.7 Cell proliferation NM_000604 =
ICAM-1 Intracellular adhesion molecule1 ↓1.6 Cell adhesion J03132 =
NCOR1 Nuclear receptor co-repressor 1 ↓1.6 Transcription NM_006311 =
 
aWe calculated the ratio of the normalized hybridization intensity of WS fibroblasts and 
young BJ cells (WS/Y). Only genes not differentially expressed between WS fibroblasts and 
old BJ HDFs were considered. 
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cyclin-dependent kinase 2 has been shown to be greatly decreased in a p21WAF-1-independent 
manner in IMR-90 cells (Frippiat et al., 2003), suggesting other players may be involved. 
 In accordance with our previous results (de Magalhaes et al., 2002), the expression of 
telomerase does not appear to protect or interfere with the appearance of SIPS or its general 
mechanisms occurring through p21WAF-1 overexpression. One plausible explanation is that 
disruption of the telomeres, rather than telomere shortening, induces SIPS. Indeed, exposure to 
oligonucleotides homologous to the telomere 3’-overhang sequence induces a senescent 
phenotype (Li et al., 2003). Yet telomerase appears to stabilize the telomeres (Blackburn, 2000). 
The inability of telomerase to interfere with SIPS suggests generalized DNA damage generated 
by H2O2 as another possible mechanism in SIPS. 
 The two main features of HDFs in SIPS are that cells remain alive despite exposure to 
stress (they do not apoptose) and their cycle is irreversibly blocked. In normal conditions a 
balance exists between the pro- and anti-proliferative signals and the pro- and anti-apoptotic 
signals. It could be that, in SIPS, this particular multi-variable balance gets reorganized, still 
allowing cell survival but blocking the cell cycle. The activation of pro-proliferative and anti-
apoptotic signal transduction pathways could inhibit pro-apoptotic pathways while the activation 
of anti-proliferative pathways inhibit growth, e.g. p21WAF-1 overexpression. For instance, p53 is 
known to regulate the expression level of p21WAF-1 while the pro-apoptotic gene BAX is also 
known to be regulated by p53 (Schuler et al., 2003). On the other hand, p53 may regulate HIF-1, 
involved in the adaptation against oxidative stress. Indeed, activation of p53 by oxidative stress 
can result in either apoptosis or growth arrest and the events that determine the decision remain 
unclear (Martindale and Holbrook, 2002). Other examples exist, such as the overexpression of 
IGFBP5 or the downregulation of IGF1R. In addition, we witness the downregulation of the pro-
apoptotic GADD153. GADD153 has been shown to be involved in the stress response to UV 
damage and oxidative stress (Guyton et al., 1996). In Hela cells, GADD153 is overexpressed 
after oxidative stress, not underexpressed as occurs in our model. The expression of the 
GADD153 pro-apoptotic gene in hepatocytes increases with age in mice and makes cells more 
susceptible to oxidative stress (Ikeyama et al., 2003). It is interesting to notice how both anti- and 
pro-apoptotic genes can be up- and downregulated as if to keep the balance between them (Fig. 
2). 
 Since previous reports indicated that hTERT transfection into BJ cells did not alter 
normal cellular functions, for instance hTERT did not alter the karyotype (Bodnar et al., 1998; 
Jiang et al., 1999; Morales et al., 1999), it was surprising to find so many differentially expressed 
genes between BJ and hTERT-BJ1 cells. Such abrupt differences indicate that the presence of 
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telomerase does more than avoid the end-replication problem, as suggested by other recent 
results (Smith et al., 2003). This suggests that telomerase-immortalized cells, while not being 
transformed, do not have the same functional abilities of normal cells. In addition, recent results 
hint SOD2 as a tumor suppressor (Plymate et al., 2003). The observed downregulation of SOD2 
in hTERT-BJ1 HDFs confirms other reports that telomerase may favor tumorigenesis by a 
telomere length-independent mechanism (Stewart et al., 2002; Lindvall et al., 2003). 
 Our data confirms previous reports that WS fibroblasts are more sensitive to oxidative 
stress than normal cells. Based on our results, WS fibroblasts do not develop SIPS. Previous 
reports indicated that SA βgal in AG00780 fibroblasts increases dramatically from PD 10.9 to 
PD 32.5 (Choi et al., 2001). Therefore, according to this biomarker the WS fibroblasts are not 
senescent at early PDs and did not get senescent when submitted to oxidative stress, which 
suggests a complex regulation of SA βgal in WS cells. 
 An old question is whether the effects of mutations in the WRN protein mimic the 
process of normal senescence. Our gene expression results suggest that similar pathways might 
be at work. The mutations in the WRN protein are suggested to induce changes that become 
irreversible. In agreement with this idea, ectopic expression of telomerase can immortalize WS 
fibroblasts, and nevertheless gene expression patterns remain abnormal (Choi et al., 2001). More 
globally, our results suggest that telomerase, although it increases the proliferative capacity of 
cells, alters the functionality of cells and, as happens when expressing telomerase ectopically in 
WS and progeria cells (Bai and Murnane, 2003), does not fully restore the cellular functions to 
young cells. 
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Table 5: Genes differentially expressed in old, pre-senescent BJ HDFs when compared to BJ HDFs at early PDsa
Genes overexpressed in old BJ fibroblasts
Symbol Gene name O/Y Function GenBank
MMP3 Matrix metalloproteinase 3 ↑35.4 Degradation of extracellular matrix NM_002422
MMP1 Matrix metalloproteinase 1 ↑6.5 Degradation of extracellular matrix NM_002421
IL6 Interleukin 6 ↑4.5 Immune response NM000600
IGFBP5 Insulin growth factor binding protein5 ↑4.4 Signal transduction M65062
PLAU Urokinase ↑3.6 Regulation of cell-surface plasminogen activation NM_002658
PAI2 Plasminogen activator inhibitor type2 ↑3.2 Fibrinolysis; Cell cycle J02685
PKM2 pyruvate-kinase-muscle 2 ↑3.1 Energetic metabolism M26252
ANX1 Annexin1 ↑3.1 Anti-inflammatory NM_000700
CTGF Connective tissue growth factor ↑3.0 Cell proliferation U14750
CAV1 Caveolin-1 ↑2.9 Signal transduction; endocytosis; potocytosis NM_001753
S100A S100 calcium binding protein A4 ↑2.7 Cell cycle control NM_002961 
p21 Cyclin dependent kinase inhibitor 1A ↑2.5 Cell cycle control U03106
PCNA Proliferating cell nuclear antigen ↑2.5 Control of DNA replication NM002592
FGF2 fibroblast growth factor 2 ↑2.3 Cell proliferation NM_002006
CDC42 Cell division cycle42 ↑2.2 Cell cycle NM_001791
AOP2 Anti-oxidant-protein2 ↑1.7 Defense system NM_004905
Genes not found expressed in young BJ fibroblasts
EGFR Epidermal growth factor receptor ↑ Control of cell growth and differentiation NM_005228
CATB Catenin, beta 1 ↑ Cell adhesion; transduction signal NM_001904
SMAD2 SMAD2 ↑ Signal transduction U68018
IL1B Interleukin1 beta ↑ Inflammatory and immune responses M15330
Genes underexpressed in old BJ fibroblasts
FES Feline sarcoma oncogene ↓2.9 Cell proliferation X52192
HMOX Heme-oxygenase ↓2.6 Defense system NM_002133
CCNF CyclinF ↓2.4 Cell cycle control NM_001761
APOJ ApolipoproteinJ ↓2.4 Lipid metabolism J02908
SPRR1B Cornifin ↓2.2 Cell structure NM_003125
MYBL2 b-myb ↓2.1 Cell cycle control X13293
IGF1R Insulin like growth factor1 receptor ↓2.1 Cell proliferation; anti-apoptotic NM_000875
E2F2 E2F transcription factor2 ↓2.1 Cell cycle control; apoptosis NM_004091
CSF1R Colony stimulating factor 1 receptor ↓2 Cell proliferation NM_005211
BIN1 Bridging integrator 1 ↓2 Cell cycle control; apoptosis NM_004305
FGF8 Fibroblast growth factor 8 ↓1.9 Cell proliferation U36223
BAD BCL2-antagonist of cell death ↓1.9 Pro-apoptotic NM_004322
CASP3 Caspase3 ↓1.9 Apoptosis NM_004346
Gene not found expressed in old BJ fibroblasts
ESR2 Estrogen receptor beta ↓ Cell-cell signaling X99101 
 
aWe calculated the ratio of the normalized hybridization intensity of old and young BJ cells 
(O/Y). Genes not expressed in one condition but whose value in the other condition is higher 
than the mean value for all genes in the corresponding array are represented as genes not 
found expressed. 
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Supplemental Data: List of the 202 genes represented on the DualChip Human General array
Symbol Gene General Function Gene bank 
23kd 23KDa Highly basic  protein Protein synthesis X56932
ACTB Beta-Actin Cell motility NM_001101
ADAM1 A disintegrin and metalloproteinase Cell migration XM_090479
ADPRT Polysynthetase Cell proliferation J03473
Aldo Aldolase A, Glycolysis NM_000034
ANX1 Annexin1 Anti-inflammatory NM_000700
AOP2 Anti-oxidant-protein2 Defense system NM_004905
APOJ ApolipoproteinJ Lipid metabolism J02908
ATM Ataxia telangiectasia mutated Protein kinase;  Cell cycle control U26455
BAD BCL2-antagonist of cell death Pro-apoptotic NM_004322
BAX BCL2-associated X protein Apoptosis NM_004324
BCL2 B-cell lymphoma2 Inhibitor of Apoptosis NM_000633
BCLX BCLX Apoptosis NM_001191
BID BH3 interacting domain death agonist Apoptosis NM_001196
BIN1 Bridging integrator 1 Cell cycle control; apoptosis NM_004305
BMP2 Bone morphogenetic protein2 Cell-cell signaling NM_001200
BSG Basigin Immonoglobulin superfamily NM_001728
CANX Calnexin Protein secretion; probably apoptosis NM_001746
CASP2 Caspase2 Apoptosis NM_001224
CASP3 Caspase3 Apoptosis NM_004346
CASP7 Caspase7 Apoptosis NM_001227
CASP8 Caspase8 Apoptosis X98172
CASP9 Caspase9 Apoptosis NM_001229
CATB Catenin, beta 1 Cell adhesion; transduction signal NM_001904
CAV1 Caveolin-1 Signal transduction; endocytosis; potocytosis NM_001753
CCNA1 CyclinA1 Cell cycle control NM_003914
CCNB1 CyclinB1 Cell cycle control NM_031966
CCND1 CyclinD1 Cell cycle control NM_053056
CCND2 CyclinD2 Cell cycle control NM_001759
CCND3 CyclinD3 Cell cycle control NM_001760
CCNE1 CyclinE Cell cycle control NM_001238
CCNF CyclinF Cell cycle control NM_001761
CCNH CyclinH Cell cycle control NM_001239
CDC42 Cell division cycle42 Cell cycle NM_001791
CDH1 Cadherine1/E-cadherine calcium-dependent glycoprotein;  Cell adhesion NM004360
CDH11 Cadherine11 calcium-dependent glycoprotein;  Cell adhesion NM_001797
CDH13 Cadherine13 calcium-dependent glycoprotein;  Cell adhesion U59289
CDK2 Cyclin dependent kinase2 Cell proliferation NM_001798
CDK4 Cyclin dependent kinase4 Cell proliferation U79269
CDK6 Cyclin dependent kinase6 Cell proliferation NM001259
CENPF Mitosin DNA replication U30872
CKB Creatin-kinase-brain Energy homeostasis M16364
cmyc c-myc Oncogenesis NM012333
COL6A2 CollagenVI-alpha2 Extracellular matrix NM_001849
COX2 Prostaglandin endoperoxidase synthase 2 Cell migration/angiogenesis NM_000963 
CROC1A Ubiquitin (E2 variant1) Cell cycle control NM_003349
CSF1 Colony stimulating factor 1 Cell proliferation M37435
CSF1R Colony stimulating factor 1 receptor Cell proliferation NM_005211
CTGF Connective tissue growth factor Cell proliferation U14750
CTSB CathepsinB Intracellular degradation and turnover of proteins NM_001904
CTSD CathepsinD Intracellular degradation and turnover of proteins NM_001904
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Symbol Gene General Function Gene bank 
CTSL CathepsinL Intracellular degradation and turnover of proteins NM_001912
cyc Cyclophilin 33A Synthesis proteins AF042385
DHFR Dihydrofolate reductase Cell cycle NM_000791
DP1 Transcription factor Dp-1 Cell cycle control NM_007111
DP2 Transcription factor Dp-2 Cell cycle control NM_006286
E2F2 E2F transcription factor2 Cell cycle control; apoptosis NM_004091
E2F3 E2F transcription factor3 Cell cycle control NM_001949
E2F4 E2F transcription factor4 Cell cycle control NM_001950
EGFR Epidermal growth factor receptor Control of cell growth and differentiation NM_005228
EGR1 Early growth response1 Transcriptional regulator NM_001964
EGR3 Early growth response3 Transcription factor NM_004430
EIF4 Eukaryotic translation initiation Protein synthesis NM_001968
EMS1 EMS1 Regulation of cell adhesion NM_005231
ESR2 Estrogen receptor beta Cell-cell signaling X99101 
ETFB Electron-transfert-flavoprotein-beta Energy generation NM_001985
FES Feline sarcoma oncogene Oncogenesis X52192
FGF2 fibroblast growth factor 2 Cell proliferation NM_002006
FGF8 Fibroblast growth factor 8 Cell proliferation U36223
FGFR Fibroblast growth factor receptor 1 Cell proliferation NM_000604
FHIT Fragile histidine triad gene Purine metabolism NM_002012
FN1 Fibronectin Cell adhesion/migration X02761
FOS c-fos Oncogenesis NM_005252
G6PD Glucose-6-phosphate-dehydrogenase Energetic metabolism NM_000402
GADD153 DNA damage inducible transcript3 Cell stress S40706
GAPD Glyceraldehyde-3-phosphate-dehydrogenase Glycolysis NM002046
GLB1 Beta1-galactosidase Glycoprotein degradation M34423
GPX Glutathione peroxidase Defense system M21304
GRB2 Growth factor receptor-bound protein2 Cell proliferation control NM_002086
GSN Gelsoline Cell mobility X04412
GSTPi Glutathione S-transferase pi Detoxification NM_000852
H2B/S Histone2b member B/S consensus Cell cycle NM_080593
H3FF Histone3  member F consensus Cell cycle NM_003533
H4FM Histone4 member M consensus Cell cycle NM_003495 
HK1 Hexokinase Glycolytic enzyme M75126
HMOX Heme-oxygenase Defense system NM_002133
HPRT Hypoxanthine phosphoribosyltransferase 1 HouseKeeping gene NM_000194
HSP27 Heat shock 27kD protein1 Defense system AB020027
HSP40 Heat shock 40kD protein1 Defense system D49547
HSP70 Heat shock 70kD protein1 Defense system AB023420
HSP90-a Heat shock 90kD protein1 alpha Defense system X15183 
HSP90-b Heat shock 90kD protein 1, beta Defense system NM_007355
ICAM-1 Intracellular adhesion molecule1 Cell adhesion J03132
IGF1 Insulin like growth factor1 Cell proliferation control X57025
IGF1R Insulin like growth factor1 receptor Cell proliferation; anti-apoptotic NM_000875
IGFBP2 Insulin growth factor binding protein2 Signal transduction; disrupts binding of IGF-1 M35410
IGFBP3 Insulin growth factor binding protein3 Signal transduction; disrupts binding of IGF-1 X64875
IGFBP5 Insulin growth factor binding protein5 Signal transduction; disrupts binding of IGF-1 M65062
IL10 Interleukin 10 Immune response NM_000572
IL11 Interleukin 11 Inflammatory  responses NM_000641
IL11RA Interleukin 11-receptor-alpha Signal transduction U32324
IL15 Interleukin 15 Immune response NM_000585
IL1A Interleukin1 alpha Inflammatory  responses NM000575
IL1B Interleukin1 beta Inflammatory and immune responses M15330
IL4 Interleukin 4 Immune response NM_000589
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IL6 Interleukin 6 Immune response NM000600
IL8 Interleukin 8 Cell adhesion/migration NM_000584 
ING1 Inhibitor of growth family, member 1 Cell proliferation NM005537
ITGA5 Integrin alpha5 Cell adhesion NM_002205
ITGA6 Integrin alpha6 Cell adhesion NM_000210
ITGB1 Integrin beta1 Cell adhesion NM_002211
JNK1 Mitogen activated protein kinase8 Stress response L26318
JNK2 Mitogen activated protein kinase9 Stress response U09759
JNK3 mitogen-activated protein kinase 10 Stress response NM_002753
JUND Jun D proto-oncogene Transcription factor NM_005354
Ki-67 Ki-67 Cell proliferation NM_002417 
KNSL5 Mitotic-kinesin-like-protein1 Cell proliferation NM_004856
KNSL6 Mitotic-centromere-associated-kinesin Cell proliferation NM_006845
MAX MAX protein Cell proliferation control NM_002382
MDH Malate dehydrogenase 1 Citric acid cycle NM_005917
MDM2 MDM2 Cell cycle control NM_002392
MEK1 Mitogen activated protein kinase kinase1 Cell proliferation control L11284
MEK2 Mitogen activated protein kinase kinase2 Cell mobility NM_030662
MMP1 Matrix metalloproteinase 1 Degradation of extracellular matrix NM_002421
MMP11 Matrix metalloproteinase 11 Degradation of extracellular matrix NM_005940
MMP12 Matrix metalloproteinase 12 Degradation of extracellular matrix NM_002426
MMP13 Matrix metalloproteinase 13 Degradation of extracellular matrix NM_002427 
MMP14  Matrix metalloproteinase 14  Degradation of extracellular matrix NM_004995 
MMP15 Matrix metalloproteinase 15 Degradation of extracellular matrix NM_002428 
MMP2 Matrix metalloproteinase 2 Degradation of extracellular matrix NM_004530
MMP3 Matrix metalloproteinase 3 Degradation of extracellular matrix NM_002422
MMP7 Matrix metalloproteinase 7 Degradation of extracellular matrix NM_002423
MMP9 Matrix metalloproteinase 9 Degradation of extracellular matrix NM_004994
MSRA Methionine-sulfoxide-reductase A/peptide Stress response AF183420 
MYBL2 b-myb Cell cycle control X13293
NCK1 NCK adaptor protein1 Cell cycle NM_006153 
NCOR1 Nuclear receptor co-repressor 1 Transcription NM_006311
NCOR2 Nuclear receptor co-repressor 2 Cell cycle NM_006312
ODC Ornithine decarboxylase1 Cell cycle & proliferation NM_002539
ON Osteonectin Ossification NM_003118
OPN Osteopontin Ossification NM_000582
p16 Cyclin dependent kinase inhibitor 2A Cell cycle control L27211
p21 Cyclin dependent kinase inhibitor 1A Cell cycle control U03106
p27 Cyclin dependent kinase inhibitor 1B Cell cycle control NM_004064
p35 Cyclin dependent kinase5 regulatory subunit1 Cell proliferation NM_003885
p53 Tumor protein p53 regulation of cell cycle AF307851
p57 Cyclin dependent kinase inhibitor 1C regulation of cell cycle NM_000076
PAI1 Plasminogen activator inhibitor type1 Fibrinolysis; Cell cycle M14083
PAI2 Plasminogen activator inhibitor type2 Fibrinolysis; Cell cycle J02685
PAK P21 activated kinase1 Cell mobility/morphology NM_002576
PCNA Proliferating cell nuclear antigen Control of DNA replication NM002592
PGR Progesterone receptor Cell-cell signaling NM_000926
PKM2 pyruvate-kinase-muscle 2 Energetic metabolism M26252
PLA2 Phospholipase A2 Signal transduction M86400
PLAU Urokinase Regulation of cell-surface plasminogen activation NM_002658
PLK Polo-like kinase Cell cycle control U01038
POLA2 Polymerase alpha  Cell cycle NM_002689
PSMD11 26S-proteasome-subunit-p44.5 Protein degradation AB003102
RAF1 c-raf-1 Oncogenesis X03484
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Symbol Gene General Function Gene bank 
RB1 Retinoblastome1 regulator of transcription NM_000321
RRM1 Ribonucleotide-reductase M1 DNA synthesis NM_001033
S100A S100 calcium binding protein A4 Cell cycle control NM_002961 
S100A8 Calprotectin Inflammatory response NM_002964 
S9 Ribosomal Proteine S9 Protein synthesis NM_001013
SDS Serine Dehydratase  NM_006843
SHC p66-SHC transforming protein1 Cell proliferation; apoptosis U73377
SM22 Transgelin Muscle development M95787
SMAD1 SMAD1 Signal transduction U59423
SMAD2 SMAD2 Signal transduction U68018
SMAD3 SMAD3 Signal transduction U68019
SMAD4 SMAD4 Signal transduction U44378
SOD2 Superoxide dismutase2 Stress response NM_000636
SPRR1B Cornifin Cell structure NM_003125
TB10 Thymosin beta 10 Cell motility NM_021103
TBXA2R Thromboxane-A2-receptor Respiration D38081
TERT Telomerase-reverse transcriptase DNA synthesis AF018167
TFAP2A Transcription factor AP2-alpha Morphology M36711
TFAP2B Transcription factor AP2-beta Neurogenesis; morphology X95694
TFAP2C Transcription factor AP2-gamma Morphology NM_003222 
TFR Transferrin receptor Transporter NM_003234
TGFBR2 TGF-beta-R2 Cell proliferation D50683
TIMP1 Tissue inhibitor of metalloproteinase1 Inhibitor of degradation of extracellular matrix NM_003254  
TIMP2  Tissue inhibitor of metalloproteinase2 Inhibitor of degradation of extracellular matrix NM_003255
TK1 Thymidine-kinase DNA synthesis NM_003258 
TNFa Tumor necrosis factor alpha Apoptosis and proinflammatory response NM_000594
TOP2 Topoisomerase2-alpha DNA replication NM_001067
TPA Plasminogen activator tissue Cell migration and tissue  remodeling NM_000930
TRF1 Telomeric repeat binding factor1 Control of mitosis U40705
TSP1 Thrombospondin 1 Cell adhesion NM_003246
TSP2 Thrombospondin 2 Cell adhesion NM_003247
Tubu Alpha-tubulin cytoskeletic NM006082
TYMS Thymidylate-synthetase DNA synthesis NM_001071 
UBE2C
Ubiquitin conjugating enzyme E2C/ubiquitin 
carrier protein Cell proliferation NM_007019
uPAR Urokinase-receptor Regulation of cell-surface plasminogen activation NM_002659
VEGF Vascular endothelial growth factor Angiogenesis; Cell proliferation AF022375
VEGFB Vascular endothelial growth factor B Angiogenesis; Cell proliferation U43368
VEGFC Vascular endothelial growth factor C Angiogenesis; Cell proliferation NM_005429
VEGFD Vascular endothelial growth factor D Angiogenesis; Cell proliferation NM_004469
VEGFR1 Vascular endothelial growth factor receptor1 Angiogenesis; Cell proliferation NM_002019
VEGFR2 Vascular endothelial growth factor receptor2 Angiogenesis; Cell proliferation NM_002253 
VEGFR3 Vascular endothelial growth factor receptor3 Angiogenesis; Cell proliferation NM_002020 
VWF Factor von willebrand Role in blood coagulation NM_000552
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CHAPTER 9: MODELS OF HUMAN AGEING 
 
 The goal of gerontology is to preserve health and well-being, and extent healthy life. We 
aim to understand the mechanisms of ageing to understand how these mechanisms lead to 
pathologies (de Grey et al., 2002; de Magalhaes, 2003a). Due to the difficulties in studying 
human ageing directly, the choice of models employed by researchers is of critical importance. 
In fact, one of the reasons why the mechanisms responsible for human ageing remain largely a 
mystery is the lack of appropriate models where scientists can test their hypothesis. 
 
9.1. Lessons from the evolution of ageing 
 
 In the first part of this work, we created a model for the evolution of mammalian ageing. 
Previous theories attempting to explain the evolution of ageing failed to explain several 
observations, such as animals with negligible senescence--which are deemed impossible to exist 
by the theory--and why ageing, a phenotype that escaped natural selection, is so similar amongst 
mammals. It is difficult to reconcile the disposable soma theory (Kirkwood, 1977) with 
observations of animals whose mortality decreases with age in the wild while reproductive 
output increases (Congdon et al., 2001). In fact, another recent 38-year field study suggested that 
older female Painted Turtles, when compared to younger animals, feature increased reproductive 
output and offspring quality while maintaining survivorship (Congdon et al., 2003). Inter-
individual comparisons in humans also failed to support the disposable soma theory (Le Bourg, 
2001). In addition, a rethinking of the evolutionary theory of ageing was recently proposed: the 
hypothesis is that intergenerational transfers--e.g. nurturing--also shape ageing in social species 
(Lee, 2003). Therefore, it appears that the classical evolutionary theory of ageing does not offer a 
complete picture on the evolution of ageing across different species. 
 In contrast to the general view of the classical evolutionary theory of ageing (reviewed in 
Rose, 1991), our work offers a specific model of how ageing may have evolved in mammals. 
Importantly, our evolutionary model explains why reptiles feature non-aging organisms and 
some life-extending traits, such as oocyte regeneration, that are absent even from whales, the 
longest-lived mammal. In fact, some researchers have found bizarre that mammals feature 
ageing when more primitive species such as fishes and reptiles appear to avoid it (Hayflick, 
1994), while others have wondered why some mammals can be found senescent in the wild 
(Finch, 1990). Our model explains these observations and contradicts some aspects of the 
classical evolutionary theory of ageing such as the disposable soma theory. Though we do not 
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question the validity of, for instance, Medawar’s model of mutation accumulation (Medawar, 
1952), our model is a step forward in having a more elaborate view of the evolutionary forces 
shaping ageing, paying special attention to human ageing. 
 We can expect that even more detailed models of the evolution of ageing in mammals 
will emerge taking into account, for instance, the evolution of longevity in different mammalian 
families after the dinosaurs disappeared. For instance, some researchers argue that the slow 
human life cycle is related to our brain’s size and energy requirements (Parker, 1990). Analysing 
such trends in hominid evolution and ageing may be profitable. Another promising future 
prospect is the analysis of the evolution of cancer in mammals following the same strategy we 
employed in developing our model. 
 The evolution of ageing serves as a theoretical framework to understand the mechanisms 
of ageing. We used our evolutionary model to suggest that the mechanisms of ageing may be 
unique in mammals. Certain pathway, such as those involved in metabolism, appear to affect 
ageing across a variety of organisms (Longo, 1999; Longo and Fabrizio, 2002; Butler et al., 
2003; Nystrom, 2003). Yet although the link between metabolic rate and pace of ageing may be 
widespread, the mechanisms of ageing need not. For instance, caloric restriction delays 
development (reviewed in Hayflick, 1994), suggesting that shifts in metabolism affect the entire 
genetic program delaying ageing independently of the mechanisms involved. Furthermore, some 
pathways that affect ageing in invertebrates do not appear to play a role in mammalian ageing. 
For instance, the way antioxidant enzymes modulate ageing in invertebrates (Orr and Sohal, 
1994) has so far not been extrapolated to mammals (Lipman et al., 1998; Schriner et al., 2000 for 
arguments). Taken as a whole, these results lead us to suggest that there may be unique 
mechanisms of mammalian ageing with various consequences in studying human ageing, which 
will be detailed throughout this chapter 9. 
 In our model, we predicted that reptiles may feature unique mechanisms to delay ageing 
and age-related debilitation. Recent findings suggest that turtles have enhanced mechanisms to 
protect against ROS formation and damage (Lutz et al., 2003). Similarly, studies on cells from 
turtles suggest that these do not reach RS even in the absence of telomerase (Christiansen et al., 
unpublished) while other results indicate that at least in some turtles telomere shortening does 
not occur in vivo (Girondot and Garcia, 1999). Moreover, our model may help explain why 
mammals lost part of their tissue regeneration capacity when compared to, for instance, 
amphibians and reptiles (Brockes et al., 2001). Taken together, these results support our model 
for the evolution of mammalian ageing and, as will be discussed in chapters 9.2., 9.4.2., and 9.6, 
make reptiles an intriguing model to study ageing. 
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9.2. Animal models 
 
 Probably the major conclusion from our work on the evolution of ageing concerns the 
choice of organisms as models of human ageing. Of course human studies should always be 
preferred, but often model organisms are unavoidable. If so, then we argue that mammals are the 
most appropriate models while lower life forms such as yeast or even invertebrates may not be 
adequate to study the human ageing process. For example, evolutionary distant bacteria have 
been used to study ageing (reviewed in Nystrom, 2002). Just recently, senescence was shown in 
a bacterium with asymmetric division, Caulobacter crescentus, in the form of a decrease in 
reproductive output with age (Ackermann et al., 2003). Yet there is no reason to expect a 
unicellular organism to age for the same reason humans age. For instance, Sir2 has been 
demonstrated as an important factor in S. cerevisiae longevity (Lin et al., 2000) and later in C. 
elegans (Tissenbaum and Guarente, 2001) but findings in Drosophila contradict the role of Sir2 
in ageing (Newman et al., 2002). Since Drosophila are considered a more reliable model of 
human biology and genetics than yeast or roundworms (Hedges, 2002), then research on Sir2 in 
yeast may be totally irrelevant for human ageing. Of course studies in lower life forms can help 
us understand the dynamics and structure of human ageing. If ageing is the corruption of life, 
then understanding how life itself works may help us understand ageing and much of what we 
know about life--e.g. DNA replication and repair--came from studies in lower life forms such as 
bacteria and yeast. Many genes that modulate ageing have been identified in model organisms, 
namely in invertebrates such as C. elegans and Drosophila (reviewed in Tower, 2000; Johnson, 
2002). These findings can serve as the basis for research into mammals (Tissenbaum and 
Guarente, 2002; Butler et al., 2003; Warner, 2003), so we do not conclude that research in 
invertebrates is irrelevant in gerontology. Nonetheless, our work argues that studies on the 
mechanisms of ageing in lower life forms must be corroborated in mammalian models before 
extrapolations into human ageing can be made and explaining human ageing based on research 
in lower life forms is incorrect. 
 Of course that even eutherians may have different mechanisms of ageing. One excellent 
example comes from the insulin-signalling pathway, which has been implicated in ageing from 
invertebrates to mice (Longo and Fabrizio, 2002; Butler et al., 2003). Deletion of the growth 
hormone receptor gene (GHR) in mice increases longevity 40-50% and delays the rate of ageing 
(Coschigano et al., 2000). Yet human patients with mutations in the GHR gene--called Laron 
syndrome--also exist and, though they have short stature and low levels of insulin-like growth 
factor I, data obtained so far does not suggest an increased longevity (Zhou et al., 1997; 
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Kopchick and Laron, 1999). Some studies suggest that insulin-like growth factor I may affect 
human longevity (Bonafe et al., 2003) and human patients with a mutated Prop1 gene may live 
longer (Krzisnik et al., 1999; Bartke et al., 2001a), though no information suggests that humans 
with this mutation approach the 50% longevity increase seen in mice mutant for Prop1 (Brown-
Borg et al., 1996). Moreover, untreated patients with growth hormone deficiency have a reduced 
longevity (Besson et al., 2003). Our view is that what occurs in other mammals may not be 
representative of human biology (reviewed in Davenport, 2003) and, namely, mice may be 
inadequate to study human ageing (Austad, 1997b for arguments). Therefore, if we base our 
understanding of human ageing on model organisms, we must have a coherent view of 
mammalian ageing before we can claim we understand the human ageing process. 
 In our work, we argued that reptiles age slower than mammals. Clearly, some reptilian 
taxa feature ageing (Perez-Campo et al., 1993; Patnaik, 1994; Townes-Anderson et al., 1998; 
Majhi et al., 2000; Jena et al., 2002). In one recent study, lizards that grew faster in early life 
showed an increased mortality in adulthood (Olsson and Shine, 2002). Yet not only reptiles age 
slower than size-equivalent mammals, but several reptilian families feature apparently non-
ageing animals. Although metabolic rates may also play a role (Castanet, 1994), they do not 
explain why, for instance, some reptiles feature continuous tooth replacement and often female 
reptiles feature oocyte regeneration. In addition, the leatherback turtle, Dermochelys coriacea, 
shows signs of endothermy (Davenport et al., 1990) and yet lives at least 30 years (Spotila et al., 
2000). We do not argue that all reptiles age slower than all mammals for that would be 
unrealistic given the flexibility demonstrated by natural selection in modulating longevity and 
ageing (Cutler, 1979; de Magalhaes, 2003a for arguments). What we argue is that mammals lack 
certain anti-ageing mechanisms that are present in some or all reptiles. As mentioned in chapter 
9.1., pathways unique to reptiles have already been identified that could contribute to the delayed 
reptilian ageing (Lutz et al., 2003; Christiansen et al., unpublished). For instance, neurogenesis is 
predominant in reptiles (Font et al., 2001). Other studies found unique traits in reptiles that could 
be useful to humans: crocodiles have been shown to possess novel antimicrobial peptides 
(Shaharabany et al., 1999; Fullerton-Smith, 2000). In addition, studying how ageing emerged in 
some reptiles may shed light on the mechanisms present in mammals. One of the major 
conclusions from our work is that reptiles are an underestimated model for the study of ageing 
and more attention should be given to study reptilian ageing or apparent absence of ageing. 
 Some amphibians and fishes also feature negligible senescence (reviewed in Finch, 1990; 
Cailliet et al., 2001). Since amphibians and fishes are evolutionary further from us than reptiles, 
they are not, a priori, better models but can still prove useful. For example, amphibians can 
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regenerate entire limbs while mammalian tissues, such as muscle, can only regenerate as isolated 
entities (reviewed in Carlson, 2003). Lastly, birds too may be useful models for understanding 
human ageing because birds are homeotherms featuring high metabolic rates and slow rates of 
ageing when compared to mammals (Holmes and Austad, 1995 & 2001). In conclusion, we 
argue that research into ageing should involve models as evolutionary close as possible to 
humans and a more diverse choice of animal models, including long-lived animals. To 
understand human mechanisms of ageing we must study humans or mammals, but developing 
anti-ageing interventions may be based on reptiles and other long-lived animals. 
 
9.3. Human models 
 
 As mentioned before, studying the human ageing process has technical difficulties but, if 
successfully tackled, would prove incredibly valuable. If some genetic factors can delay or 
accelerate human ageing, then identifying such factors is a powerful approach. 
 
9.3.1. Centenarians 
 
 Clearly, there are genetic determinants behind human longevity (Ljungquist et al., 1998; 
Gudmundsson et al., 2000; Barzilai et al., 2001; Terry et al., 2003). Finding polymorphisms or 
alleles that correlate with centenarians is not a new strategy in gerontology (Bonafe et al., 2003; 
Louet et al., 2003). For example, it was shown previously that the different alleles of the ApoE 
gene are distributed differently in centenarians and controls aged 20-70 years (Schachter et al., 
1994). Yet ApoE was chosen as a candidate gene. Due to our lack of knowledge regarding the 
human ageing process, candidate genes are presently hard to find. For example, in mice, klotho 
has been associated with premature ageing (Kuro-o et al., 1997). A recent study found a 
correlation between a variant of the human klotho homologue and longevity (Arking et al., 
2002), demonstrating how genes found in model organisms may be later studied in humans. Yet 
with the human genome (Lander et al., 2001; Venter et al., 2001), genome-wide approaches 
become possible without no a priori knowledge about the genes involved. For example, a 
genome-wide scan found evidence of linkage to human longevity in a locus on chromosome 4 
(Puca et al., 2001). 
 The major drawback of this approach is that it may locate genes that affect longevity 
without affecting ageing (Perls et al., 2002). For example, long-lived individuals may feature 
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alleles or polymorphisms that when absent simply increase disease predispositions that decrease 
longevity. 
 
9.3.2. Werner’s syndrome 
 
 The phenotype of WS has for long fascinated gerontologists. Even if WS is not real 
accelerated ageing, the capacity one gene has to modulate so many age-related changes is 
astonishing. That was one of the reasons why we decided to study SIPS in WS fibroblasts. 
Although we failed to develop a model of SIPS in WS fibroblasts, our results demonstrate that 
WS fibroblasts are more sensitive to oxidative stress in the form of H2O2. Our results also 
suggest that the DNA-binding activity of p53 does not increase significantly in WS fibroblasts 
after a single H2O2 stress at 24 or 72 hrs after the stress (de Magalhaes et al., in press), indicating 
changes in the stress response involving p53. Since the WS fibroblasts grew slowly and showed 
the morphology of old cells both before and after a single H2O2 stress, these results suggest an 
uncoupling between SA β-gal and the senescent morphogenesis. One possibility is that cells that 
would normally enter SIPS instead die in WS affecting tissue regeneration. More work is 
necessary to unravel the mechanisms behind SA β-gal activation and the role of WRN in the 
phenotype of WS fibroblasts. For instance, ATF-2 and p38MAPK in WS cells should be 
investigated since these appear to play an important role in inducing SA β-gal (Frippiat et al., 
2002). In addition, recent results suggest that WRN plays a structural role in DNA repair 
independent of its enzymatic activities (Chen et al., 2003b), so studying its interaction partners is 
a promising avenue. Future experiments could also focus on the senescent phenotype of WS cells 
aged in culture as well as comparisons between those obtained from young and old patients. 
 Previously, it was known that p53-mediated apoptosis is attenuated in WS cells (Spillare 
et al., 1999) and WRN can induce p53 in response to DNA damage (Blander et al., 2000). 
Together with our results, this suggests changes in the response to DNA damage in WS 
fibroblasts, which is in accordance with the increased genomic instability of WS cells (Fukuchi 
et al., 1989). Though further work is necessary, perhaps the increased susceptibility of WS cells 
to oxidative stress as well as the diminished activation of apoptotic and senescent pathways 
contributes to the cancer susceptibility of WS patients. In addition, our results suggest that the 
gene expression patterns of WS fibroblasts are more closely related to young BJ than to 
senescent BJ HDFs, though protein comparisons suggest that the premature ageing process of 
WS fibroblasts shares only part of the in vitro ageing process of normal fibroblasts (Toda et al., 
1998). Gene expression patterns of progeria fibroblasts have also been more closely related 
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HDFs from old than to young donors, though gene expression during RS has not been previously 
correlated with progeria fibroblasts (Park et al., 2001). Determining how WRN influences gene 
expression patterns appears a promising approach and certainly much work will emerge in a near 
future. Recent results at a gene expression level suggest that WS is indeed accelerated ageing 
(Kyng et al., 2003). 
 Of course that WS may be a result of some indirect effect of WRN, as suggested by 
others (Johnson et al., 1999). It appears certain that WS derives from lack-of-function rather than 
the toxic effect of an abnormal WRN (Chen et al., 2003b for arguments). Yet, for instance, 
perhaps mutating WRN changes the expression of some other gene that in turn causes the 
accelerated ageing phenotype. Alternatively, perhaps accelerated ageing in WS and other 
progeroid syndromes is caused by an increased cell loss due to RS, apoptosis, or deficient cell 
replacement, leading to the waning of multiple tissues, as proposed previously (Warner and 
Sierra, 2003). Yet since WS is the pathology that more accurately resembles accelerated ageing, 
such prospect appears unlikely. In fact, many of the genes involved in progeroid syndromes 
appear to affect nuclear proteins: most notably Hutchinson-Gilford’s syndrome (Eriksson et al., 
2003), but also Cockayne Syndrome Type I (Henning et al., 1995). Therefore, it appears likely 
that proteins affecting DNA metabolism are involved in ageing. The way WS fibroblasts are 
susceptible to oxidative stress suggests that changes at the DNA level are a causal factor in 
ageing, as will be detailed in chapter 10.4. Obviously, studying these diseases and the 
mechanisms involved appears a promising approach to understand the human ageing process. 
Mouse models may also prove fruitful. For example, a mouse model of Hutchinson-Gilford’s 
syndrome has been recently described (Mounkes et al., 2003).  
 No disease is a true phenocopy of human ageing and that is why the term “segmental 
progeria” is often used. In fact, even if certain diseases accelerate age-related pathologies, it 
should not be assumed that the mechanisms are the same. For instance, the morphology of 
cataracts in WS differs from senile cataracts (reviewed in Martin, 1978). Therefore, studying 
progeroid syndromes must be carefully approached. Nevertheless, we think that understanding 
progeroid syndromes in mouse and man, and how WRN can modulate so many age-related 
changes should increase our knowledge over normal ageing. 
 
9.4. Cellular models 
 
 Although we advocate studies in long-lived turtles and WS, performing such studies in 
vivo has clear limitations. That was why we studied WS fibroblasts instead of WS patients. 
98 
Studies like those in Blanding’s and Painted Turtles are informative but required decades of field 
work (Congdon et al., 2001 & 2003). A quicker and cheaper way is to study cells of long-lived 
animals (Austad, 2001b). That is why cellular studies will continue to be an important approach. 
Namely, studies involving human cells will continue to be important tools to understand human 
ageing. 
 
9.4.1. Senescence, RS, and SIPS 
 
As mentioned in chapter 2.4., cells from older donors divide less vigorously (Waters and 
Walford, 1970; Hayflick, 1994). It is likely that changes occur at a cellular level as the human 
body ages, but these changes are not as obvious as it may seem at first. For example, studies 
comparing HDFs from young donors and centenarians failed to find significant differences in 
terms of cumulative population doublings and growth kinetics (Tesco et al., 1998). On the other 
hand, recent findings suggest that HDFs from centenarians are less resistant to H2O2-induced 
DNA damage. The same study found conflicting results in terms of the proportion of DNA 
breaks in centenarians (Chevanne et al., 2003). Similar studies in mice showed that there is a 
correlation between longevity and oxidative stress resistance of senescent cells (Yegorov and 
Zelenin, 2003). Studies on small intestine stem cells showed an age-related functional decline in 
mice (Martin et al., 1998), though extrinsic factors should not be completely discarded. Similar 
studies found age-related differences in the signalling cascades of mice hepatocytes (Li and 
Holbrook, 2003). Old stem cells have a diminished function when subjected to stress, suggesting 
intrinsic changes (reviewed in Van Zant and Liang, 2003). Also, cells transplanted from animal 
to animal also appear to age and die, suggesting intrinsic mechanisms (reviewed in Hayflick, 
1994). Therefore, identifying what changes occur in human cells as we age may prove valuable 
to understand ageing. For example, understanding why cells become less responsive to external 
insults and signals may be important to understand human ageing.  
 Since RS was first discovered by Hayflick and Moorhead (Hayflick and Moorhead, 
1961), it has been the subject of much attention. As mentioned in chapter 2.4., the relation 
between RS and ageing is unclear and several studies suggest that the changes occurring during 
in vivo and in vitro ageing are different (Takeda et al., 1992; Chevanne et al., 2003 for 
arguments). Also mentioned in chapter 2.4., senescent cells can been found in vivo, though 
mostly in situations of pathology (Mendez et al., 1998a; Mendez et al., 1998b; Paradis et al., 
2001; Going et al., 2002; Minamino et al., 2002). For instance, one recent in vivo study on 
human muscle found an overexpression of p21WAF1 in aged donors (Welle et al., 2001 & 2003) 
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and another study found increased levels of p16INK4a associated with ageing human kidney 
(Chkhotua et al., 2003). Cells taken from mice -/- for p66shc have an impaired p53 and p21WAF1 
stress response (Migliaccio et al., 1999). Whether SIPS or RS are responsible for the appearance 
of senescent cells in vivo is unclear but perhaps apoptosis and cellular senescence play a role in 
the ageing phenotype (Campisi, 2003 for arguments). Finally, if RS and SIPS are just a tumour 
protecting mechanism, then the increase in the proportion of senescent cells in vivo may be a 
result and not a cause of ageing. 
 Mice mutant for the murine WRN homologue do not age faster and yet their fibroblasts 
display hypersensitivity to 4-nitroquinoline-1-oxide and reduced replicative potential (Wang et 
al., 2000a). This demonstrates how cellular studies may not be representative of organismal 
ageing, at least in mice. In humans, immortalization of cells taken from patients with WS, 
Hutchinson-Gilford’s syndrome, or ataxia telangiectasia does not fully reverse the phenotype of 
these cells (Saito and Moises, 1991; Choi et al., 2001; Naka et al., in press). Moreover, cellular 
studies may be biased because culture conditions may be inaccurate representation of in vivo 
conditions (reviewed in Rubin, 1997). For example, as mentioned in chapter 2.3., 20% O2 is not 
representative of physiological conditions (Halliwell, 2003). Recent results show that oxygen 
sensitivity limits the proliferative capacity of murine fibroblasts (Parrinello et al., 2003). Future 
experiments must consider O2 toxicity as an important factor. For example, one future 
experiment would be to test whether WS cells proliferate differently at lower O2 concentrations.  
 In conclusion, it appears that SIPS may be an important mechanism in certain age-related 
pathologies and stress-prone tissues but there is little evidence that either SIPS or RS occur 
widely in normal ageing. Based on present information, we do not think SIPS or RS are accurate 
models of the human ageing process. Cellular senescence may be used as a marker of pathology 
or even of ageing and to investigate the age-related increase in cancer incidence, but it is unlikely 
to be a cause of ageing. Therefore, though studies at a cellular level are a worthwhile method to 
study human ageing, it is dubious which aspects to study. Studying cellular responses to external 
stressors and signals appears a promising enterprise as these appear to change during the normal 
human ageing process and in progeroid syndromes such as WS. 
  
9.4.2. Comparative biology 
 
 As mentioned earlier, one of the conclusions of our work is that comparative biology may 
yield important clues about human ageing. To avoid time-consuming and expensive in vivo 
studies, cellular studies may help clarify why different species age at different rates. For 
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instance, it is clear that intrinsic differences exist between human and murine cells (reviewed in 
Smogorzewska and de Lange, 2002). In addition, a correlation appears to exist between stress 
resistance in vitro and mammalian longevity (Kapahi et al., 1999) and skin fibroblasts from 
long-lived dwarf mice are more resistance to a variety of stressors (Murakami et al., 2003). 
Understanding these differences may prove valuable to understand ageing. For instance, studying 
SIPS should be extrapolated to other mammalian species. 
 Based on our work, we predict that experimental studies using cells from long-lived 
organisms are a potentially important approach to study ageing and cancer, as previously 
suggested (Austad, 1997a & 2001). Studies using long-lived animals such as Blanding’s Turtles 
(Congdon et al., 2001) or Bowhead whales (George et al., 1999) may prove valuable to our 
understanding of ageing and cancer. In fact, we tried to obtain cells from both Blanding’s Turtles 
and Bowhead whales by contacting, respectively, Justin Congdon of the Savannah River 
Ecology Laboratory in Aiken, South Carolina, USA, and John George of the Department of 
Wildlife Management in Barrow, Alaska, USA. Unfortunately, we failed to obtain the necessary 
cultures. James Christiansen of Drake University in Des Moines, Iowa, USA, offered to give us 
immortal Painted Turtle cells--a species with negligible senescence (Congdon et al., 2003)--, but 
we gave up on reptilian cells since experimental conditions (Rund et al., 1998) would be 
impossible to obtain in our laboratory in time to start any relevant experiment. 
 One major problem with cellular studies involving different species is that culture 
conditions may vary. For instance, reptilian cells cannot be cultured for long times at 37°C 
(Goldstein, 1974; Rund et al., 1998). Changes in culture parameters may bias comparisons 
between different cell lines. Even so, comparisons between, for instance, different mammalian 
cell lines may prove relevant to understand mammalian ageing and consequently human ageing. 
In fact, for instance, studies of telomere biology in non-human primates are already underway 
(Steinert et al., 2002). We anticipate this is an area with much potential. 
 
9.5. Computer models 
 
 Computer models of RS have been built based on extensive computer simulations 
(Kitano and Imai, 1998) and many others have suggested computational approaches to study 
ageing (Hood, 2003; Kirkwood et al., 2003). As will be detailed in chapter 11, we also published 
a strategy to understand human ageing based on computational approaches: we described the 
modern computational tools in the context of gerontology, providing ideas on how to apply 
computer models to study human ageing. Overall, our proposal is that, due to the difficulties in 
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studying human ageing, researchers aim to uncover the structure of the human ageing process, as 
well as find key controlling nodes which can eventually be developed into a Boolean model of 
human ageing. 
 We think high-throughput computational methodologies will play a crucial role in 
understanding human ageing. One promising approach involves DNA microarrays, which may 
be applied to mammals or even humans. If the amount of data generated is large enough, it may 
be possible to interpret cross-sectional human studies and extract valuable information. Indeed, 
gene expression results have been obtained by comparing young and old samples of human skin 
(Ly et al., 2000), retina (Yoshida et al., 2002), and muscle (Welle et al., 2001 & 2003), and 
proteomic studies on brain ageing have already been undertaken (Chen et al., 2003c). Gene 
expression results have also suggested that WS is accelerated normal ageing (Kyng et al., 2003). 
Although many genomic features remain obscure and could play a role in ageing, we think 
transcriptional regulation is the key to understand how the ageing process is controlled in 
mammals, as suggested by others (Martin, 1978; Cutler, 1979; Roy et al., 2002; Hood, 2003). 
Based on the likelihood that transcriptional regulation plays an important role in determining 
mammalian rate of ageing, we defend that transcriptional studies will play an important role in 
the future. Potentially powerful techniques involve the study of transcription either through pure 
computational methods, such as transcription factor binding site predictions, or by coupling 
DNA microarray data to computational techniques. 
 In accordance with our theoretical framework, we developed a computational toolkit to 
serve as an example of our strategy: Ageing Research Computational Tools (ARCT). ARCT is 
based on our previous work on evolution that led us to advocate comparative biology as a 
powerful approach to understand ageing. Studies involving phylogenetic profiles, functional 
interactions, and transcriptional regulation are made possible through our toolkit (de Magalhaes 
and Toussaint, submitted for publication; Appendix). ARCT is available online at: 
http://genomics.senescence.info/software/ 
 We applied computational approaches to the data obtained using the DualChip Human 
General. For instance, we tried to determine whether TFBS detection could help explain our 
gene expression results through the detection of putative p53 and HIF-1 binding sites. 
Unfortunately, our results did not show any significant trends. We also failed to find any 
chromosomal clustering from our genes differentially expressed in young and old BJ HDFs 
(Figure 25). Since another recent paper found such clusters in BJ HDFs (Zhang et al., 2003), we 
can only assume that the relatively small amount of genes (i.e. 202) we studied by the DualChip 
Human General does not allow us to estimate chromosomal clustering. 
 
 
Figure 25: Chromosomal location of genes upregulated in BJ HDFs at late cumulative 
population doublings when compared to young controls (Table 5 of article 3 in chapter 8). 
Overall expression patterns do not reveal any significant chromosomal clustering. The 
clustering in chromosome 7 is due to transcriptional variants of the same gene. Calculated 
using the Ageing Research Computational Tools 0.7beta through build 34 of the Homo 
sapiens genome at the NCBI’s Map Viewer: http://www.ncbi.nlm.nih.gov/mapview/ 
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9.6. Developing anti-ageing therapies 
 
 As emphasized throughout this work, the ultimate goal of gerontology is to understand 
human ageing to enhance health and preserve life. In fact, the gerontological community should 
re-assess its goals as understanding the basic ageing process should be a much higher priority 
than understanding age-related diseases, as argued by others (Adelman, 1998; Hayflick, 2000). 
Unfortunately, at present, there is no proven way to delay human ageing (reviewed in Olshansky 
et al., 2002). Although neglected for a long time, the possibility of developing true anti-ageing 
therapies is now within our reach (de Grey, 2003a; de Magalhaes, 2003b). Our definition of anti-
ageing therapies does not involve interventions that solely extend longevity but rather 
interventions that delay the ageing process by, for instance, delaying the rate of ageing. The most 
useful method to detect changes in rate of ageing is to calculate the rate at which mortality 
increases with age (Kowald, 2002 for arguments). Although other methods may be more 
accurate, due to common restrictions on sample size, the Gompertz equation remains the most 
accurate way to determine rate of ageing. 
 If chromatin changes play a role in ageing, as will be detailed in chapter 10.4., then anti-
ageing therapies may involve chromatin remodelling factors. One study showed that feeding 
sodium 4-phenylbutyrate (PBA) to Drosophila extends longevity by about 40% (Kang et al., 
2002). PBA is a histone deacetylase inhibitor, which induces hyperacetylation of histones 
resulting in a relaxing of the binding of histones to chromatin that in turn affects gene 
transcription (Lea and Randolph, 1998). Of course these results must be interpreted carefully. 
PBA was initially used in humans to treat urea cycle disorder (Brusilow et al., 1984) and it has 
been used to treat several human diseases (reviewed in Kang et al., 2002). Even so, it may be 
possible to create drugs that target specific chromatin modifications. Epigenomics is a growing 
science (reviewed in Novik et al., 2002) and some evidence indicates that methylation is 
involved in human age-related degeneration (Post et al., 1999). Epigenetic events are crucial in 
cancer (Jones and Baylin, 2002). Therefore, this is an area with much promise and, for instance, 
microarray analysis of DNA methylation is becoming a reality (Shi et al., 2003). It is important 
to clarify that although genetic mechanisms may regulate ageing (de Magalhaes, 2003a), fixing 
those mechanisms should not be as simple as fixing the telomeres in RS. 
 In our work, we suggested that instead of identifying changes as people grow old, it may 
be relevant to identify changes that occur during development that allow ageing to commence, as 
will be detailed in chapter 11. If ageing and development are two distinct processes, as it might 
be the case (Miller, 1999 for arguments), then identifying the changes that occur prior to, for 
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example, puberty, may prove valuable to develop anti-ageing interventions. One possibility, for 
instance, are mtDNA mutations accumulating from early in life (Khrapko et al., 2003). 
Development and ageing, however, may be connected (Parker, 1990 for arguments). 
 One ongoing approach is to identify potential therapeutic targets in model organisms 
(Rose et al., 2002b for arguments). In a recent example, a study identified several molecules that 
extend longevity in S. cerevisiae and suggested them as of potential therapeutic interest against 
human ageing (Howitz et al., 2003). Our work, of course, argues against such approaches and 
deems such conclusions as imprudent. For instance, as mentioned in chapter 9.1., the impact of 
antioxidants in invertebrate longevity has not been reproduced in mammals and, as will be 
detailed in chapter 9.6.1., telomerase modulates ageing differently across different species. 
Although testing interventions to delay ageing in animal models may be inavoidable (Warner et 
al., 2000 for arguments), it is important to keep a sceptical open mind. 
 As mentioned in chapter 1.3.2., several attempts have been made to delay ageing through 
antioxidants. Even though the free radical theory of ageing is unproven, much research is 
conducted to develop anti-ageing dietary supplements involving antioxidants. Although it is 
possible to decrease oxidative damage in mice by feeding them acetyl-L-carnitine and/or R-
alpha-lipoic acid (Hagen et al., 2002; Liu et al., 2002a & 2002b), there is no evidence that 
feeding mice antioxidants increases longevity or delays rate of ageing (Lipman et al., 1998 for 
arguments). On the other hand, p66shc shows that oxidative stress may affect apoptosis and 
longevity in mice (Migliaccio et al., 1999). Intriguingly, the forkhead transcription factor 
FOXO3a has been recently shown to protect quiescent cells from apoptosis by overexpressing 
mitochondrial superoxide dismutase and increasing oxidative defences (Kops et al., 2002). Some 
evidence indicates that p66shc is somewhat related to the forkhead transcription factor family 
(Nemoto and Finkel, 2002; Purdom and Chen, 2003a, 2003b), which in turn has been associated 
with extended longevity in lower life forms (Lin et al., 1997; Honda and Honda, 1999; McElwee 
et al., 2003). Perhaps upregulating oxidative defences might be a more promising approach. 
Indeed, some results from mice indicate that overexpression of M1B, a forkhead box 
transcription factor, can prevent age-related proliferation defects in regenerating liver (Wang et 
al., 2001).  
 Another ongoing study involves the search for caloric restriction mimetics in primates. 
The idea is to identify compounds that replicate the effects of caloric restriction without having 
to eat less (reviewed in Lane et al., 2002a & 2002b). The fact that this study was initiated in 
1987 illustrates one of the greatest problems in developing anti-ageing therapies: the long time it 
takes to test anti-ageing products (Davenport and Toy, 2002). Obviously, human studies based 
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on rate of ageing are impossible and model organisms may be inaccurate. One possibility is to 
test anti-ageing therapies in specific age-related pathologies. Despite its medical interest, this is a 
biased approach because an alleviation of an age-related pathology may not be a result of a 
delayed ageing process. The most promising possibility is to develop biomarkers of ageing that 
can accurately predict how aged someone is, perhaps in combination with caloric restriction and 
primate studies, as proposed by others (Ingram et al., 2001). DNA microarrays are one 
promising approach. 
 Based on our work, mammalian models and long-lived species are preferred over lower 
life forms. One intrinsic problem in the study of ageing is that models that live less than humans 
are preferred. If we aim to develop anti-ageing therapies we must learn from other species’ 
virtues, not mistakes. As mentioned in chapter 9.2., understanding the unique mechanisms 
behind reptilian neurogenesis and oocyte regeneration may be helpful to humans. Similarly, anti-
ageing therapies based on long-lived species such as certain reptiles, whales, and birds may be a 
promising approach. As pointed by others, studying long-lived animals is  a much better way to 
develop anti-ageing therapies than short-lived animals because long-lived animals may have 
already obviated some deleterious processes still present in short-lived ones (Strehler, 1986). 
Research is already underway to understand tissue regeneration in adult urodele amphibians to 
promote mammalian regeneration (Brockes and Kumar, 2002). Cancer research may also benefit 
from studies on whales (Austad, 1997a). For example, in accordance to what we argued in 
chapter 9.4., understanding stress response mechanisms, such as the response to DNA damage, 
may allow us to develop novel ways to preserve the viability of cells, such as stem cells. 
 In fact, several studies suggest stem cells as of great potential in anti-ageing research 
(reviewed in Lanza et al., 1999a, 1999b; de Grey, 2003c). For example, ageing has been linked 
to an age-related inability of stem cells to replenish mature cells and therapeutic interventions 
that enhance stem cell functional capacity might ameliorate many of the age-associated atrophies 
in several organ systems (Donehower, 2002). Even the brain degeneration may benefit from stem 
cells (Le Belle and Svendsen, 2002). With nuclear transfer experiments such as Dolly (Wilmut et 
al., 1997), it is now possible to generate embryonic stem cells from adult individuals that can be 
used to treat age-related diseases (Cibelli et al., 2002). Therefore, stem cells remain one of the 
most promising avenues for anti-ageing research. 
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9.6.1. Telomerase alters the normal cellular functions 
 
 The telomeres are the perfect example of our reserves towards employing distant models 
to study ageing. Telomere dysfunction in S. cerevisiae leads to senescence (Lunblad and 
Szostak, 1989; Lowell and Pillus, 1998). Yet, as mentioned in chapter 3.3., telomerase-negative 
mice are normal up to four generations (Rudolph et al., 2001) and telomerase overexpression 
does not alter ageing in mice (Artandi et al., 2002). On the other hand, telomerase dysfunction in 
humans causes dyskeratosis congenita (Vulliamy et al., 2001). It is therefore nearly impossible 
to determine whether telomerase is of potential anti-ageing interest based on model organisms 
and so we will focus on what we know about telomerase and human ageing. 
 The importance of the telomeres in RS and the ability of telomerase to immortalize 
human cells led to the suggestion that telomerase can be used as an anti-ageing therapy 
(reviewed in Fossel, 1996). As mentioned in chapter 3, hTERT expression immortalizes most, 
though probably not all (Halvorsen et al., 2000; Di Donna et al., 2003), human cell types 
(Bodnar et al., 1998). Culture conditions with low levels of O2 or p16INK4a disruption are often 
necessary for cellular immortalization (Kiyono et al., 1998; Forsyth et al., 2003), suggesting that 
either telomerase is not sufficient for cellular immortalization or inadequate culture conditions 
may prevent immortalization of certain cell lines, as will be mentioned in chapter 10.2. Even so, 
the principle is that if telomerase can prevent RS, it may also prevent cellular ageing in vivo. One 
study found that the telomeric repair efficiency is lower in cells from an old than in cells from a 
young donor; and a slightly lower efficiency was also reported in WS cells (Kruk et al., 1995). In 
addition, a recent study found a correlation between telomere length and mortality in people over 
60 years of age (Cawthon et al., 2003). As such, telomere dysfunction may play a role in age-
related debilitation.  
 Previously, experimental evidence raised questions on whether telomerase is likely to 
become a source of anti-ageing therapies (Vaziri et al., 1999; Wang et al., 2000b). Our gene 
expression results support these views and show considerable changes due to ectopic hTERT 
expression as well as alterations in the DNA-binding activities of ATF-2 and NF-κB. 
Interestingly, mitochondrial superoxide dismutase, which was the gene most down-regulated in 
our study, has been recently hinted as a tumour suppressor (Plymate et al., 2003). Confirming 
previous reports that telomerase favours tumorogenesis by a telomere length-independent 
mechanism (Stewart et al., 2002), a recent study found that hTERT expression in HDFs leads to 
an upregulation of epiregulin, a potent growth factor involved in tumorogenesis (Lindvall et al., 
2003). Another recent study found that telomerase modulates the expression of growth-
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controlling genes to enhance cellular proliferation (Smith et al., 2003), as also indicated by our 
results. Taken together, these results suggest that hTERT-immortalized cells are not functionally 
equivalent to normal cells and using hTERT for therapeutic purposes must be approached with 
caution. On the other hand, telomerase appears a promising target to fight cancer and indeed 
several recent proposals have been made to develop anti-telomerase treatments (Hahn et al., 
1999; Shammas et al., 1999; Shay and Wright, 2002; Asai et al., 2003; Huard and Autexier, 
2003; Nguyen et al., 2003; Saretzski, 2003). Another possibility is using a transient telomerase 
activation in certain diseases--being dyskeratosis congenita the most obvious example--or cell 
lines with telomerase expression stringently controlled (Effros, 2003 for arguments). 
 One possibility is that the differences in gene expression witnessed between BJ and 
hTERT-BJ1 HDFs derive from the transfection methodology rather than hTERT activity. We do 
not think this is the case for several reasons. Firstly, the initial reports describing the hTERT-BJ1 
cells line indicated that hTERT transfection into BJ cells did not alter normal cellular functions. 
Transfection of hTERT into other cell lines and comparisons with “vector only” clones were also 
performed (Bodnar et al., 1998; Jiang et al., 1999; Morales et al., 1999). Secondly, our results 
suggesting that telomerase favours tumorogenesis by telomere-independent mechanisms has 
been reported in other cell lines and models, including some overlap with our gene expression 
results (Oh et al., 2001; Stampfer et al., 2001; Stewart et al., 2002; Lindvall et al., 2003; Smith 
et al., 2003). Taken together, these results suggest that telomerase activity promotes 
tumorogenesis independently of telomere elongation. 
 It is unproven that telomerase can be used as an anti-ageing therapy. For instance, some 
evidence suggests that hTERT transient expression can occur in human cell lines when necessary 
for regeneration (Osanai et al., 2002), and there is little evidence to suggest that further hTERT 
expression is necessary in human tissues (Stephens et al., 2003 for arguments). Importantly, 
telomerase may alter the normal cellular functions and promote cancer. Therefore, in conclusion, 
we argue that telomerase is unlikely to become a source of anti-ageing therapies. 
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CHAPTER 10: DNA DAMAGE, AGEING, AND SIPS 
 
 One of the main objectives of our work was to establish the role of the telomeres in SIPS. 
Since, unlike genomic damage, damage to the telomeres in normal HDFs cannot be repaired, 
telomere shortening may result in single-strand DNA that would in turn trigger SIPS through the 
p53 pathway (reviewed in von Zglinicki, 1998). Our strategy was to employ a telomerase-
immortalized cell line, hTERT-BJ1, to investigate the mechanisms involved in SIPS. Since in 
hTERT-BJ1 HDFs the telomeres can be repaired, we hoped to find clues about the role of 
telomeres in SIPS. 
 
10.1. Critical telomere shortening is not necessary for SIPS 
 
 Based on the similar results we obtained in BJ and hTERT-BJ1 cells under SIPS, one of 
our conclusions was that the telomeres do not play a major role in causing SIPS. Telomere 
shortening did not reach critical lengths with stress. Previous findings also failed to find a 
relevant telomere shortening following H2O2 (Chen et al., 2001b) or t-BHP stress (Dumont et al., 
2001). Radiation-induced senescence was also telomere-independent and SA β-gal positive cells 
did not show shorter telomeres (Suzuki et al., 2001b). In support of our results, two other studies 
showed that telomerase-immortalized normal HDFs can reach senescence without telomeres 
reaching critical lengths (Gorbunova et al., 2002; Matuoka and Chen, 2002). The increased 
telomere shortening, though probably not solely a result of compensatory cycling, may derive 
from damage to the telomeres, but it is unlikely that such low amounts of telomere shortening are 
responsible for SIPS. One hypothesis is that a small amount of telomere shortening disrupts the 
telomeres or is a signal of telomere dysfunction, but such conclusions are a fruit of speculation. 
 Although it has been proposed that the telomeres are gatekeepers of the genome (von 
Zglinicki, 2002), there is no a priori reason to expect the telomeres to be different from the rest 
of the genome in sensing DNA damage. Single strand regions appeared to accumulate more 
often in the telomeres than in other regions of the genome (Petersen et al., 1998), but other 
results suggested that double-strand breaks mediate cytotoxicity following oxidative stress such 
as H2O2 (Cantoni et al., 1996; Cantoni and Giancomoni, 1997). Other results also argued that 
cell death from H2O2 does not derive from specific single strand breaks but rather from multiple 
damage sites to the DNA (Ward et al., 1985). Therefore, no evidence exists that specific damage 
to the telomeres is the cause of SIPS. One hypothesis is that disruption of the telomeres rather 
than telomere shortening per se is involved in SIPS. As mentioned in chapter 4.2., the 
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introduction of telomeric oligonucleotides into HDFs induced growth inhibition based on the 
p53/p21WAF1 pathway (Saretzki et al., 1999). Recent results also show that exposure to 40 µM of 
oligonucleotides homologous to the telomere 3’-overhang sequence induces a senescent 
phenotype. Though the concentration of oligonucleotides used may be biologically unrealistic, 
one proposal is that telomere shortening or DNA damage may disrupt the telomere loop causing 
the exposure of the 3’-overhand and triggering senescence through a DNA-damage response (Li 
et al., 2003). In addition, other players may be involved in SIPS such as TRF1 and TRF2 
(Smogorzewska et al., 2000), and TRF1’s interacting partners PINX1 (Zhou and Lu, 2001), 
POT1 (Loayza and de Lange, 2003), tankyrase (Smith and de Lange, 2000), and TIN2 (Kim et 
al., 1999). For example, some evidence suggests that TIN2 alters the conformation of TRF1, 
which favours a tertiary telomeric structure that hinders telomerase from gaining access to 
telomeres (Kim et al., 2003). Although there is presently no evidence to suggest any of these 
proteins may play a role in SIPS, since we lack a detailed vision of telomere regulation, further 
research in this area will certainly give us a better view of the mechanisms involved. Future 
experimental perspectives should include telomeric proteins in addition to telomere length. 
 Based on our work, however, genotoxic damage should be considered the main cause of 
SIPS. Telomere damage recruits telomerase which stabilizes the telomeres (Blackburn, 2000) 
and telomerase associates with human telomeres enhancing genomic stability and DNA repair 
(Sharma et al., 2003). One possible mechanism involves the cooperation between telomerase and 
Ku, a protein involved in DNA repair (Chai et al., 2002). A recent study found that 
overexpression of hTERT’s C-terminal polypeptide sensitized HeLa tumour cells to H2O2-stress 
without affecting hTERT’s activity or telomere length. Though not fully understood, these 
results suggest that hTERT plays a role in mediating resistance to oxidative stress (Huang et al., 
2003). Yet our results do not suggest any beneficial effect of hTERT expression in SIPS, 
contradicting the hypothesis that telomeres play a key role in SIPS. Other results suggest similar 
conclusions (Matuoka and Chen, 2002), despite a possible protection against apoptosis and 
necrosis conferred by hTERT (Gorbunova et al., 2002). Perhaps stabilizing the telomeres offers 
protection against apoptosis, but not against SIPS, suggesting that SIPS does not derive from the 
telomere-based signalling cascade. In fact, other recent results suggest that high hTERT 
expression can, in some cases, induce a senescent-like growth arrest in HDFs (Gorbunova et al., 
2003), so a telomere-independent senescence-inducing mechanism exists, as will be detailed in 
the next chapter. Generalized DNA damage generated by H2O2 is therefore the mechanism 
predominant in SIPS. This is one of the major conclusions of our work. 
 
109 
10.2. DNA damage induces cellular senescence through complementary pathways 
 
 An important part of our work was to study the mechanisms involved in SIPS. Since 
hTERT-BJ1 and control BJ HDFs did not appear to feature unique mechanisms, we interpreted 
the results obtained for both cell lines in conjunction. 
 Working with Christophe Frippiat, we found that the levels of TGF-β1 increase in 
AG04431 human skin fibroblasts exposed to H2O2 (Frippiat et al., 2001; Figure 26A). Yet our 
results in BJ cells do not support a role for TGF-β1 in SIPS, at least in our model (Figure 26B). 
The lack of upregulation by stress of ATF-2’s DNA-binding activity supports the view that TGF-
β1 is not involved in SIPS of BJ cells, unlike the results shown in IMR-90 HDFs (Frippiat et al., 
2002). Since TGF-β appears to regulate DNA synthesis differently in sparse and non-confluent 
cultures (Stathakos et al., 1993), one hypothesis is that vigorously dividing HDFs, such as BJ 
HDFs, react differently to TGF-β. A future possibility would be to study TGF-β1 in sparse BJ 
and hTERT-BJ1 HDFs rather than confluent cultures. Even so, we do not think TGF-β1 is a 
major player in SIPS of BJ or hTERT-BJ1 HDFs. 
 Our proposed mechanism involves the p53/p21WAF1 pathway. p53 has been previously 
implicated in SIPS but since its protein level under SIPS returns to control level 48 hrs after a 
single subcytotoxic H2O2 stress, its role has been downplayed (Chen et al., 1998 & 2000b). 
Although we did not find a significant increase of p53’s protein level after subcytotoxic H2O2 
stress, we found a sustained, marked increase of p53’s DNA-binding activity, which is a novel 
finding. Evidence suggests that post-translational modifications are the molecular basis for p53 
activation (Brooks and Gu, 2003), and activate p53 during cellular senescence (Atadja et al., 
1995) and in response to stress (Colman et al., 2000), thus corroborating our results and 
suggesting that p53’s role in SIPS has been underestimated. Although preliminary, our results 
from WS fibroblasts also suggest a role for p53 in SIPS since p53’s DNA-binding activity was 
only slightly increased in WS fibroblasts that did not endure an increase in SA β-gal activity. 
 Activation of p21WAF1 independently of p53 has been reported (Tahara et al., 1995), but 
p21WAF1’s activation in response to DNA damage is likely to be p53-mediated (Michieli et al., 
1994). For example, radiation-induced senescence appears to be dependent on p53 (Suzuki et al., 
2001b). Though we cannot discard that other players may be involved, in BJ HDFs SIPS is 
regulated by the p53/p21WAF1 pathway which in turn affects pRb’s phosphorylation status. A 
recent study found that p53-mediated senescence can occur via, so far unknown, factor(s) other 
than p21WAF1, suggesting we still lack a complete picture of the pathways involved (Wyllie et al., 
2003). Other recent results also demonstrate p21WAF-1-independent growth arrest and suggest that 
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Figure 26: Steady-state level of TGF-β1 mRNA at different doses of H2O2 stress in AG04431 
HDFs (A). Steady-state level of TGF-β1 mRNA after a single H2O2 stress or five repeated 
UVB stresses in BJ and hTERT-BJ1 HDFs (B). According to the t-test, the probability of both 
or either stresses decreasing the expression of TGF-β1 is above the common threshold of 5% 
and so we conclude that TGF-β1 mRNA levels do not change with UVB or H2O2 
subcytotoxic stress in BJ and hTERT-BJ1 HDFs. mRNA was extracted at 48 hr after stress. 
The results are presented as mean values ± S.D. from three independent experiments. mRNA 
extraction and RT-PCR conditions according to previously described protocols (Frippiat et 
al., 2001). 
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p21WAF-1 degradation via ATR is in fact essential for correct DNA repair following low doses of 
UV irradiation (Bendjennat et al., 2003). Intriguingly, other results from our laboratory indicate 
that the kinase activity of CDK2 can be greatly decreased in a p21WAF-1-independent manner in 
IMR-90 HDFs (Frippiat et al. 2003). 
 Based on p53’s importance, we tried to use antisense oligonucleotides against p53 
(Biognostik, Göttingen, Germany) but these failed to diminish p53’s DNA-binding activity and 
thus we decided to abandon this approach (Figure 27). Perhaps studies using interference RNA 
may be conducted in the future. IMR-90 HDFs expressing E6, and thus lacking p53 activity, are 
still able to develop a senescent phenotype after subcytotoxic H2O2 stress involving a slight 
activation of p21WAF1 and pRb hypophosphorylation (Chen et al., 1998 & 2000b). This 
suggested that p53 is not essential in SIPS and complementary pathways exist in regulating pRb. 
Further work is necessary to elucidate these mechanisms. 
 One recent report argued that HDFs with both the p16INK4a and p53/telomere pathways 
are more sensitive to SIPS (Itahana et al., 2003). Given the relatively high resistance to H2O2 of 
BJ HDFs, and since the p16INK4a pathway is present in BJ HFDs but inactive during RS 
(Beausejour et al., 2003), our results support the idea that cell lines without an activated p16INK4a 
pathway are more resistance to SIPS. Since hTERT expression did not change stress resistance, 
we cannot corroborate the idea that ablation of the telomere pathway increases resistance to 
stress.  
 In fact, our results also cast some doubts on the role of p16INK4a in SIPS. Other results had 
already suggested that p16INK4a is not overexpressed in senescent BJ cells (Shelton et al., 1999) 
or following H2O2 stress (Chen et al., 2001b). One possible explanation is that p16INK4a is 
involved in maintaining growth arrest but does not participate in triggering SIPS. For example, 
oncogenic ras can induce p16INK4a in BJ HDFs, showing that the p16INK4a pathway is present in 
BJ HFDs just inactive during RS (Beausejour et al., 2003). One hypothesis is that the increased 
resistance to oxidative stress in BJ HDFs avoids p16INK4a activation. 
 Contrary to what happens in BJ HDFs, p16INK4a is widely overexpressed in pre-senescent 
and senescent WI-38 HDFs with relatively long telomeres (Beausejour et al., 2003), suggesting 
that telomere shortening and p53 do not cause RS in WI-38 HDFs. Instead, perhaps RS in WI-38 
HDFs is a response to stress or inappropriate culture conditions. One hypothesis is that p53 
triggers telomere-driven RS while p16INK4a triggers senescence in response to certain forms of 
damage and signals--e.g. oncogenic signals or changes in intra-cellular oxidative potential. 
Recent results show that oxygen sensitivity limits the proliferative capacity of murine fibroblasts 
(Parrinello et al., 2003). In addition, knocking-out cytoplasmic superoxide dismutase induces 
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Figure 27: DNA-binding activity of p53 in BJ HDFs. Control indicates cells incubated 
without oligonucleotides. Random means random oligonucleotides were added for 24 hrs to 
the medium with a final concentration of 10 µM. Anti-p53 means p53 antisense 
oligonucleotides were added to the medium for a final concentration of 10 µM for 24 hrs. 
C10-2.5 is a control sample with various amounts of protein to test the sensitivity of the kit. 
To determine the DNA-binding activity of p53 we used the TransAM kit (ActiveMotif, San 
Diego, CA, USA), according to manufacturer’s instructions. The results are presented as 
mean values ± S.D. We had previously demonstrated by fluorescent microscopy that it took 
less than 8 hrs for oligonucleotides to incorporate into BJ and hTERT-BJ1 HDFs and so 
concluded that the antisense p53 was not inhibiting p53’s DNA-binding activity. 
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senescence in HDFs (Blander et al., 2003). Oxygen sensitivity affects WI-38 HDFs 
immortalization with hTERT (Forsyth et al., 2003). Evidence also suggests that epithelial cells 
reach senescence due to p16INK4a, not short telomeres: if p16INK4a is inactivated, the proliferative 
capacity of epithelial cells is increased and senescence is only reached when telomeres are 
critically short (Romanov et al., 2001). Perhaps RS results from either telomere shortening or 
telomere-independent mechanisms such as inadequate culture conditions (Ramirez et al., 2001); 
therefore, for example, epithelial, WI-38, and WS cells may reach senescence not due to short 
telomeres but due to their increased sensitivity to O2. In contrast, BJ cells, which are more 
resistant to oxidative stress (Lorenz et al., 2001), reach RS due to critically short telomeres. We 
speculate that cellular senescence evolved as an anti-cancer mechanism to prevent uncontrollable 
cellular growth, DNA damage, or other oncogenic signals. In fact, HeLa immortal tumour cells 
may also reach senescence with long telomeres and high telomerase activity if the p53 and pRb 
pathways are restored (Goodwin and DiMaio, 2001). 
 Recent results also suggest that p16INK4a may prevent reversal of senescence by activating 
pRb which in turn changes the chromatin structure (Morrison et al., 2002; Narita et al., 2003). 
p53 inactivation reverses senescence in some but not all HDFs. p16INK4a suppression confers 
sensibility to p53 inactivation leading to a reversal of senescence. Recent results also suggest that 
p16INK4a may act independently of pRb. Lastly, hTERT does not reverse senescence in HDFs, 
perhaps due to lack of proliferation (Beausejour et al., 2003). 
 The interaction between apoptotic and senescent pathways has been demonstrated and is 
probably antagonistic (reviewed in Wang et al., 2003). For example, senescent HDFs are 
resistant to apoptosis (Wang, 1995) and p21WAF1 is cleaved during apoptosis to shift cancer cells 
from growth arrest to apoptosis (Park et al., 1998; Zhang et al., 1999). In our work, we proposed 
a rearrangement of apoptotic/anti-proliferative pathways as opposed to anti-
apoptotic/proliferative pathways in SIPS. A key player is p53. Although the cascade of events is 
unclear, activation of p53 by oxidative stress can induce growth arrest--to prevent the replication 
of damaged DNA--or apoptosis--to eliminate defective cells (reviewed in Sionov and Haupt, 
1999; Martindale and Holbrook, 2002; Oren, 2003). The proportion of apoptotic versus 
senescent cells is dose dependent (Chen and Ames, 1994; Chen et al., 2000b; Toussaint et al., 
2002a). Probably the amount of damage endured by cells determines whether cells should enter 
apoptosis--if the damage is too high--or growth arrest--if the damage is lower, so it can be 
repaired. Alternatively, perhaps oxidative stress activates apoptotic pathways due to the role of 
ROS as intra-cellular signalling molecules (reviewed in Green and Reed, 1998). Since even at 
112 
subcytotoxic levels a cell population is not homogeneous, under subcytotoxic stress apoptotic 
pathways are slightly activated but overcome by growth arrest and SIPS pathways. 
 ROS have been shown to increase at later cumulative population doublings in HDFs 
(Atamna et al., 2000 for arguments). Protein oxidation also increases with cumulative population 
doubling in proliferating BJ HDFs, perhaps as a result of decreased proteasome and lysosomal 
cathepsin activity. It was suggested that oxidized proteins accumulate throughout life until 
reaching a level that inhibits the proteasome (Sitte et al., 2000a). Interestingly, similar results 
were found in confluent BJ HDFs (Sitte et al., 2000b). Yet if RS in BJ HDFs derives from the 
telomeres, the protein oxidation should be a result, not consequence of these processes. We 
suggest such studies should be extended to immortal hTERT-BJ1 HDFs to assess the causal 
relationship between protein oxidation and RS. Unpublished data from our laboratory, however, 
suggests that proteasome activity is not impaired in H2O2-, UVB-, and t-BHP-induced SIPS in 
WI-38 and AG04431 HDFs. Moreover, the data on decreased proteasome activity (Sitte et al., 
2000a & 2000b) shows that the decreased proteasome activity occurs after many weeks of 
hyperoxia at 40% O2, suggesting that the cells were not only in SIPS but also ready to die. A 
decrease in proteasome activity was observed in our laboratory at several days after highly 
cytotoxic H2O2 stress (unpublished). 
 As mentioned in chapter 3.2.1., other proteins, such as ATM, ATR, and DNA-PK may be 
responsible for sensing DNA damage (Yang et al., 2003 for arguments). Although ATM has 
been hypothesized as a sensor of stress (Rotman and Shiloh, 1997), recent results suggest that the 
ATM-dependent pathway is not critical for SIPS induced by oxidative stress, at least in some cell 
lines (Naka et al., in press). Also recently, it has been shown that the early growth response 1 
protein acts upstream of p53 in mouse cells (Krones-Herzig et al., 2003). On the other hand, 
recent results show that CDK4 overexpression upregulates p16INK4a, p53, and p21WAF1 and yet 
bypasses the p16INK4a-associated senescence due to telomere-independent stress (e.g. inadequate 
culture conditions) and telomere-dependent senescence (Ramirez et al., 2003). Therefore, our 
work is but a small glimpse of the complex mechanisms involved and much work remains before 
we fully understand the cell cycle and its regulatory loops. Even so, we think SIPS is caused by 
the DNA-damage response deriving from genotoxic damage. 
 
10.3. RS versus SIPS 
 
 One discussion is whether RS and SIPS are the same process. As mentioned in chapter 
2.4., there are clear similarities and differences between the two. At a proteomic level, the 
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protein expression changes observed in RS were only partially observed in SIPS (Dierick et al., 
2002). Our results also suggest differences in gene expression between RS and SIPS. It has been 
proposed that changes specific of SIPS and/or changes specific of each model of SIPS are 
“molecular scars” of subcytotoxic stresses (Brack et al., 2000). Therefore, one hypothesis is that 
RS and SIPS are different processes, as suggested by others (Wright and Shay, 2001). 
 Although telomere dysfunction is the main cause of RS, considerable gene expression 
differences have been verified in different cell lines during RS. The position of the co-expressed 
genes along the chromosomes appears clustered; a phenomenon termed chromosomal clustering 
(Zhang et al., 2003). Due to the stochastic nature of ageing, even if RS originates in a common 
mechanism, the phenotypic changes may differ. As such, another possibility is that RS and SIPS 
are the same process despite some phenotypic differences. 
 Another way of comparing RS and SIPS is by comparing the underlying mechanisms. If 
we consider RS as either derived from telomere signalling cascades or inadequate culture 
conditions, then even though the role of telomeres in SIPS may be less prominent than in RS, 
SIPS and RS are the same process, each capable of originating from two or more signalling 
cascades. Besides, the role of pRb and p53 in RS and SIPS proves that there are common players 
involved, suggesting, for instance, that both RS and SIPS evolved as anti-tumour mechanisms. 
Others have suggested that telomere-independent mechanisms of cellular senescence should not 
be considered RS (Wright and Shay, 2001). If we follow this definition then RS and SIPS are 
clearly not the same process. The question thus is how RS should be defined. We think the 
debate of RS versus SIPS is a futile one because what matters is the understanding of the 
mechanisms involved and how they relate to human biology. Whether telomere-induced 
senescence should be named RS and telomere-independent senescence should be named 
something else is irrelevant from the perspective of understanding ageing and is a discussion that 
will generate more heat than light. Lastly, it is important to find which mechanism is 
predominant in vivo. For example, in rat kidneys, p16INK4a levels increase dramatically with 
growth and ageing. SA β-gal was also associated with ageing in the epithelium. Yet these 
changes occurred without significant telomere shortening (Melk et al., 2003), so telomere-
independent mechanisms prevail, at least in some stress-prone tissues as mentioned in chapter 
2.4.  
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10.4. DNA metabolism and ageing 
 
 Despite the large number of theories of ageing, only a fraction of genes has been 
identified that is capable of modulating ageing in mammals. Many genes that affect ageing in 
mammals are involved in DNA metabolism. For example, mice with a mutation in XPD, a gene 
encoding a DNA helicase that functions in both repair and transcription, feature a phenotype 
resembling accelerated ageing (de Boer et al., 2002). RS in human cells derives essentially from 
changes in the DNA, namely, in the telomeres (Bodnar et al., 1998). Even SIPS in our model 
involving BJ cells is likely to result from the genotoxic action of H2O2. In addition, pRb interacts 
with lamin A/C (Mancini et al., 1994), and recent results suggest that pRb mediates 
heterochromatin formation during RS (Morrison et al., 2002; Narita et al., 2003). Histone 
deacetylase antagonizes p53 (Lagger et al., 2003) and chromatin structural changes are involved 
in RS (Ning et al., 2003; Zhang et al., 2003), though how this correlates with human ageing 
remains undetermined. Therefore, it appears likely that the DNA plays an important role in 
ageing (de Magalhaes et al., in press). As mentioned in chapter 1.3.3., the idea that functional or 
structural changes in chromosomes are at the basis of ageing is not new. To quote Leonard 
Guarente (Guarente, 1996): “It would perhaps be appropriate that chromosomes, which 
orchestrate the genesis, development, and maturation of organisms, also direct the final chapter 
in the life cycle.” 
 Mice deficient for topoisomerase IIIβ develop normally and yet have a reduced longevity 
(Kwan and Wang, 2001). Though it is only an evolutionary distant model, mutations in the yeast 
Sgs1 protein--with homology to WRN and other helicases--cause accelerated ageing in yeast 
(Sinclair et al., 1997). Interestingly, Sgs1 interacts with topoisomerase III (Ng et al., 1999; Duno 
et al., 2000). WS cell lines have been previously shown to be hypersensitive to topoisomerase 
inhibitors (Pichierri et al., 2000a & 2000b). Although the exact mechanisms are unclear, these 
results suggest a role for DNA structure in WS. 
 Many results support the role of WRN in DNA metabolism (reviewed in Opresko et al., 
2003): WRN interacts with p53 (Blander et al., 1999) and can induce p53 in response to DNA 
damage (Blander et al., 2000); interestingly, p53-mediated apoptosis is attenuated in WS 
fibroblasts (Spillare et al., 1999). The ability of WRN to attack unusual DNA formations (Orren 
et al., 2002 for arguments) suggests that WRN functions as a key factor in resolving aberrant 
DNA structures to maintain the genetic integrity in cells (reviewed in Shen and Loeb, 2000; 
Bohr et al., 2002; Fry, 2002). Recent results also implicate chromatin alterations in the pathology 
of WS (Kyng et al., 2003). 
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 The interaction between WRN and the telomeres is also intriguing. Mean telomere loss is 
accelerated in WS fibroblasts but these exit the cell cycle with longer telomeres than normal, 
senescent human cells (Schulz et al., 1996). Intriguingly, TRF2 binds and activates WRN 
(Opresko et al., 2002). WRN interacts with Ku, suggesting that WRN is involved in telomere 
maintenance (Li and Comai, 2000), as happens with Sgs1 (Johnson et al., 2001). hTERT 
expression in WS cells prevents RS but does not fully restore WS cells into normal cells (Choi et 
al., 2001). Interestingly, recent results indicate that WRN may downregulate telomerase (Bai and 
Murnane, 2003). Either telomere imbalance plays a role in the phenotype of WS or rather the 
accelerated telomere shortening is a sign of genomic imbalance and a consequence of WS. The 
recent findings showing an inverse correlation between telomere shortening and bird and 
mammalian longevity support this hypothesis (Haussmann et al., 2003; Vleck et al., 2003), as do 
some preliminary results showing that at least in some turtles’ telomere shortening does not 
occur in vivo (Girondot and Garcia, 1999). 
 Our proposal is that chromatin changes accumulate with ageing making cells respond 
differently to insults and stress. Changes in chromatin remodelling genes make yeast more 
susceptible to stress (Tsukiyama et al., 1999). Other results from yeast also suggest that 
chromatin structure may play a role in yeast ageing (Lin et al., 2000), as proposed by others 
(Guarente, 1996, 1997; Campisi, 2000; Bitterman et al., 2003). Although limited, some data on 
mammals also suggest chromatin changes during ageing. Heterochromatinization may change 
during human ageing (Lezhava, 2001). Results from mice also suggest age-related chromatin 
changes during ageing (Lindner et al., 1999; Sarg et al., 2002). Of course that these changes may 
be a result rather than a cause of ageing. Chromatin condensation is a signal of apoptosis (Arends 
et al., 1990; Collins et al., 1994). If the number of apoptotic cells increases with age it is normal 
to find a correlation between chromatin condensation and age. Yet the involvement of WRN in 
ageing and DNA metabolism, and to a less extend of lamin A/C (Glass et al., 1993; Gotzmann et 
al., 1999; Stierle et al., 2003), the way WRN cells are more sensitive to oxidative stress, and the 
way chromatin structural changes seem to occur faster in WS cells (Almagor and Cole, 1989) 
lead us to argue that chromatin structural changes are a key regulating factor in human ageing 
(de Magalhaes et al., in press).  
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CHAPTER 11: HOW BIOINFORMATICS CAN HELP REVERSE ENGINEER HUMAN 
AGEING 
 
 One of the problems in gerontology is that there is much data but few explanations and 
no criteria on how to assimilate the most important information. Since mathematics and statistics 
give a meaning to data, we wanted to develop ways to turn data into knowledge. Through 
bioinformatics, researchers can gather and store large amounts of data and use computing power 
to develop more complex models (reviewed in Baldi and Brunak, 2001). The integration of 
information from several sources is problematic, particularly in ageing with conflicting results 
from different models. In truth, a combination of both computer-based and experimental 
approaches will be necessary to understand a complex process such as ageing. Consequently, we 
wanted to develop strategies on how to integrate data from different models into one coherent 
model of human ageing. We propose a systems biology strategy for modelling human ageing by 
integrating data from different models. This part of the discussion is in press at Ageing Research 
Reviews (de Magalhaes and Toussaint, in press). 
 
11.1. Introduction 
 
 Ageing is an intrinsic age-related process of loss of viability and increase in vulnerability 
(Comfort, 1964). Studying human ageing has two major difficulties: the complexity of the 
ageing phenotype with its widespread changes and pathologies associated with chronological age 
and the near impossibility of performing in vivo studies. Consequently, most researchers resort to 
models that may or may not be accurate representations of the human ageing process. So to 
understand human ageing is an enormous challenge, not only due to the complexity inherent to 
ageing but also since our hypotheses are based on extrapolations and our theories will have to be 
tested indirectly. 
 It is not surprising then that human ageing remains a mysterious process. We still cannot 
answer the most important questions: Why do species age at different paces? What determines 
the rate of ageing? How can we distinguish causes from effects of ageing? What changes occur 
in an adult human being to make the chances of dying duplicate approximately every eight 
years? In the end, why do we age? So far we already know several genes that modulate rate of 
ageing in animals, such as p66shc (Miggliaccio et al., 1999), but, optimistically, only a few in 
humans such as the progeroid genes responsible for Werner’s (Yu et al., 1996) and Hutchinson-
Gilford’s syndromes (Eriksson et al., 2003). Yet these genes alone show the extraordinary 
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influence of genetic mechanisms on ageing. Just discovering more genetic players in the human 
ageing process would be a major breakthrough. 
 Scientific discovery has always been limited by the available technologies. Given the 
modern methods to gather huge amounts of data, such as the recent genome sequencing efforts 
(Lander et al., 2001; Venter et al., 2001; Waterston et al., 2002), computational methods offer a 
powerful set of tools to help understand the ageing process and its genetic network (reviewed in 
Luscombe et al., 2001; Yaspo, 2001). In this article, our objective is to focus on computational 
tools that may be useful for the study of human ageing by: (1) data-mining methods, such as 
comparative genomics, phylogenetic footprinting, and DNA microarrays, that may be employed 
to gather information about ageing; (2) in silico methodologies aimed at interpreting information, 
such as algorithms to understand complex networks, that may be useful to model the genetic 
network of human ageing. 
 
11.2. Data-mining methods 
 
 Computational data-mining approaches are particularly appropriate in areas with much 
data but few explanations, such as gerontology. If researchers can find patterns in data to 
perceive information, then information may enhance our knowledge over ageing. The goal of 
applying computational data-mining approaches is to extract useful information from large 
amounts of data by employing mathematical methods that should be as automated as possible. 
 
11.2.1. Comparative genomics of ageing 
 
 Having the human genome offers the digital genetic code that is the source of ageing 
while having several fully sequenced genomes offers data-mining opportunities to decipher that 
code. Since genomes had a common ancestor, every base pair in each organism can be explained 
as a combination of the ancestral genome with evolution, and so comparing different genomes is 
a powerful way to analyze and interpret genome sequence. Comparative genomics allows 
researchers to, for instance, discover new genes, assign function to unknown genes, and gather 
information on protein interactions (reviewed in Wei et al., 2002; Ureta-Vidal et al., 2003). 
 Early studies using the several available microbial genomes already showed how 
comparative genomics can be used to gather information about gene function (reviewed in 
Yaspo, 2001; Wei et al., 2002). One method involves determining the presence or absence of 
proteins across several genomes to build a phylogenetic profile for each one. Functionally related 
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proteins are expected to have similar profiles and thus can be grouped together, giving hints on 
the function of several unknown proteins (Pellegrini et al., 1999). Another approach to find 
functionally related proteins involves a “Rosetta stone” analogy. In brief, if the homologues of a 
pair of proteins in an organism are found fused into a single protein chain in another organism’s 
genome, it can be used to infer a functional interaction (Marcotte et al., 1999a). Lastly, more 
detailed comparisons may be performed. In one example, the DNA repair proteins of 
Escherichia coli and Saccaromyces cerevisiae were compared to the entire sets of protein 
sequences of several fully sequenced genomes. Multiple alignments of the protein families found 
were constructed using algorithms such as ClustalW (Thompson, 1994). This method allowed an 
identification of novel enzymatic and DNA-binding domains involved in repair, as well as an 
improved view on the evolution of repair systems and how these depend on environmental 
conditions and the cell’s physiology. By identifying domains with disrupted functional motifs, 
researchers can also predict proteins without enzymatic activity (Aravind et al., 1999). 
 It may be possible to discover novel proteins involved in ageing through phylogenetic 
profiles using as reference, for example, proteins involved in progeroid syndromes. In addition, 
many different organisms exhibit extraordinary similar ageing phenotypes at radically different 
paces. For example, some primates such as baboons (Bronikowski et al., 2002) or rhesus 
monkeys exhibit a similar ageing process to humans but twice as fast and mice age 25-30 times 
faster than humans do (Finch, 1990); on the other hand, whales appear to age slower than 
humans (George et al., 1999). These observations are independent of environmental conditions, 
suggesting that genetic factors are largely responsible for rate of ageing in mammals (Miller, 
1999; de Magalhaes, 2003). Although different rates of ageing may also be due to metabolic 
rates, these alone do not explain the variety in mammalian rates of ageing (Austad, 1997). 
Eventually, it will be possible to compare whole sets of protein families across mammalian 
species with different rates of ageing in hope of finding some sort of correlation, for example, in 
the form of expanded or contracted protein families. 
 Since the digital core of information from which ageing arises is ultimately knowable 
(Hood, 2003), comparative genomics offers an accessible set of tools to study ageing in humans. 
The major limitation in applying the described methodologies to mammals is the need for several 
fully sequenced genomes, which should occur within a reasonable future. For example, 
expansion and contraction of protein families in mice--mostly reproduction, immunity, and 
olfaction--do not suggest any involvement with ageing (Waterston et al., 2002). Yet with the 
prospect of having several fully sequenced mammalian genomes within the next few years--
namely, human, mouse, rat, chimpanzee, rhesus macaque, cow, pig, and dog genomes 
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(http://www.genome.gov/page.cfm?pageID=10002154)--comparative genomics offers a 
powerful approach to study human ageing. 
 
11.2.2. Transcriptional regulation of ageing 
 
 One of the major discoveries of the sequencing of the mouse and human genomes is the 
extraordinary genetic similarity between mice and humans. According to the latest projections, 
mice share roughly 99% of the total number of human genes (Waterston et al., 2002), and some 
scientists argue that humans and their close relatives--e.g. chimpanzees--have the same set of 
genes (for example: Wade, 2001). Recent evidence indicates that alterations in transcription 
discriminate humans from other primates, not different genes (Enard et al., 2002). It appears that 
the genes may well be very similar in humans and other animals, but they are used or transcribed 
differently and the way they are transcribed determines the differences between humans and 
other animals (Hood and Galas, 2003; Levine and Tjian, 2003). Therefore, transcriptional 
regulation may be a key in mammalian ageing, as already suggested (Roy et al., 2002; Hood, 
2003). 
 Transcriptional regulation is a complex process that only recently began to be understood 
(reviewed in Arnone and Davidson, 1997; Fickett and Wasserman, 2000). Importantly, 
transcriptional regulation is also digital in nature. It is located in the non-coding genetic 
sequence, largely in the form of cis-regulatory sequences that are critical in development and 
cellular differentiation. These regulatory sequences are specific targets of transcription factors 
(TFs) that, together with proteins that bind them, control gene activity. Since transcriptional 
regulation is located in the genetic information, bioinformatics is also attempting to tackle 
regulatory networks. 
 One promising computational tool for the identification and characterization of regulatory 
regions is phylogenetic footprinting (reviewed in Hardison et al., 1997; Pennacchio and Rubin, 
2001; Ureta-Vidal et al., 2003). As with comparative genomics, the principle behind 
phylogenetic footprinting is that regulatory regions tend to be conserved across different species. 
One example of how phylogenetic footprinting can be used involves the stem cell leukaemia 
(SCL) gene. Briefly, clones containing the human, mouse, and chicken SCL gene were 
sequenced. Comparing human and mouse sequences revealed several homology peaks, a subset 
of which corresponded to previously known SCL enhancers. Chicken sequences corresponding 
to human/mouse peaks identified a conserved non-coding region with no known functions. Using 
a transgenic reporter assay, it was possible to characterize that region as a new neural 
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transcriptional enhancer (Gottgens et al., 2000). In other experiments, phylogenetic footprinting 
has been used in the discovery of mammalian regulatory elements of genes such as Bruton’s 
tyrosine kinase, β-globin (Hardison et al., 1997), and interleukins 4, 5, and 13 (Loots et al., 
2000). With the availability of more genomes, phylogenetic footprinting should gradually 
become more powerful (for example: Hardison et al., 1997). 
 Since TFs bind specific sequences, it is possible to find putative transcription factor 
binding sites (TFBS) in genome sequence through computational algorithms (reviewed in 
Stormo, 2000; Ohler and Niemann, 2001; Pennacchio and Rubin, 2001). One major problem 
with putative TFBS identified by computational methods, and, to a lesser degree, in phylogenetic 
footprinting, is the presence of false positives. Experimental verification is often necessary. In 
addition, TFs in metazoans often interact with each others, making it difficult to find the 
complete set of regulatory interactions. To minimize this problem, more efficient algorithms, or 
combination of algorithms, can search clusters of TFBS or TFBS conserved between mouse and 
human sequence (Wagner, 1999; Levy and Hannenhalli, 2002). Although these methods are 
becoming increasingly efficient, the true power of putative TFBS detection emerges when taken 
together with other types of data, as will become apparent ahead. 
The principle in studying transcriptional regulation may also involve a comparative 
biology approach in an attempt to understand why different mammals age at different rates. Only 
instead of searching genes, we would be searching regulatory sequences. The importance of 
transcriptional regulation should not be underestimated. For example, as much as 40% of human 
TFBS are not functional in rodents (Dermitzakis and Clark, 2002). Using phylogenetic 
footprinting it may be possible to find the TFs that control key genes involved in ageing while 
detecting putative TFBS may help us gather hints about mechanisms of ageing. If indeed the 
differences in rate of ageing are due to subtle transcriptional differences amongst mammals, then 
the study of transcriptional proteins and regulatory sequences will be relevant for ageing 
research. In other words, if ageing and cancer can be seen as the corruption of the genetic 
program, then the study of transcriptional regulation might allow researchers to understand why 
it becomes corrupted with age. 
 
11.2.3. DNA microarrays 
 
 DNA microarrays based on the quantification of mRNA levels are a growing technology 
(reviewed in Lockhart and Winzeler, 2000). Although the correlation between mRNA and 
protein levels is not always linear (Gygi et al., 1999), DNA microarrays have the technological 
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edge over proteomics and protein microarrays (reviewed in Pandey and Mann, 2000; MacBeath, 
2002) due to their capacity to produce large amounts of gene expression data from different 
conditions in relatively little time. The principle is that changes in mRNA levels between 
different conditions also reflect changes in the system under study and often at a protein level. 
 Studies of complex processes in yeast have showed the power of DNA microarrays by 
measuring mRNA levels for practically every yeast gene. One experiment attempted to relate the 
gene expression program to the sequence of events in sporulation by measuring gene expression 
at t = 0, 0.5, 2, 5, 6, 7, 9, and 11.5 hours during sporulation. By grouping genes according to their 
expression profiles during sporulation, it was possible to find functional links and provide clues 
about the function of previously uncharacterized genes. Clustering of gene expression patterns 
allowed hints about the function of hundreds of genes and, for example, a 10-fold increase in the 
number of identified genes that participate at the middle stages of sporulation. DNA microarrays 
have also become crucial to understand transcriptional regulation. In the same experiment, 
consensus sequences for the USR1 transcriptional regulator were found by computational 
approaches upstream of the start codon of many genes clustered according to expression 
patterns. These results allowed an association between a temporal pattern of gene expression, a 
stage in sporulation, and a transcriptional regulator with its respective regulatory sequence. The 
role of the Ndt80 TF was also investigated through either ectopically expressing Ndt80 or 
eliminating it. In theory, this approach can be used to find nearly every gene regulated by a TF 
under the experimental conditions used, though false negatives may exist since genes are often 
controlled by multiple TFs. Together with analysis of putative Ndt80 binding sites, this work 
allowed the identification of several genes presumably controlled by Ndt80 (Chu et al., 1998). 
Clustering genes with similar expression patters with age may allow researchers to find 
functional links. Yet the objective in applying DNA microarrays to study ageing is to relate the 
gene expression program with the sequence of events of the ageing process in hope that will 
allow us to determine the regulation of ageing. One major problem is that, unlike yeast 
sporulation, the ageing process may not be programmed. Others have suggested that age-related 
changes in gene expression are deleterious for they represent a shift from what is assumed to be a 
young pattern (for example: Lee et al., 1999; Jiang et al., 2001). Yet instead of indicating causes 
of ageing, gene expression profiles as animals age may represent the tissue’s response to ageing. 
For instance, if ageing derives from damage accumulation, then gene expression patters will 
change with age as a response to damage. Therefore, due to the unique and unclear basis of 
ageing, data obtained from gene expression patterns must be carefully interpreted. For example, 
one study on cellular senescence found disparate changes in gene expression between two 
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different cell types despite the same telomere-dependent mechanism. Yet up-regulated 
senescence-specific genes showed chromosomal clustering between both cell types, leading to 
the suggestion that chromatin changes are involved in cellular senescence (Zhang et al., 2003). It 
is clear that changes occur in human cells as we with age, but gene expression profiles may only 
reflect a response to those changes rather than the changes themselves. 
 One important application of DNA microarrays for the study of ageing would be to find 
markers of ageing. For example, DNA microarray analysis of malignant lymphomas has proven 
useful in detecting genes that can be employed to classify and predict the prognosis of tumours 
(reviewed in Schwaenen et al., 2003). Finding gene expression patterns capable of serving as 
indicators of how aged an animal or a human is would prove useful for research. For instance, if 
the recent advances in sequencing power are anything to go by, then in 10 years we may be able 
to sequence a human genome in one day (for example: Hood, 2003). Having a method to 
measure biological ageing would allow us to calculate the pace of ageing in individuals and 
possibly find clues about the genetic players that modulate the ageing process. Even now, such 
method would allow us to compare, for example, single-nucleotide polymorphisms amongst 
individuals with different paces of ageing. 
Other technical variants and applications of DNA microarrays exist (reviewed in 
Lockhart and Winzeler, 2000). One powerful technique for the understanding of transcriptional 
regulation is genome-wide location analysis (reviewed in Wyrick and Young, 2002). In yeast, 
the technique involves a DNA microarray with the complete set of yeast intergenic regions. 
DNA enriched with an antibody against the TF of interest is labelled and hybridized against the 
microarray revealing which promoters, and often which genes, are regulated by the TF. This 
technique has also been used to study the E2F TF family in human cells using a selection of 
about 1,200 human promoter sequences. Several genes were identified as potentially activated by 
E2F, including many genes with no previous connection to E2F (Ren et al., 2002). 
Applying genome-wide location analysis to study ageing is a potentially powerful 
approach not only in understanding cellular senescence but also the ageing process. It could shed 
light on what genes are regulated by TFs suspect of participating in ageing--for example, the 
redox-regulated TFs such as AP-1, Sp1, and NF-κB (Lavrovsky et al., 2000). Furthermore, it 
could help elucidate the roles of these and other TFs at different ages. For instance, 
understanding which genes are activated at different ages by p53 could help clarify p53’s role on 
ageing and cancer mechanisms. Of course we may face the same problem of finding responses to 
ageing rather than causes. If genes do not exist to cause ageing, then neither do regulatory 
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sequences. Yet these respond to stimulus and if these responses change during ageing then 
finding them may help understand what causes ageing. 
When applying DNA microarrays to the study of ageing we face the problem of how to 
focus on human ageing. It appears difficult to obtain data on gene expression at different ages for 
humans using longitudinal studies. One idea could be to use cross-sectional studies. Although 
such studies are obviously biased by the variability amongst individuals (Hofer and Sliwinski, 
2001), if done on a sufficient number, cross-sectional studies may prove useful (Weindruch et 
al., 2002). Of course, cross-sectional studies appear the only solution to study long-lived 
animals, such as whales or turtles, and they have already been employed to study, for example, 
rhesus monkeys (Kayo et al., 2001). Therefore, at least using longitudinal studies, we are likely 
to depend on model organisms. 
 Studying ageing in animals has the additional problem of having to deal with several 
different cells types--over 200 in vertebrates (Alberts et al., 1994). As far as we know, ageing 
can be caused simultaneously in all tissues, it can be a result of changes in a particular organ, or 
it can even involve different genetic programs at different tissues. Indeed, previous studies 
already indicated that gene expression profiles are specific for the ageing process of each organ 
(reviewed in Weindruch et al., 2002). Interpreting gene expression profiles in multicellular 
organisms is a difficult problem, which will rely on having a substantial amount of data from 
different tissues to allow researchers to isolate which age-related gene expression changes are 
passive effects, causes, or responses to ageing. Techniques for measuring tissue-specific gene 
expression have been applied to Caenorhabditis elegans (reviewed in Reinke, 2002) and could 
be employed in mammals to discriminate tissue-specific age-related gene expression changes. 
Lastly, different forms of data-analysis, such as chromosomal clustering (Zhang et al., 2003), 
may reveal information that is otherwise unobvious. 
 In conclusion, DNA microarrays may provide much data and even information for the 
study of ageing. The great advantage of DNA microarrays is that it is not necessary to know 
what genes are important in the process under study. Large amounts of age-related gene 
expression data from different tissues of, for instance, mice, would prove an invaluable resource 
for the study of ageing. At present, microarray databases, such as Standford’s (Sherlock et al., 
2001), already contain a few datasets regarding ageing (reviewed in Jennings and Young, 1999). 
With time, researchers can hope to have the age-related transcriptome of different tissues from 
several model organisms. 
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11.3. Modelling human ageing 
 
Computational methods offer several data-mining tools, as previously mentioned, and an 
exponentially increasing amount of data (Table 4). To understand biological systems, the amount 
of data needed is colossal because biological systems are intrinsically complex with diverse, 
often multifunctional, elements that interact in nonlinear ways (Toussaint et al., 1991). In turn, 
data and information can be analyzed and interpreted by way of computer and mathematical 
methods to create models that are easier to study than biological systems. Ultimately, these 
models allow us to increase our knowledge about the process under study. If we could simulate, 
for instance, cellular senescence in silico, it would be a major development. Yet the grail of 
gerontology is the reconstruction of the genetic network of human ageing: the identification of 
the causal structure of the ageing process’s gene network. 
 
11.3.1. System structure and identification 
 
 Uncovering a complex process such as human ageing will depend on the employment of 
both computational tools and experimental approaches. The integration of these two forms of 
information requires a systems biology approach (reviewed in Ideker et al., 2001a; Kitano, 
2002a, 2002b). Systems biology is based on information--e.g. the quantification of a gene 
product--obtained from a given biological system under different genetic and/or environmental 
conditions. Information is then mathematically treated to construct a model that explains the 
system. For example, insights into the regulation of galactose use (GAL) in yeast have been 
obtained through systems biology. To study the GAL pathway, mRNA and protein data were 
obtained from yeast strains under different environmental and genetic conditions. Exemplifying, 
strains were examined each with a different GAL gene deleted. Using previously known protein-
protein and protein-DNA interactions, previous models of the GAL pathway, and the new data, it 
was possible to build an integrated physical-interaction network for over 300 genes. Several 
putative interactions were also identified through gene expression analysis combined with TFBS 
scans or simply by searching genes with correlated expression profiles. New regulatory 
phenomena were also proposed, some of which later experimentally verified (Ideker et al., 
2001b). 
 Applying systems biology to study human ageing is not straightforward. The accuracy 
and detail of a model is dependent on how much data we can gather in how many different 
circumstances (Selinger et al., 2003). From a mathematical perspective, we can imagine 
Table 4 
 
List of major databases and bioinformatics websites 
 
Name: Website: 
  
EMBL http://www.embl-heidelberg.de/ 
EMBL’s genome browser http://www.ensembl.org/ 
European Bioinformatics Institute http://www.ebi.ac.uk/ 
NCBI http://www.ncbi.nlm.nih.gov/ 
TIGR http://www.tigr.org 
USCS Genome Bioinformatics http://genome.ucsc.edu/ 
  
Selection of databases that may be useful to gerontologists 
 
Baltimore Longitudinal Study of Aging http://blswww.grc.nia.nih.gov/ 
BodyMap http://bodymap.ims.u-tokyo.ac.jp/ 
GeneCards http://bioinformatics.weizmann.ac.il/cards/ 
Human Protein Reference Database http://www.hprd.org 
Protein Data Bank http://www.rcsb.org/pdb/ 
SAGE KE database of 
genes/interventions 
http://sageke.sciencemag.org/cgi/genesdb 
Swiss-Prot http://us.expasy.org/sprot/ 
Telomere Database http://www.genlink.wustl.edu/teldb/index.html 
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modelling ageing as mapping the rules that make a young organism old. If a large number of 
genes are involved in the process, as it appears likely, then a large number of measurements are 
necessary to understand the rules governing those genes. The duration of ageing even in animal 
models makes ageing a difficult subject of study when compared to, for instance, yeast 
sporulation. In addition, a major limitation to study ageing in humans or model organisms, such 
as mice, is the relatively small amount of ways to change ageing (Table 5). Therefore, and since 
our understanding of the ageing process is still in its infancy, modelling human ageing will have 
to be accomplished in phases. The first phase must be the identification of the elements involved 
in the human ageing process, possibly with knowledge about interactions between them. In 
addition, we must attempt to learn more about the structure of the ageing process. For instance, 
does ageing derive from damage accumulation, programmed gene expression changes, changes 
in DNA structure, or some other process?  
 Experimental approaches have already proven useful in identifying a few genes that may 
be involved in human ageing. The new computational tools described earlier will be determinant 
to find novel genes involved in ageing. DNA microarrays, in particular, are a powerful approach. 
For example, studying cellular processes such as stress response and DNA repair may help us 
gather clues about functional interactions between proteins suspect of being involved in ageing 
(Table 5) and previously uncharacterized proteins. If indeed certain progeroid syndromes in both 
mice and men are cases of accelerated ageing, then finding new functional links involving these 
proteins is a promising approach. Also, large-scale gene expression profiles of ageing animals 
may help clarify the structure of the ageing process, something that so far eluded researchers.  
 
11.3.2. System-level perturbations in model organisms 
 
 As we identify the elements of the ageing process we can attempt to predict its progress 
by perturbing each component of the system. Due to the duration of human ageing, model 
organisms will play a critical role. Namely, perturbations of ageing in model organisms by, for 
instance, genetic interventions will be crucial to obtain the amount of data necessary to 
understand ageing. Another type of perturbation results from evolution and the way several 
species have different rates of ageing. 
The major problem of using animal models is that the genetics of ageing in model 
organisms may or may not be similar to the genetics of ageing in humans. For example, 
mutations in the mouse homologue to the Werner’s syndrome gene have no visible effect on 
their ageing process (Lombard et al., 2000; Wang et al., 2000). One critical paradox in studying 
Table 5 
 
Major perturbations of the aging phenotype in mice 
 
Name Perturbation Reference 
   
Ames dwarf Homozygous mice show over 50% 
increases in life-span. 
Brown-Borg et al., 
1996 
Caloric restriction Delay of the aging process. Weindruch and 
Walford, 1998 
GHR (growth hormone 
receptor) 
Increase in life-span of 40-50% in 
homozygous knock-outs. 
Coschigano et al., 
2000 
Ghrhr (Growth 
hormone releasing 
hormone receptor) 
Life-span increase of about 20% in 
homozygous knock-out mice. 
Flurkey et al., 2001 
IGF-1R (insulin-like 
growth factor receptor) 
Heterozygous mice live 26% longer 
than wild-type. 
Holzenberger et al., 
2003 
klotho Possible accelerated aging phenotype 
of homozygous knock-outs. 
Kuro-o et al., 1997 
p53 Heterozygous mutant mice display 
signs of accelerated aging. 
Tyner et al., 2002 
p66shc Roughly 30% increase in life-span in 
-/- mice. 
Migliaccio et al., 
1999 
Snell dwarf mice Life-span increase of 42% in 
homozygous mice. 
Flurkey et al., 2001 
Telomere dysfunction 
and ATM deficiency 
Possible accelerated aging in double 
mutant mice. 
Wong et al., 2003 
urokinase-type 
plasminogen activator 
Roughly 20% increase in life-span of 
transgenic mice. 
Miskin and Masos, 
1997 
XPD (xeroderma 
pigmentosum, group D) 
Possible accelerated aging phenotype 
due to homozygous mutation. 
de Boer et al., 2002 
   
Potential perturbations of the aging phenotype in humans 
 
Name Perturbation Reference 
   
CKN1 (Cockayne 
Syndrome Type I) 
Possible accelerated aging due to 
mutation. 
Henning et al., 1995 
WRN (Werner 
Syndrome gene) 
Premature aging due to recessive 
mutation. 
Yu et al., 1996 
LMNA (lamin A) Possible premature aging due to 
dominant mutation. 
Eriksson et al., 2003 
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ageing is that as we move across evolution in search of models closer to humans, these have 
increasingly longer life spans, making them increasingly more difficult and expensive to study. 
For example, studying genetic perturbations is much easier in C. elegans than in mice, but genes 
found in mice have more chances of being successfully extrapolated to humans than genes found 
in C. elegans. Although studies in, for instance, invertebrates will continue to yield putative 
genes involved in human ageing (for example: Tower, 2000; Hekimi and Guarente, 2003), we 
must have a coherent view of ageing mechanisms in several species, including mammals, before 
we can extrapolate conclusions to human ageing. 
Model organisms have already given useful insights on biological complexity and on the 
organization and dynamics of the ageing process. Some successful work using DNA microarrays 
has been done in Drosophila melanogaster (for example: Zou et al., 2000), C. elegans (for 
example: Lund et al., 2002), and mice (for example: Lee et al., 1999, Cao et al., 2001; Jiang et 
al., 2001; Miller et al., 2002). Interestingly, some of the studies employing DNA microarrays on 
mice also studied caloric restriction and/or life-extending mutations (for example: Lee et al., 
1999; Cao et al., 2001; Miller et al., 2002). If the mechanisms of ageing are similar amongst 
mammals, as it may be the case (de Magalhaes and Toussaint, 2002), then mammalian ageing is 
a combination of the basic mechanisms of ageing, metabolic rates, and species-specific traits. 
Gene expression studies comparing different primates as well as different rodents have already 
been used to identify species-specific patterns of expression (Enard et al., 2002). Performing 
such studies using a temporal resolution of ageing, at least in rodents, would allow us to 
determine the progression of gene expression as animals age, thus helping us find common 
responses to ageing or even causative factors in mammalian ageing. 
If ageing and development are two independent processes (for example: Miller, 1999), it 
is also important to identify the changes in animals before vulnerability starts to increase. In 
other words, to identify what changes occur prior to the sexual peak that make ageing 
commence. If we aim to develop ways to stop ageing, then this is the question we must ask, not 
what changes drive senescence in adulthood. Therefore, gene expression changes prior to the 
increase of age-related vulnerability may reveal important clues about the ageing process, though 
care must be taken to discriminate such changes from developmental changes. 
 Although we focus on mRNA quantification and genomics, other data can be gathered 
such as protein studies (for example: MacBeath, 2002), metabolic fluxes (for example: Nielsen, 
1998; Strohman, 2002), and even the study of age-related changes or clinical features of ageing 
(for example: Mitnitski et al., 2002). The aim is to obtain as much data as possible under as 
many different conditions to help explain the observed differences. For example, metabolic 
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control analysis may be applied to study metabolic fluxes in animals under caloric restriction and 
ad libitum-fed controls. Studying what metabolites differ between controls and caloric restricted 
mice may contribute to our understanding of ageing. 
 
11.3.3. Reconstructing the genetic network of human ageing 
 
Eventually, we would like to create models that allow us to control the ageing process. 
Due to the limitations on gathering data about ageing, great accuracy in describing human ageing 
will be impossible in the near future. Therefore, we propose Boolean networks to define the 
genetic network of human ageing. Simple mathematical descriptions such as Boolean networks 
classify gene interactions as 1 or 0 (Kauffman, 1993). Given the large amounts of genes 
presumably involved in a complex process such as ageing, Boolean networks offer a simple and 
accessible way to model the genetic network of ageing. Although they fail to take into account 
genes at intermediary levels and are sometimes seen by biologists as inaccurate, Boolean 
networks make it easy to model complex networks from large amounts of data (Figure 28). 
Given the complexity of the ageing phenotype, Boolean networks appear as a realistic way to 
simulate the genetic network of ageing within a reasonable future. A Boolean model of human 
ageing would already be incredibly useful for medicine in predicting potential anti-ageing 
interventions. 
Several algorithms have been proposed to reconstruct the genetic network of complex 
processes based on DNA microarray data (for example: D’Haeseleer et al., 2000; Whade and 
Hertz 2000; Wagner, 2001; de la Fuente et al., 2002; Yeung et al., 2002). Unfortunately, these 
statistical approaches require amounts of data unrealistic for the present status of ageing 
research. In addition, DNA microarray data will probably be obtained from model organisms, 
not humans. Therefore, the greatest challenge in reconstructing the genetic network of ageing 
will be to integrate data coming from different sources--e.g. DNA microarrays and mutagenesis 
experiments in model organisms, cellular senescence, and genomics--into one coherent 
framework, as suggested by others (Jazwinski, 2002; Kirkwood et al., 2003; Hood, 2003).  
As mentioned, gene expression data must be combined with other sorts of information--
e.g. TFBS prediction--in order for us to understand a system. For example, in one experiment, 
regulatory motif pairs were used together with gene expression data to study the synergism 
between them. This approach allowed the identification of novel motif combinations regulating 
transcription and the modelling of regulatory networks in yeast (Pilpel et al., 2001). If indeed 
transcriptional regulation plays a key role in ageing, then both data-mining strategies to find the 
 
Figure 28: (A) Basin of attraction of a random Boolean network with six attractors. The 
attractors (centre) are the outcome of the system--for instance, an attractor can be a step in 
cellular differentiation, a phenotype, even a disease--while the wiring represents biological 
connections with their own rules describing the level of interaction. Each state can represent, 
for example, gene activity. Particularly useful for modelling cellular or even yeast cell cycles, 
Boolean networks also take into account the robustness of biological systems where small 
perturbations to one state may not affect the general outcome, which is in accordance to what 
we know about aging--for instance, many diseases accelerate mortality without affecting rate 
of aging. (B) Cellular automata, or cells, are computer simulations that try to model Nature 
and life by employing a single set of rules. This image shows the network wiring between two 
time-steps for a large number of cells (n = 400, on the perimeter), highlighting just one cell. 
Although these methods are somewhat rough ways of portraying life, they can be much useful 
in understanding the dynamics and organization of complex genetic networks such as aging. 
Images generated using DDLAB by Andy Wuensche: http://www.santafe.edu/~wuensch/ 
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relevant transcriptional information and the integration of DNA microarray data from model 
organisms, such as mice, are crucial. In another example of data integration, researchers 
combined protein information from experimental data, phylogenetic profiles, correlated mRNA 
expression levels, and patterns of domain fusions--involving the “Rosetta stone” analogy 
method--for practically all S. cerevisiae proteins. The result was the discovery of 93,000 
functional links between proteins which allowed them to assign function to a previously 
uncharacterized protein family, a yeast homologue of human colon-cancer genes, and the yeast 
prion Sup35 (Marcotte et al., 1999b). In the end, modelling human ageing will require multiple 
approaches with several feedback loops. To reconstruct the genetic network of human ageing we 
need a strategy integrating the discovery of the genes involved with systematic perturbations of 
ageing (Figure 29).  
 
11.4. Conclusion: is it possible to reverse engineer human ageing? 
 
 Reverse engineering is “the process of analyzing a subject system to identify the system’s 
components and their interrelationships and create representations of the system in another form 
or at a higher level of abstraction.” (Chikofsky and Cross II, 1990). To reverse engineer human 
ageing would be to reconstruct the genetic network of ageing; to find the mechanisms by which a 
human becomes old and find how to delay and perhaps even reverse the ageing process. In 
practice, reverse engineer of ageing would allow us to predict which genes actively regulate rate 
of ageing and eventually what genes could we target to delay human ageing and postpone age-
related pathology and degeneration. 
 In theory, it is possible to reverse engineer a complex process (D’Haeseleer et al., 2000). 
Yet given the, previously mentioned, limitations in studying human ageing, we find it unlikely 
that the genetic network of ageing will be understood in detail within a near future. The number 
of experiments required to fully understand a complex phenotype such as ageing is at present 
beyond our technology (Wagner, 2001; Krupa, 2002). Yet just finding a few more genes 
involved in ageing would be a major breakthrough; as it would be to understand the structure of 
the ageing process. Indeed, others have claimed long ago how the goal of gerontology should be 
to discriminate causes from effects of ageing and find the one or few physiological processes that 
control ageing (Medawar, 1955). Although ageing is a complex process that involves many 
genes and pathways, different genes influence ageing, directly or indirectly, in different ways. In 
fact, the recent history of the analysis of complex processes shows that even in the most complex 
of processes we are likely to find key controlling nodes (for example: Risch, 2000; Kitano, 
 
Figure 29: Understanding the genetic network of human aging is based on two general phases: 
1) identifying the genetic players involved; 2) systematically perturbing aging and 
elements/pathways suspect of being involved in aging of model organisms by, for instance, 
genetic interventions (reviewed in Case, 2003); the integration of results allows us to 
continually improve our models. A variety of experimental and computational approaches can 
be used for both aims. Through genetic manipulations, gene expression studies can help 
discover novel genes involved in aging as well as clarify the role of genes under study. 
Databases too can be used by, for instance, comparative genomics, to find potential genetic 
players affecting aging. Comparative genomics can also be used to assess if genes found in 
model organisms may play a role in human aging. Cellular studies can be useful, for instance, 
in conjunction with animal models to investigate specific cellular processes. Lastly, studies on 
transcriptional regulation may be employed to investigate the regulatory signals affecting the 
genes in question as well as find new elements involved in aging. Colour indicates large-scale 
databases. Arrows indicate the flow of information. 
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2002b). Both in practice (for example: Migliaccio et al., 1999) and in theory (for example: 
Wagner, 2001), it appears possible to locate such nodes in human ageing. Even if we cannot 
reconstruct the entire genetic network of ageing, locating a few key regulatory processes would 
be invaluable. For example, if we could develop a draft Boolean model of what genes determine 
rate of ageing in primates, it would allow us a better understanding of human ageing and 
possibly the identification of potential therapeutic targets; optimistically, such findings would 
open the path for the development of ways to delay age-related pathology and senescence. 
 New tools provide new goals. Until recently, it was unthinkable to attempt to identify all 
genes involved in ageing. Yet the modern high-throughput technologies allow us to consider the 
possibility of defining most if not all players involved in ageing as well as how they interact to 
form the ageing process. Eventually, we will be able to predict the effect of each gene on the 
ageing process. 
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General Conclusion 
 
 
 
 In this work, we developed a refined model of the evolution of human ageing. Our model 
offers a much more accurate view than the flawed classical evolutionary theory of ageing and 
contradicts the disposable soma theory. Others too have recently argued in favour of more 
detailed models to explain the evolution of ageing in mammals (Lee, 2003). The model we 
developed explains several observations such as why most reptiles feature life-extending traits 
absent from all studied mammals. In addition, our model led us to conclude that model 
organisms are not accurate representations of human ageing. If human models are not possible, 
then mammalian models should be favoured. Although lower life forms can serve as basis for 
research, we must have a coherent view of mammalian ageing before we can claim we 
understand the human ageing process. We think that extrapolating findings in lower life forms 
into human ageing (for example: Howitz et al., 2003) is incorrect. Our work also led us to 
conclude that studies in long-lived animals such as some turtles and whales may allow us to 
enhance our understanding over mechanisms of ageing and even lead to the development of anti-
ageing interventions. Recent findings support our view (Girondot and Garcia, 1999; Lutz et al., 
2003; Christiansen et al., unpublished). 
  
 We established a model for the study of SIPS in BJ and hTERT-BJ1 HDFs. Based on our 
research, the global model of SIPS was improved. We demonstrated that the TGF-β1 pathway 
does not operate in all cell lines and we were the first to publish SIPS in telomerase-
immortalized normal HDFs. Others later confirmed our results (Gorbunova et al., 2002; Matuoka 
and Chen, 2002). We found no evidence that damage specific to the telomeres is at the origin of 
SIPS and so our results indicate that the telomeres do not play such a crucial role in SIPS as 
previously proposed. In particular, telomerase expression does not appear to affect SIPS. 
Contrary to results at the protein level, we detected an increase in the DNA-binding activity of 
p53 at 72 hrs after a single H2O2 stress. Though in accordance with previously established 
posttranslational modifications of p53 during RS (Atadja et al., 1995), this is a new finding and 
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redefines the role of p53 in SIPS, suggesting an important role for the p53/p21WAF1 pathway, in 
conjunction with pRb, in SIPS. We also proposed a general rearrangement of the gene 
expression networks during SIPS, involving antagonistic players in apoptosis, senescence, and 
cellular survival and proliferation. Therefore, we argued that the activation of DNA response 
pathways due to the genotoxic damage generated by H2O2 is the primary mechanism in SIPS. 
 Understanding the molecular basis of SIPS may have implications for cancer research but 
we do not think that SIPS and RS are representative of organismal ageing. Nonetheless, RS and 
SIPS may serve as biomarkers of ageing and may help understand age-related changes in stress-
prone tissues and the age-related increase in cancer incidence. Some cellular studies should be 
useful to understand human ageing. We suggested extending research into how cells respond to 
external insults and signals across different mammals and in long-lived animals, and across cells 
derived from human donors of different ages. We also argued that the debate of RS versus SIPS 
is irrelevant and instead researchers should focus on understanding the mechanisms involved. 
Yet telomere-independent mechanisms likely prevail in vivo in age-related pathology. 
 
 Our results suggest changes in the stress response of WS fibroblasts when compared to 
normal HDFs. In addition, we suggested an uncoupling between SA β-gal and the senescent 
morphogenesis in WS fibroblasts. We also confirmed previous reports that WS fibroblasts are 
more sensitive to oxidative stress. Our research over WS led us to suggest that DNA metabolism 
plays a critical role in ageing. Understanding why these changes are presumably accelerated in 
WS may prove relevant to understand the normal human ageing process.  
 
 Based on ours as well as other recent results (Lindvall et al., 2003 for arguments), we 
advise caution in using telomerase in anti-ageing therapies. Not only it remains unclear whether 
telomerase may reverse ageing but telomerase expression may alter the normal cellular functions 
and promote tumorogenesis. We propose developing anti-ageing interventions by identifying key 
players involved in the ageing process of humans, not model organisms. To that purpose, 
identifying biomarkers of ageing, through, for example, gene expression patterns, to accurately 
evaluate how aged someone is would prove priceless. Although we find lower life forms as 
potentially flawed models of human ageing, we do not propose that studies in these models be 
discarded, but rather that researchers use a sceptical open-minded approach. 
 
 We also proposed ways to integrate the modern computational approaches into ageing 
research. Although we find it unlikely that a full understanding of ageing may be achieved 
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within a near future, we argued that understanding the structure and finding key regulatory genes 
of the human ageing process is possible. We focused on two general ways of studying human 
ageing: age-related changes--e.g. at a gene expression or protein level--and changes in 
mammalian rates of ageing, in addition to the aforementioned progeroid syndromes such as WS. 
Eventually, combining information from all of these studies may allow us to build a Boolean 
model of the genetic network of human ageing and thus lead to the development of anti-ageing 
therapies. Lastly, we suggested that instead of focusing on age-related deleterious changes, 
researchers should also focus on the changes that occur prior to the age-related increase in 
vulnerability but that allow ageing to commence. Understanding these changes may be important 
in developing anti-ageing interventions. It is our opinion that we are at the dawn of a new era in 
which ageing will finally be conquered. 
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Appendix 
 
 
 
 In chapter 11 we presented a theoretical basis on how to apply computational approaches 
to study ageing. Yet we also wanted to demonstrate our strategy. Therefore, we developed a 
computational toolkit and used it to investigate theories of ageing in the context of comparative 
genomics. Although the scope of our findings are limited, we think our approach represents a 
first step in integrating comparative genomics in ageing research and serves as a foundation for 
future research. 
 
How the genome regulates aging: development of a comparative genomics method to study 
human aging and a test of theories of aging (submitted for publication) 
 
 In article 1, we suggested that the mechanisms of ageing in mammals may be similar and 
unique. If true, then the rate of ageing in mammals is genetically controlled (Miller, 1999; de 
Magalhaes, 2003a for arguments). In this article, we proposed a methodology for studying the 
genomic basis of ageing. Our reasoning was that by employing computational tools to mine data 
from the genome we may be able to gather clues about the genetics of human ageing. 
 The first step was to develop a comparative genomics methodology and software to 
investigate how the genome regulates ageing. Afterwards, we tested theories of ageing in the 
context of comparative genomics using our methodology and computational toolkit. Our study at 
a comparative genomics level suggested a possible role for the Fanconi anaemia proteins in the 
age-related changes of murine hematopoietic stem cells. We also failed to find any evidence that 
mitochondria-encoded proteins play a role in regulating primate ageing--though they may be 
related to human longevity--and identified a putative regulatory region in the WRN promoter. 
With the ongoing avalanche of high-throughput data, our methodology may prove valuable to 
identify genetic players involved in the human ageing process. 
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Abstract 
 
 The duration of aging in humans makes it almost impossible to perform in vivo studies 
and so the genetic basis of human aging remains largely a mystery. Since the rate of aging 
amongst mammals is mostly determined by the genome, one promising strategy is to employ 
computational tools to mine information from the recent wealth of genomic data. Herein, we 
propose a comparative genomics method to study each type of genetic information that may 
regulate mammalian aging as well as an algorithm to find such information. To implement our 
method, we developed a computational toolkit, which we employed to test theories of aging in 
the context of comparative genomics. Our results fail to suggest a role for the mitochondrial 
DNA in determining primate rate of aging, though it may be involved in age-related pathology. 
We also suggest that the Fanconi anemia genes may help explain the age-related changes of 
hematopoietic stem cells during murine aging. Lastly, we identified a putative regulatory region 
in the Werner-syndrome promoter. Our toolkit is available at: 
http://genomics.senescence.info/software/ 
 
Keywords: aging, bioinformatics, computational biology, genetics of aging, genomics 
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Introduction 
 
 The crowning achievement in gerontology will be to understand human aging, the age-
related process of loss of viability and increase in vulnerability that is intrinsic to all human 
beings [1]. Although several genes have already been shown to regulate aging in short-lived 
organisms [2], progeroid genes are, so far, the only identified genes that may modulate, in this 
case accelerate, aging in humans [3]. Finding other genes involved in human aging is of great 
importance. Yet due to the duration of aging in humans, there are clear technical limitations in 
performing in vivo studies and so the genetic basis of human aging remains largely a mystery.  
 Amongst mammals we observe a large variety of rates of aging, about 50-fold differences 
[4]. Humans appear to age significantly slower than most other mammals, including other 
primates. For instance, rhesus macaques, chimpanzees, and baboons either in the wild or in 
captivity age about twice as fast as humans [5, 6, 7]. The way the rate of aging varies widely 
from species to species, but little between populations of the same species under different 
environmental conditions, shows that the rate of aging is mostly regulated by the genome [8, 9]. 
As suggested by others, finding which genes determine rate of aging would prove crucial to 
develop ways to ameliorate age-related adverse effects and provide clues about what 
mechanisms modulate human aging [2]. Therefore, comparative genomics of aging applied to 
mammals can, theoretically, help researchers understand the genetic basis of aging.  
 Although others have argued in favor of genomics to study aging [10], much debate 
exists over what type of genetic information regulates aging in mammals. Besides, researchers 
still lack a strategy on how to employ the modern computational tools to locate such information 
when several mammalian genomes become available. Herein, we propose a comparative 
genomics method to help understand human aging. To implement our methodology, we 
developed a computational toolkit aimed at the comparative genomics of aging. Lastly, we tested 
theories of aging in the context of comparative genomics. We chose to test the two most widely 
accepted theories of aging: DNA damage [11] and oxidative damage derived from reactive 
oxygen species leakage from mitochondria [12, 13]. 
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Results 
 
A comparative genomics method to study human aging 
 
 Genomic differences determine rate of aging in mammals, but finding the information 
that controls aging is problematic since a mammalian genome holds a colossal amount of 
information. When compared to other primates, humans show a significantly different rate of 
aging despite our evolutionary proximity and genomic similarity [14]. For example, humans and 
chimpanzees share about 99.4% of their DNA in functionally important coding regions [15] and 
have essentially the same set of genes [16]. Even mice, that age 25-30 times faster than humans, 
share an estimated 99% of our total number of genes [17]. Consequently, the regulation of aging 
is located in only a fraction of the genome, as proposed by others [18]. Indeed, there is little 
evidence that major genomic features are involved in aging. For instance, genome size does not 
correlate with longevity amongst mammals [19]. Comparing the mouse and human genomes 
suggests that the relation between coding and non-coding regions also does not appear to play a 
part in aging. The mouse genome has fewer CpG islands and different patterns of G+C 
distribution [17], though at present there is no evidence such features are involved in aging. 
Although the telomeres have been implicated in aging, telomere length does not correlate with 
longevity in primates [20]. Therefore, we propose a three-way strategy to study the subtle 
genomic information that may regulate aging in mammals (Figure 1). 
 
Phylogenetic profile of human DNA repair proteins 
 
 One hypothesis is that rate of aging differs in mammals due to different genes. For 
example, perhaps humans feature protective genes that short-lived mammals lack. If so, then a 
promising approach is to compare genomes to determine the phylogenetic distribution of genes 
between different species. In the context of gerontology, the aim is to determine the presence or 
absence of genes in different species to find trends or cohorts of genes whose presence correlates 
with rate of aging. 
 To test the hypothesis that DNA repair defects are implicated in aging [11], we generated 
the phylogenetic profile of human DNA repair proteins (Table 1). We based our approach on a 
previously published description of human DNA repair pathways [21] and on the list of 126 
genes taken from the authors’ website (http://www.cgal.icnet.uk/DNA_Repair_Genes.html). As 
detailed in the methods section, we would prefer to use only mammals. Yet given the limited 
 
 
Figure 1: Strategies to identify the genomic information regulating human aging. Although 
the genomic information determines a species’ rate of aging, we do not know for sure what 
type of information. It could be the simple presence or absence of genes, which would be easy 
to detect by way of phylogenetic profiles employing BLAST once we have enough fully 
sequenced mammalian genomes. Sadly, the regulation of aging will probably involve 
functional differences between proteins or other gene products that are harder to identify. 
Even so, by way of, for example, ClustalW alignments we may find conserved regions whose 
level of conservation correlates with rate of aging. Finally, the regulation of aging may 
involve differences in the transcriptional regulation of genes. Yet using, for instance, 
phylogenetic footprinting it may be possible to locate conserved regions in the regulatory 
sequences of different mammals that will allow us to find the information behind the 
regulation of aging. 
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mammalian genomes presently available, we included non-mammalian organisms as a 
demonstration of the method, since only hits in the mouse were carefully analyzed. 
 Due to possible inaccuracies in genome annotation and the limited number of mammalian 
genomes, our results are preliminary. Even so, it was intriguing that amidst a highly conserved 
protein family (>95% conservation of functional genes using our threshold, please see Table 1), 
mice appear to lack two proteins, FANCE (NP_068741) and FANCF (NP_073562), involved in 
the human Fanconi anemia. Suspected of being a progeroid syndrome [22], Fanconi anemia is a 
bone marrow disease and its genes appear to be involved in tolerance or repair of DNA 
crosslinks. FANCE and FANCF regulate the activation of the Fanconia anemia DNA repair 
pathway through FANCD2 [23].  
 
Functional characterization of primate mitochondrial-encoded proteins 
 
We know that differences between humans and other mammals result not only from 
different genes, but mostly from alternative splicing and differences in gene function between 
homologous genes. To investigate aging, it will likely be necessary to take a closer look at the 
gene products and so a functional characterization of proteins is necessary. Unlike functional 
genomics, where the aim is to identify, for instance, functional motifs, while studying aging the 
aim is to relate protein function or dysfunction with rate of aging. Although we also compared 
the DNA repair proteins of mice and humans in terms of amino acid (aa) similarity (not shown), 
such comparisons are unlikely to prove fruitful if only human and murine proteins are available.  
Mitochondrial-encoded proteins have been implicated in aging [12] and age-related 
diseases [13]. To test this hypothesis, we compared the mitochondrial-encoded proteins of 
several organisms using the data from the NCBI website 
(ftp://ftp.ncbi.nih.gov/genbank/genomes/MITOCHONDRIA/Metazoa/). Our selection of model 
organisms was based on the criteria set in the methods section and so species evolutionary closer 
to humans were preferred, also taking into account metabolic and aging rates. In total, we 
selected the mitochondrial DNA (mtDNA) of 27 species, mostly mammals but also reptiles, 
birds, and amphibians, as described in the methods section. Multiple comparisons using all 
mitochondrial proteins revealed little information, as did those involving only mammalian 
proteins (not shown). We then tried to find unique or disrupted functional motifs in the proteins 
of, respectively, long-lived and short-lived mammals through the algorithm described in the 
methods section. Given that other primates age considerably faster than humans, we also 
investigated whether unique motifs could exist in primates or even humans that confer us 
Table 1: Sample of phylogenetic profile of human DNA repair proteins representing putative 
functionally equivalent proteins in several model organisms. In this table, the criteria for an 
homolog to be considered a putative functionally equivalent protein was: be at least 60% in 
length and 40% in residue similar to the human reference CDS. Human and bacteria are also 
included in the profile as controls. We manually verified all mouse genes for which we found 
no hits. Calculated using BLASTP 2.2.6 and as database all non-redundant GenBank CDS 
translations+PDB+SwissProt+PIR+PRF. 
 
 
Reference protein       man    mouse      fly     worm    ecoli    
TDG (410 aa):           1        1        1        0        0         
MBD4 (580 aa):          1        1        0        0        0         
XPA (273 aa):           1        1        1        1        0         
XRCC1 (633 aa):         1        1        1        0        0         
MUTYH (546 aa):         1        1        0        0        1         
RAD23A (363 aa):        1        1        1        1        0         
FANCF (374 aa):         1        0        0        0        0         
NUDT1 (179 aa):         1        1        0        0        0         
ERCC2 (760 aa):         1        1        1        1        0         
XRCC2 (280 aa):         1        1        0        0        0         
 
. . . 
 
OGG1 (345 aa):          1        1        1        0        0         
XRCC5 (732 aa):         1        1        1        0        0         
MSH3 (1128 aa):         1        0        0        0        0         
RPA2 (270 aa):          1        1        1        0        0         
MSH2 (934 aa):          1        1        1        1        0         
ERCC3 (782 aa):         1        1        1        1        0         
FANCE (536 aa):         1        0        0        0        0         
MSH6 (1360 aa):         1        1        1        1        0         
RAD18 (495 aa):         1        1        0        0        0         
PRKDC (4128 aa):        1        1        0        1        0         
Final results         125/125  120/125  85/125   67/125   5/125     
Percentage             100%     96%      68%      54%      4%        
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delayed aging. Although we found no unique functional motifs in long-lived mammals, we found 
a few unique residues in human mitochondrial-encoded proteins. One example is residue 64 of 
NADH dehydrogenase subunit 1 or MTND1 (Figure 2A). Intriguingly, a mutation in this same 
residue has been hinted as a secondary mutation in Leber’s optic neuropathy [24]. We also found 
some unique residues in primates when compared to other animals that occurred in highly 
conserved residues and thus liked to be functionally relevant (Figure 2B).  
 
Transcriptional regulation and aging 
 
 Others have speculated how differences in the rate of aging amongst mammals derive 
from “subtle changes in the transcriptional regulation of a subset of critical genes” [25]. Indeed, 
evidence suggests that as much as 40% of human transcription binding sites are not functional in 
rodents [26]. Therefore, regulatory proteins and sequences may be the key to understand 
mammalian aging, as proposed by many others [18, 22]. 
 Following the same principle described previously, we also tried to relate the 
mitochondrial promoter to rate of aging. Interestingly, we found 12 mismatches in short-lived 
mammals and none in long-lived mammals, but we found no overall correlation between 
regulatory motifs and rate of aging in mammals. We also focused on primate regulatory regions 
but failed to find any significant differences in the transcriptional regulation of mitochondrial-
encoded genes amongst primates. As with proteins, there were some unique positions in the 
human promoter but not in putative regulatory important regions and so we assume these were 
false positives. Lastly, RNA genes in the mtDNA were also studied but we also failed to find any 
correlation between these and rate of aging in mammals (not shown). 
 One of the few proteins suspected of being involved in human aging is the Werner 
protein (WRN), which is involved in DNA repair and appears to accelerate human aging [3]. 
Since there is only one mammalian homologue of WRN--in the mouse--and it does not appear to 
be involved in murine aging, comparing multiple promoters is unlikely to be profitable at 
present. Therefore, we studied the human WRN promoter through our toolkit in search of 
putative transcription factor binding sites (TFBS) thought to be involved in aging (Figure 3). We 
found two large SP1 clusters at -386 to -225 and -783 to -668 bp from the translation start site, of 
which the former has been biologically determined to play a role in the regulation of WRN by 
SP1 [27]. 
A  
pongo/1-318            GLLQPFADALKLFTKEPLKPSTST 
macaque/1-318          GLLQPFADAMKLFTKEPLKPSTST 
gibbon/1-318           GLLQPFADAMKLFTKEPLKPSTST 
homo/1-318             GLLQPFADAMKLFTKEPLKPATST 
gorilla/1-318          GLLQPFADAMKLFTKEPLKPSTST 
chimp/1-318            GLLQPFADAMKLFTKEPLKPSTST 
bonono/1-318           GLLQPFADAMKLFTKEPLKPSTST 
                       *********:**********:*** 
ARCT output for MTND1: GLLQPFADAMKLFTKEPLKPATST 
                                           ^ 
                       --------- ---------- ---   
 
B 
MTCO2  MTCYB 
 
chimp/1-227            GDLRLLDVDNR  
bonono/1-227           GDLRLLDVDNR  
gorilla/1-227          GDLRLLDVDNR  
homo/1-227             GDLRLLDVDNR  
pongo/1-227            GDLRLLDVDNR  
gibbon/1-227           GDLRLLEVDNR  
macaque/1-227          GDLRLLEVDNR  
dog/1-227              GELRLLEVDNR  
horse/1-227            GELRLLEVDNR  
bwhale/1-227           GELRLLEVDNR  
fwhale/1-227           GELRLLEVDNR  
hippo/1-227            GDLRLLEVDNR  
sheep/1-227            GELRLLEVDNR  
nzbat/1-227            GQLRLLEVDNR  
jbat/1-227             GDLRLLEVDNR  
mouse/1-227            GELRLLEVDNR  
rat/1-227              GELRLLEVDNR  
marsupial/1-228        GQLRLLEVDNR  
opossum/1-235          GQLRLLEVDNR  
elephant/1-228         GELRLLEVDNR  
monkey/1-229           GEFRLLEVDNR  
salamander/1-229       GQFRLLEVDNR  
frog/1-229             GQFRLLEVDNR  
turtle/1-228           GHFRLLEVDHR  
falcon/1-227           GHFRLLEVDHR  
buteo/1-227            GHFRLLEVDHR  
alligator/1-229        GHFRLLEVDHR  
                       *.:***:**:* 
  
marsupial/1-381        TPPHIKPEWYFLFAYAILRSI  
opossum/1-382          TPPHIKPEWYFLFAYAILRSI  
chimp/1-380            TPPHIKPEWYFLFAYTILRSI  
bonono/1-380           TPPHIKPEWYFLFAYTILRSV  
homo/1-378             TPPHIKPEWYFLFAYTILRSV  
gorilla/1-380          TPPHIKPEWYFLFAYAILRSV  
pongo/1-380            TPPHIKPEWYFLFAYAILRSV  
gibbon/1-380           TPPHIKPEWYFLFAYAILRSV  
macaque/1-380          TPPHIKPEWYFLFAYTILRSV  
monkey/1-378           TPPHIKPEWYFLFAYTILRSI  
mouse/1-381            TPPHIKPEWYFLFAYAILRSI  
rat/1-380              TPPHIKPEWYFLFAYAILRSI  
sheep/1-379            TPPHIKPEWYFLFAYAILRSI  
dog/1-379              TPPHIKPEWYFLFAYAILRSI  
bwhale/1-379           TPAHIKPEWYFLFAYAILRSI  
fwhale/1-379           TPAHIKPEWYFLFAYAILRSI  
hippo/1-379            TPPHIKPEWYFLFAYAILRSI  
horse/1-379            TPPHIKPEWYFLFAYAILRSI  
nzbat/1-379            TPPHIKPEWYFLFAYAILRSI  
jbat/1-379             TPPHIKPEWYFLFAYAILRSI  
elephant/1-378         TPLHIKPEWYFLFAYAILRSV  
salamander/1-380       TPPHIQPEWYFLFAYAILRSI  
frog/1-379             TPPHIKPEWYFLFAYAILRSM  
turtle/1-379           TPPHIKPEWYFLFAYAILRSI  
falcon/1-380           TPPHIKPEWYFLFAYAILRSI  
buteo/1-380            TPPHIKPEWYFLFAYAILRSI  
alligator/1-386        TPTHIKPEWYFLFAYAILRSI  
                       ** **:*********:****:  
 
Figure 2: A: multiple alignment of several primates MTND1 sequence from residues 44 to 67 
generated with ClustalW. Residue 64 is highlighted. The ARCT output for MTND1 
represents the human sequence indicating a unique human residue (“^”) as well as the 
conserved residues in the multiple alignment (“-”). 
 B: multiple alignments of various animal sequences of MTCO2 and MTCYB created 
using ClustalW. Residues 131 to 141 of MTCO2 are show with residue 137 highlighted while 
residues 265 to 286 of MTCYB are shown with residue 280 highlighted. The complete set of 
results is available at: http://genomics.senescence.info/software/mtdna/ 
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A computational toolkit to research the genomic basis of human aging 
 
 To automate research into the comparative genomics of aging, we developed a toolkit of 
Perl modules and scripts: Aging Research Computational Tools (ARCT). All of our results were 
obtained through ARCT, which is composed of tools for generating phylogenetic profiles and 
multiple alignments, determining putative TFBS, and performing phylogenetic footprinting. 
Included are the algorithms and statistical analysis tools described in the methods section. 
Simple sequence analysis tools are also included such as CpG island detection and estimation of 
synonymous versus nonsynonymous substitutions to search positive selection. Given our 
comparative biology approach, we also developed a Phylogenetic Tree Plotter (PTP) that can be 
used to display phylogenetic relationships of different species. 
 We tried to make ARCT automated, capable of dealing with large amounts of data, and 
easy to customize and upgrade. External links are also provided and it is easy to perform BLAST 
searches, or access programs like ClustalW and Gibbs through ARCT. The ARCT toolkit, 
documentation, and more detailed examples of ARCT are available for download on the website: 
http://genomics.senescence.info/software/ 
 
4. Discussion 
  
 Analysis of DNA repair genes across different taxa has been done in unicellular 
organisms [28]. Yet similar methods cannot be fully implemented in mammals due to the lack of 
sequenced genomes, and so we only compared human and mouse DNA repair pathways. Even 
so, the DNA repair pathways appeared well-conserved and our results do not suggest the 
involvement of DNA repair pathways in aging. 
 Our most significant finding concerned Fanconi anemia, which mostly affects the bone 
marrow and has been hinted as an accelerated aging syndrome [22, 23]. Intriguingly, DNA repair 
defects in hematopoietic stem cells have been linked with mouse aging [29] and DNA repair 
defects have been described in rodents when compared to humans [30]. Even though our results 
might derive from errors in genome annotation and sequencing, our findings may help explain 
the rapid age-related decline of hematopoietic stem cells in mice [31]. Mice knock-outs of other 
Fanconi anemia genes yield a much milder phenotype than the human disease [32]. We speculate 
that this occurs because mice, when compared to humans, already have a faster depletion of 
hematopoietic stem cell stocks due to the lack of the FANCE and FANCF proteins. 
  
Figure 3: Putative TFBS in the upstream sequence of the human WRN (NM_000553). Note 
that in our algorithm the entire process is automated, from downloading the sequence from 
RefSeq to generating a display with putative TFBS. All the user must do is type the accession 
number. “-1” represents the translation start site. Each row in the TFBS cluster distribution 
represents the concentration of TFBS at varying thresholds. 
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 Although, so far, expansion and contraction of protein families in mice--mostly 
reproduction, immunity, and olfaction--do not suggest any involvement in aging [17], 
phylogenetic profiles may be useful to build phylogenetic profiles of long-lived mammalian 
species when complete genome sequences are available, as has been done in lower life forms 
[28]. Even so, simple presence/absence algorithms will most likely not suffice to discover the 
regulation of aging in mammals. 
 If the mtDNA was to influence aging, we should expect to find functional differences 
amongst its proteins, RNA genes, or in its regulatory region. Although we cannot exclude that 
nuclear-encoded mitochondrial proteins and transcription factors (TF) are involved in aging, our 
results do not support the hypothesis that information encoded in the mtDNA plays a role in 
determining primate rate of aging. It was intriguing that some sequences very well-conserved 
throughout different metazoan classes have unique changes in primates, suggesting there may be 
functional differences in primate mitochondrial-encoded proteins. The mutation of Alanine to 
Serine in residue 64 of MTND1 has been suggested as a secondary mtDNA mutation in Leber’s 
optic neuropathy, a hereditary, normally mid-life onset, disease [24]. It is interesting that humans 
are the only known primate with Alanine while most other primates feature Serine. One 
hypothesis is that Alanine in residue 64 of MTND1 plays a role in preventing Leber’s optic 
neuropathy in the more long-lived primate Homo sapiens. 
 Our analyses of the WRN promoter revealed a previously unknown SP1 cluster of 
putative TFBS. Although false positives are common in TFBS algorithms, given the high density 
of the second SP1 cluster that we identified in the WRN promoter (-783 to -668 bp from the 
translation start site), we suggest that this cluster merits experimental verification and may also 
contribute to the regulation of WRN. Although we cannot exclude the possibility that other 
regions of the genome hold important information, we think comparative genomics of 
transcriptional regulation is one of the most promising data-mining methods to study human 
aging. 
 Through comparisons between protein families and regulatory regions amongst animals 
with varying rates of aging, it may be possible to determine key proteins involved in aging by, 
for example, locating disrupted functional motifs in proteins of short-lived rodents, or novel 
domain architectures in long-lived mammals, or vice-versa. In addition, if longevity evolved in 
primates [33], searching for positive selection of proteins appears a promising method, as has 
been employed [34]. Since we advocate comparisons between evolutionary close species such as 
mammals or even primates, we are likely to find little genetic differences and therefore the 
signal-to-noise ratio will be higher than employing other taxa. At present our method works 
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through a raw, unbiased analysis but specific analysis of motifs will be possible as soon as more 
mammalian genomes become available, also making it possible to research entire coding and 
regulatory regions. 
 One question is whether the aim should be to find conserved or disrupted sequences and 
proteins. In other words, should the differences in rate of aging amongst, for instance, primates, 
be related to subtle differences in key, well-conserved genes, or more widespread differences in 
divergent genes? Recent findings indicate that transcriptional regulator families are taxon-
specific, in contrast to, for instance, the transcription initiator complex that is well-conserved 
amongst eukaryotes [35]. As such, we speculate that the most divergent of genes amongst 
primates and mammals are those involved in aging. Interestingly, the most divergent protein in 
the mtDNA, as estimated by aa similarity, was MTATP8 both in our selection of animals and 
amongst primates. 
 If studying human aging in vivo is almost impossible, then studies in silico may succeed 
where experimental approaches have failed. For instance, finding the genomic information that 
makes baboons, rhesus macaques, or chimpanzees age twice as fast as humans would be a major 
breakthrough. With the prospect of having several fully sequenced mammalian genomes within 
the next few years--namely, human, mouse, rat, chimpanzee, rhesus macaque, cow, pig, and dog 
genomes (http://www.genome.gov/page.cfm?pageID=10002154)--comparative genomics is a 
powerful approach to study human aging. Our method and ARCT offer a basis for future 
research as comparative genomics will play a crucial role in understanding the genetic basis of 
human aging. 
 
Methods 
 
Measuring rate of aging and selection of model organisms 
 
 To measure a species’s rate of aging, two methods were used. Firstly, the mortality rate 
doubling time (MRDT) was calculated using the equation: 
α
 0.693   MRDT = . The α parameter 
derives from the Gompertz equation, Rm = R0eαt where Rm is the chance of dying at age t and R0 
is the non-exponential factor in mortality [1, 5]. For example, baboons age twice as fast as 
humans because the MRDT for humans is between 7.6 and 8.9 years and for baboons is between 
3.5 and 4.8 [7]. Although other mathematical models exist, due to frequent data limitations in 
studying animal aging and mammalian populations the Gompertz equation was preferred. 
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 Secondly, physiological observations were used based on a careful review of the 
literature. Rhesus macaques, for instance, exhibit age-related changes in the eyes that are similar 
to those of humans only about twice as fast and chimpanzees aged over 35 years display several 
age-related changes typical of elderly humans [5, 6]. 
 Metabolic rates were also considered, though these alone only explain the variation in 
rates of aging to a small extent [4]. Nonetheless, finding the metabolic basis of longevity 
determination may have medical applications. Uncovering what determines the progression of 
the genetic program--for instance, in caloric restriction-- may allow researchers to develop anti-
aging interventions [36]. 
 Evolutionary close species were preferred because their use increases the signal-to-noise 
ratio and the likelihood that these species share mechanisms regulating aging. Non-primate and 
non-mammalian species were also employed to allow the identification of functionally or 
regulatory relevant regions [37]. As an example, a selection of models that fit the criteria is 
presented in Table 2. The 27 species used in our analysis of the mtDNA were: Gorilla gorilla 
(NC_001645), Pongo pygmaeus (NC_001646), Pan troglodytes (NC_001643), Pan paniscus 
(NC_001644), Hylobates lar (NC_002082), Cebus albifrons (NC_002763), Macaca sylvanus 
(NC_002764), Homo sapiens (NC_001807), Balaenoptera musculus (NC_001601), 
Balaenoptera physalus (NC_001321), Loxodonta africana (NC_000934), Mus musculus 
(NC_005089), Ovis aries (NC_001941), Hippopotamus amphibius (NC_000889), Canis 
familiaris (NC_002008), Rattus norvegicus (NC_001665), Equus caballus (NC_001640), 
Isoodon macrourus (NC_002746), Didelphis virginiana (NC_001610), Chalinolobus 
tuberculatus (NC_002626), Artibeus jamaicensis (NC_002009), Chrysemys picta (NC_002073), 
Alligator mississippiensis (NC_001922), Falco peregrinus (NC_000878), Buteo buteo 
(NC_003128), Andrias davidianus (NC_004926), Xenopus laevis (NC_001573). 
 
Building phylogenetic profiles 
 
 The first step in building phylogenetic profiles was to identify the presence or absence of 
homologs across different species. Homologs of each human CDS were identified by searching 
multiple databases using BLAST. For comparisons between closely related species, BLAST is a 
reliable algorithm [38] and the loss of sensitivity is compensated by its speed [39]. 
 Mouse homologs were then analyzed. Since only less than 1% human genes fail to have 
an homolog in the mouse [17], a stringent threshold was used to identify hits, defined as human 
proteins lacking a functional equivalent in the mouse genome. One criterion was the 1:1 
Table 2: Suggested model organisms for studying aging at a genomic level. Last common 
ancestral represents estimates--often still under debate--of when a species and humans split, in 
millions of years ago (Mya). References: [5, 6, 7, 33, 48]. 
 
Species (last common 
ancestral) 
MRDT in years Observations 
   
Humans 7.6-8.9  
Chimpanzees (5.4 Mya) Similar to humans Our closest relatives, which age 
surprisingly faster than humans 
Other primates (23 Mya) 3.5-4.8 (baboons), 8 
(rhesus macaques) 
As with chimpanzees, some other 
primates appear to age about twice 
as fast as humans 
Mice and rats (91 Mya) 0.3 Two of the fastest aging mammals 
Bats (92 Mya) 3-8 Featuring a slow rate of aging for 
their size and metabolism 
Some common mammals 
from farm to domestic 
animals (92 Mya) 
3 (dog), 4 (horse), 1.5 
(sheep) 
 
Long-lived mammals such 
as elephants and whales 
(92 Mya)   
8 (elephants)  
Slowly aging reptiles (200 
Mya) 
Often no MRDT 
detected 
Since mammals evolved from 
slowly aging reptiles, it may be 
useful to research reptilian species 
Long-lived birds such as 
gulls, fulmars, or parrots 
(310 Mya) 
>6 Although evolutionary further from 
us than reptiles, birds share our high 
metabolic rates and might be useful 
in the study of human aging  
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ortholog, since only about 80% of human and murine genes are 1:1 orthologs [17]. In addition, 
other criteria were: global amino acid identity (i), aa conservation (c), 
sequencequery  oflength 
 sequencesboth between alignment  oflength  (l), or a combination of these criteria--e.g. il. 
Different criteria were used to obtain different distributions of putative functional related 
proteins for different thresholds (in the range 0.4 to 0.8 for each criterion), which allowed us to 
focus on the protein groups most divergent/convergent. Although ARCT was used to automate 
all these processes, each hit was manually confirmed by a comprehensive review of the 
literature. 
 
Algorithm for locating aging-related genomic regions 
 
For n sequences of the same protein from multiple organisms (Seq1, Seq2 . . . Seqn), a 
multiple alignment was generated: Alnall(Seq1 to Seqn). Alnall may include, for instance, animal 
species from different classes, only mammals, or only primates. For a given sub-group of 
organisms, a novel alignment was generated as well as an alignment of the reference sequences 
minus those in the sub-group, respectively: Alnqr(Seqx, Seqy, Seqz . . .) and Alnall-qr. There may 
be only one query sequence (e.g. a human sequence Seqh) in which case Seqh was used instead of 
Alnqr. 
 To find disrupted sequences, the algorithm first found mismatches between the query 
sequences Alnqr. The rationale being that if degeneration occurred, conservation would be absent 
in comparisons between sequences taken from animals of different families. Then non-conserved 
positions were matched against the non-conserved positions in Alnall-qr. A position conserved in 
Alnall-qr that is a mismatch in Alngr was assumed as a degenerate position in a functionally 
important region. 
 A complementary strategy was to find novel functional motifs. Conserved positions in 
Alnqr were compared with Alnall-qr. If these were not conserved in Alnall-qr or conserved but with 
a different residue or nucleotide, a novel functional motif was assumed to had evolved. If Alnqr 
are closely related or if there is only one query sequence, then only positions conserved in Alnall-
qr but with a different residue in Alnqr were assumed to be novel and functionally relevant; the 
rationale being that closely-related query sequences cannot be assumed to have novel functions 
unless these have been demonstrated to be functionally important. 
The algorithms used were the ClustalW 1.83 [40] multiple alignment algorithm and the 
motif sampling algorithm Gibbs [41] implemented through ARCT. 
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In general, the threshold for finding a disrupted residue was that it must be a mismatch in 
Alnqr but not in Alnall-qr and a single residue must be conserved in at least 30% of the sequences 
in Alnall-qr. Yet if the similarity of the query sequences is above 90%, then weak matches are also 
considered as mismatches in Alnqr. For finding novel functional residues, a sole residue must be 
in at least 60% of the query sequences, though adjustments for highly divergent or well-
conserved sequences are calculated. Since these are mostly arbitrary values, they may also be 
modified by the user. The novel residue found in Alnqr may not occur in more than 10% of the 
sequences in Alnall-qr. Finally, the strategy for investigating nucleotides is similar but a more 
stringent threshold is used since false positives are more likely to occur. Normally, a 20-30% 
adjustment is used, but that can be modified by the user. 
 
Studying transcriptional regulation 
 
 Position weight matrices were taken from TRANSFAC version 6.0 [42] to build a 
database of 23 transcription factors (TF) thought to be involved in aging: AP-1, AP-2, C/EBP, 
CRE-BP1/c-Jun, CREB, E2F, E47, Elk-1, HNF-3, HSF1, Max, MyoD, NF-AT, NF-κB, SRF, 
STAT1, STAT3, Sp1, TATA, c-Myb, c-Myc/Maxi, p300, p53. All these matrices are available 
on our website as well as a literature review of the importance of each. Included in ARCT are 
tools to search for the corresponding TFBS--the list is, of course, fully customizable.  
 The algorithm for finding putative TFBS involves a scoring system that gives a histogram 
of the TFBS found on each segment. For a given sequence of length l, there are 
100
l  thresholds, 
so the histogram only works for large sequences (l > 200). For each threshold, clusters are 
established according to the 
l
nTFBS  ratio being nTFBS the number of putative TFBS found. The 
threshold determines the size of the allowed clusters, so the histogram contains clusters of 
different sizes. The highest scoring cluster is then used as reference to normalize the others, 
which are drawn in different shades of blue. 
 
Aging Research Computational Tools (ARCT) 
  
 All programs were developed in Perl making use of the Bioperl [43] and TFBS [44] 
modules. Online programs were developed using the CGI module. The default criteria for a CpG 
145 
island is a 500-bp stretch of DNA with a C+G content of 55% and an 
CpG expected
CpG observed  in excess of 
0.65, as described in [45]. 
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Addendum: Estimation of false positives and possible solutions 
 
 The comparative genomics of aging has the major problem of trying to find subtle 
differences when the human genome has about three billion base pairs. Based on the size of the 
human, mouse, and chimpanzee genomes and their predicted nucleotide similarity [14, 17], we 
calculated the chances of finding false positives through comparative genomics depending on the 
length of the sequence and the similarity used as threshold (Figure 4A). Considering the three 
billion base pairs in the human genome, our results suggest that genome-wide comparisons 
between the human and chimpanzee genomes is bound to fail since even looking for sequences 
with 100% similarity we are likely to find false positives of over 300 base pairs. Even using a 
combination of the mouse and the chimpanzee genomes at a stringent threshold we are likely to 
find false positives if we search sequences below 100 base pairs. Besides, not only genetic 
information regulating aging is probably a small fraction of the genome but it is hidden amongst 
a variety of noises, and we are not strictly looking for conserved regions to identify function but 
rather to correlate the genomic information with rate of aging. It would require several 
mammalian genomes (>20) to find the information in question through genome-wide scans 
(Figure 4B). Therefore, we must refine our searches. 
 We can restrict our analysis to coding regions, which involve an estimated 60 million bp 
or 20 million amino acids [46]. Amino acid similarity between human and mouse proteins varies 
considerably and it may be possible to find trends correlating these changes with aging [17]. A 
similar approach is to search regulatory regions. These can be defined, for instance, as 2,000 bp 
upstream of genes since, although regulatory regions tend to be closer to the transcription start 
site, due to possible annotation errors it is recommended the use of a large range. Assuming 
30,000 human genes gives 60 million nucleotides, which, like searching through coding regions, 
greatly increases our data-mining odds. Obviously, our chances of finding false positives 
decrease if we are trying to find a needle in a smaller haystack. Interestingly, if we are looking 
for subtle genomic differences then primate genomes allow us to use a more stringent threshold 
and thus decrease the likelihood of false negatives but reference sequences from other mammals 
are also necessary to identify relevant regions. 
 Lastly, by taking into account our knowledge about aging, we can focus on pathways 
previously implicated in aging and derive specific hypothesis. Unbiased genome-wide screens 
may be possible when several mammalian genomes are available. At present, however, 
comparative genomics is more useful if used in a Bayesian context. 
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Figure 4: A: Probability of finding a false negative in the mouse (small lines) or chimpanzee 
genome (large lines) while searching for conserved sequences. Thresholds represent 
nucleotide similarity between the human and mouse (85, 95, and 100%) or human and 
chimpanzee (97 and 100%) genome. Nucleotide similarity was assumed to be 80% between 
the mouse and 95% between the chimpanzee and the human genome [14, 17]. These values 
represent overall genome comparisons and since specific genomic regions--e.g. coding 
regions--are not taken into consideration they should be seen as approximations to the real 
biological values. 
 B: Number of false positives according to sequenced genomes based on the probability 
of finding a 95% sequence match for genomes with three billion nucleotides with an average 
90% similarity with the human genome. Obviously, these are estimates of sequence similarity 
and so our results are approximations of the real biological values.  
 We employed the cumulative function of the binomial distribution, so that the chances 
represent the probability that there is a false positive of at least a given similarity. The 
probability (pseq) that a sequence of length (l) will be a certain threshold (thr) similar to its 
homologous sequence in another organism can be calculated using the binomial distribution 
[47]: mlmseq ddmml
lp −−



−= )1(!)!(
! in which m is the number of mutations, l(1 - thr), and d 
is the degeneracy or 1 minus the overall similarity between the two genomes. False positives 
can be estimated using the cumulative binomial distribution: ∑
=
=
m
m
seqseq pP
0
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Résumé 
 
La durée de vie humaine normale fait que les études gérontologiques doivent être basées sur des 
modèles comme des animaux et des cellules. La sénescence réplicative et la sénescence induite 
par les stress (SIPS) sont deux modèles cellulaires partageant de nombreuses caractéristiques 
communes. Bien que les télomères jouent un rôle majeur dans la sénescence réplicative, leur 
implication dans la SIPS n’est pas claire. 
 
Dans ce travail, nous voulons tout d’abord réfléchir sur la validité des modèles de vieillissement 
humain. Nous avons publié un nouveau modèle de l’évolution du vieillissement humain. Ce 
modèle offre une vue plus précise de l’évolution du vieillissement humain et suggère que les 
études sur modèles humains devraient être favorisées, bien que des études sur d’autres 
mammifères, des reptiles et des oiseaux peuvent s’avérer utiles. 
 
Deuxièmement, nous voulons élucider l’importance des télomères dans la SIPS et étudier 
l’expression génique des cellules en SIPS. Utilisant des fibroblastes humains immortalisés par la 
télomérase, nous n’avons trouvé aucune évidence que les dommages spécifiques aux télomères 
sont à l’origine de la SIPS.  Dans notre modèle publié, ni le TGF-β1, ni un raccourcissement 
critique des télomères ne semblent jouer un rôle crucial dans la SIPS. Nous suggérons que des 
dommages généralisés à l’ADN sont à l’origine de la SIPS et proposons un réarrangement dans 
les réseaux d’expression génique dû au stress. Nos travaux suggèrent aussi la plus grande 
prudence pour toute thérapie anti-vieillissement basée sur la télomérase. 
 
Enfin, nous avons publié des stratégies pour l’intégration des approches bioinformatiques en 
biogérontologie. Bien qu’une résolution du problème du vieillissement nous paraisse très 
éloignée, nous défendons qu’il sera possible d’identifier des génes-clés dans le vieillissement 
humain. 
